業績
2023年
英文掲載 (原著論文)
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, Imokawa S, Shirai M, Akahori D, Inoue Y, Mori K, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study. Thorax. 78(8):825-34, 2023
Aono Y, Suzuki Y, Horiguchi R, Inoue Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Mii S, Takahashi M, Suda T. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. Am J Respir Cell Mol Biol. 68(2):201-212, 2023
Enomoto N. Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice. Int. J. Mol. Sci. 23(23), 15027, 2022
Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, Aono Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Toyoshima M, Kono M, Imokawa S, Sano T, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Shirai M, Mori K, Masuda M, Fujisawa T, Inui N, Nakamura Y, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study. Respir Med.224:107577,2024
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023
Fujisawa T, Tanaka Y, Ikegami K. Analysis of motility and mucociliary function of tracheal epithelial cilia. Methods Cell Biol. 176:159-180, 2023
Fujisawa T, Akiyama N, Morita T, Koyauchi T, Matsuda Y, Mori M, Miyashita M, Tachikawa R, Tomii K, Tomioka H, Hagimoto S, Kondoh Y, Inoue Y, Suda T. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 28(7):659-68, 2023
Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy. Cancer Immunol Immunother. 72(8):2717-28, 2023
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer. J Cancer Res Clin Oncol. 149(7):2963-74, 2023
Inui N, Toi Y, Yoneshima Y, Morise M, Hata A, Kubota K, Saeki T, Tamura T. Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase. Adv Ther. 40(11):4928-4944, 2023
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study. J Immunother Cancer. 11(7):e007056, 2023
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. A predictive model for acute exacerbation of idiopathic interstitial pneumonias. Eur Respir J. 5;61(5):2201634, 2023
Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Funai K, Honda T, Misawa K, Miyake H, Takeuchi H, Inui N, Suda T. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy. Respir Res.10;25(1):25, 2024
Miyashita K, Hozumi H, Inoue Y, Suzuki T, Suda T. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan. Respir Investig. 61(3):364-70, 2023
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Karayama M, Suzuki Y, Fujisawa T, Enomoto N, Inui N, Ojima T, Suda T. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 12(1):2155250, 2023
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Suzuki Y, Karayama M, Enomoto N, Fujisawa T, Inui N, Ojima T, Suda T. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respir Res.21;25(1):95, 2024
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8):775-83, 2023
Naoi H, Suzuki Y, Miyagi A, Horiguchi R, Aono Y, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Mii S, Ichihara M, Takahashi M, Suda T. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. J Immunol.1;212(7):1221-1231,2024
Nihashi F, Furuhashi K, Horiguchi R, Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung. Allergol Int. 9:S1323-8930(24)00012-1,2024
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias.Respirology.3, 2023 (in press)
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias. Respirology. 29(2):136-145,2024
Suzuki Y, Fukada A, Mori K, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis. ERJ Open Res. 9;9(3):00749-2022, 2023
Suzuki Y, Tsukui H, Kawase A, Funai K, Suda T. Tracheal Lymphoid Follicular Hyperplasia Causing Airway Stenosis. Respir Endosc. 1(2):130-31, 2023
Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis. BMJ Open Respir Res. 10(1):e001763, 2023.
Takuma S, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Mori K, Shimizu M, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy. Respir Med.223:107542,2024
Tanaka Y, Suzuki Y, Saku A, Kono M, Hashimoto D, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Standardised 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford). 17, 2023 (in press)
Aono Y, Suzuki Y, Horiguchi R, Inoue Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Mii S, Takahashi M, Suda T. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. Am J Respir Cell Mol Biol. 68(2):201-212, 2023
Enomoto N. Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice. Int. J. Mol. Sci. 23(23), 15027, 2022
Enomoto N, Yazawa S, Mochizuka Y, Fukada A, Tanaka Y, Naoi H, Aono Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Toyoshima M, Kono M, Imokawa S, Sano T, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Shirai M, Mori K, Masuda M, Fujisawa T, Inui N, Nakamura Y, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study. Respir Med.224:107577,2024
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023
Fujisawa T, Tanaka Y, Ikegami K. Analysis of motility and mucociliary function of tracheal epithelial cilia. Methods Cell Biol. 176:159-180, 2023
Fujisawa T, Akiyama N, Morita T, Koyauchi T, Matsuda Y, Mori M, Miyashita M, Tachikawa R, Tomii K, Tomioka H, Hagimoto S, Kondoh Y, Inoue Y, Suda T. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists. Respirology. 28(7):659-68, 2023
Inoue Y, Inui N, Karayama M, Asada K, Fujii M, Matsuura S, Uto T, Hashimoto D, Matsui T, Ikeda M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy. Cancer Immunol Immunother. 72(8):2717-28, 2023
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer. J Cancer Res Clin Oncol. 149(7):2963-74, 2023
Inui N, Toi Y, Yoneshima Y, Morise M, Hata A, Kubota K, Saeki T, Tamura T. Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase. Adv Ther. 40(11):4928-4944, 2023
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Ikeda M, Matsuda H, Inami N, Kaida Y, Funayama S, Ichikawa S, Goshima S, Suda T. Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study. J Immunother Cancer. 11(7):e007056, 2023
Karayama M, Aoshima Y, Suzuki T, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. A predictive model for acute exacerbation of idiopathic interstitial pneumonias. Eur Respir J. 5;61(5):2201634, 2023
Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Funai K, Honda T, Misawa K, Miyake H, Takeuchi H, Inui N, Suda T. Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy. Respir Res.10;25(1):25, 2024
Miyashita K, Hozumi H, Inoue Y, Suzuki T, Suda T. Nationwide survey of adult patients with pulmonary alveolar proteinosis using the National Database of designated intractable diseases of Japan. Respir Investig. 61(3):364-70, 2023
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Karayama M, Suzuki Y, Fujisawa T, Enomoto N, Inui N, Ojima T, Suda T. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 12(1):2155250, 2023
Miyashita K, Hozumi H, Furuhashi K, Nakatani E, Inoue Y, Yasui H, Suzuki Y, Karayama M, Enomoto N, Fujisawa T, Inui N, Ojima T, Suda T. Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respir Res.21;25(1):95, 2024
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8):775-83, 2023
Naoi H, Suzuki Y, Miyagi A, Horiguchi R, Aono Y, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Mii S, Ichihara M, Takahashi M, Suda T. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling. J Immunol.1;212(7):1221-1231,2024
Nihashi F, Furuhashi K, Horiguchi R, Kitahara Y, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. CLEC10A expression defines functionally distinct subsets of conventional type 2 dendritic cells (cDC2) in the mouse lung. Allergol Int. 9:S1323-8930(24)00012-1,2024
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias.Respirology.3, 2023 (in press)
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, Kato S, Yokomura K, Kono M, Hashimoto D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Goshima S, Inui N, Suda T. Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias. Respirology. 29(2):136-145,2024
Suzuki Y, Fukada A, Mori K, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis. ERJ Open Res. 9;9(3):00749-2022, 2023
Suzuki Y, Tsukui H, Kawase A, Funai K, Suda T. Tracheal Lymphoid Follicular Hyperplasia Causing Airway Stenosis. Respir Endosc. 1(2):130-31, 2023
Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Neutrophil-lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis. BMJ Open Respir Res. 10(1):e001763, 2023.
Takuma S, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Mori K, Shimizu M, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Neutrophil-lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy. Respir Med.223:107542,2024
Tanaka Y, Suzuki Y, Saku A, Kono M, Hashimoto D, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Standardised 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford). 17, 2023 (in press)
英文掲載 (症例報告)
Mochizuka Y, Enomoto N, Akahori D, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Katsumata M, Hashimoto D, Imokawa S, Fujisawa T, Inui N, Nakamura Y, Tabata K, Johkoh T, Suda T. "Bull's-Eye" Sign and Its Longitudinal Change on HRCT in Pulmonary Sarcoidosis. Am J Respir Crit Care Med. 2023, in press
2022年
英文掲載 (原著論文)
Akahori D, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Suda T: Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice. Int J Mol Sci 23(16):8996, 2022.
Aono Y, Suzuki Y, Horiguchi R, Inoue Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Mii S, Takahashi M, Suda T: CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. Am J Respir Cell Mol Biol. 2022.
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, Imokawa S, Shirai M, Akahori D, Inoue Y, Mori K, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium aviumcomplex lung disease: a multicentre retrospective cohort study. Thorax thoraxjnl-2022-219116, 2022.
Aoshima Y, Enomoto Y, Fukada A, Kurita Y, Matsushima S, Meguro S, Kosugi I, Kawasaki H, Katsura H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Iwashita T: Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts. Am J Transl Res 13(11):12318-12337, 2021.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T: Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 77(2):143-153, 2022
Fujiwasa T, Tanaka Y, Ikegami K: Analysis of motility and mucocilicary function of tracheal epithelial cilla. Merhod in Cell Biology.
Fukada A, Suzuki Y, Mori K, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Tanaka Y, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Fujino Y, Nakamura H, Suda T: Idiopathic pleuroparenchymal fibroelastosis: 3-D CT assessment of upper lobe lung volume. Eur Respir J 2200637, 2022
Hozumi H, Kono M, Hasegawa H, Kato S, Inoue Y, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T: Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model. Respir Res 23(1):57, 2022.
Hozumi H, Kataoka K, Kondoh Y, Isayama T, Okada J, Sugiura K, Mori K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T: Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis. Chest 160(6):2149-2157, 2021
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T: Response. Chest 160(6):e683-e685, 2021.
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T: Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer. J Cancer Res Clin Oncol. 2022.
Karayama M, Inoue Y, Yoshimura K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy. J Immunother 45(2):125-131, 2022.
Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Suda T: Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 71(1):203-217, 2022
Katsumata M, Fujisawa T, Kamiya Y, Tanaka Y, Kamiya C, Inoue Y, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Maekawa M, Setou M, Watanabe H, Ikegami K, Suda T: Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium. BMC Pulm Med 22(1):186, 2022.
Koyauchi T, Niida H, Motegi A, Sakai S, Uchida C, Ohhata T, Iijima K, Yokoyama A, Suda T, Kitagawa M: Chromatin-remodeling factor BAZ1A/ACF1 targets UV damage sites in an MLL1-dependent manner to facilitate nucleotide excision repair. Biochim Biophys Acta Mol Cell Res 1869(11):119332, 2022.
Koyauchi T, Suzuki Y, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Suda T: Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians. Respir Investig 60(6):779-786, 2022.
Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T: Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study. Respir Res 23(1):79, 2022.
Mochizuka Y, Kono M, Katsumata M, Hirama R, Watanuki M, Oshima Y, Takeda K, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Enomoto N, Nakamura Y, Suda T, Nakamura H: Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis. Intern Med 61(3):395-400, 2022.
Nakayasu H, Shirai T, Hirai K, Suzuki T, Akamatsu T, Sakurai S, Asada K: Impaired cough-related quality of life in patients with nontuberculous mycobacteriosis. Respir Investig S2212-5345(22)00121-6, 2022.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T: Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis. Thorax 77(7):727-730, 2022.
Suda T, Kondoh Y, Hongo Y, Yoshida M, Hiroi S, Iwasaki K, Takeshima T, Homma S: Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis. Respir Investig 60(6):806-814, 2022.
Suzuki T, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis. BMC Pulm Med 22(1):290, 2022.
Suzuki Y, Aono Y, Akiyama N, Horiike Y, Naoi H, Horiguchi R, Shibata K, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma. Autophagy 18(9):2216-2228, 2022.
Tanaka Y, Suzuki Y, Hasegawa H, Yokomura K, Fukada A, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis. Respir Res 23(1):142, 2022.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T: Transient leukocytopenia following combination therapy for COVID-19. Respir Investig 60(1):158-161, 2022.
Tsuchiya K, Yoshimura K, Iwashita Y, Inoue Y, Ohta T, Watanabe H, Yamada H, Kawase A, Tanahashi M, Ogawa H, Funai K, Shinmura K, Suda T, Sugimura H: m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer. Cancer Gene Ther 29(10):1355-1372, 2022.
Watanabe H, Karayama M, Yasui H, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide. Cancer Treat Res Commun 29:100493, 2021.
Watanabe H, Shirai T, Hirai K, Akamatsu T, Nakayasu H, Tamura K, Masuda T, Takahashi S, Tanaka Y, Kishimoto Y, Oishi K, Saigusa M, Yamamoto A, Morita S, Asada K: Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients. J Asthma 59:1796-1804, 2022.
Aono Y, Suzuki Y, Horiguchi R, Inoue Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Mii S, Takahashi M, Suda T: CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation. Am J Respir Cell Mol Biol. 2022.
Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, Imokawa S, Shirai M, Akahori D, Inoue Y, Mori K, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium aviumcomplex lung disease: a multicentre retrospective cohort study. Thorax thoraxjnl-2022-219116, 2022.
Aoshima Y, Enomoto Y, Fukada A, Kurita Y, Matsushima S, Meguro S, Kosugi I, Kawasaki H, Katsura H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Iwashita T: Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts. Am J Transl Res 13(11):12318-12337, 2021.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T: Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 77(2):143-153, 2022
Fujiwasa T, Tanaka Y, Ikegami K: Analysis of motility and mucocilicary function of tracheal epithelial cilla. Merhod in Cell Biology.
Fukada A, Suzuki Y, Mori K, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, Tanaka Y, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Fujino Y, Nakamura H, Suda T: Idiopathic pleuroparenchymal fibroelastosis: 3-D CT assessment of upper lobe lung volume. Eur Respir J 2200637, 2022
Hozumi H, Kono M, Hasegawa H, Kato S, Inoue Y, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T: Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model. Respir Res 23(1):57, 2022.
Hozumi H, Kataoka K, Kondoh Y, Isayama T, Okada J, Sugiura K, Mori K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T: Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis. Chest 160(6):2149-2157, 2021
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T: Response. Chest 160(6):e683-e685, 2021.
Inoue Y, Inui N, Karayama M, Asada K, Matsuura S, Ikeda M, Uto T, Fujii M, Hashimoto D, Matsui T, Matsuda H, Inami N, Toyoshima M, Kaida Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Suda T: Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer. J Cancer Res Clin Oncol. 2022.
Karayama M, Inoue Y, Yoshimura K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy. J Immunother 45(2):125-131, 2022.
Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Suda T: Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 71(1):203-217, 2022
Katsumata M, Fujisawa T, Kamiya Y, Tanaka Y, Kamiya C, Inoue Y, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Maekawa M, Setou M, Watanabe H, Ikegami K, Suda T: Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium. BMC Pulm Med 22(1):186, 2022.
Koyauchi T, Niida H, Motegi A, Sakai S, Uchida C, Ohhata T, Iijima K, Yokoyama A, Suda T, Kitagawa M: Chromatin-remodeling factor BAZ1A/ACF1 targets UV damage sites in an MLL1-dependent manner to facilitate nucleotide excision repair. Biochim Biophys Acta Mol Cell Res 1869(11):119332, 2022.
Koyauchi T, Suzuki Y, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Suda T: Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians. Respir Investig 60(6):779-786, 2022.
Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T: Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study. Respir Res 23(1):79, 2022.
Mochizuka Y, Kono M, Katsumata M, Hirama R, Watanuki M, Oshima Y, Takeda K, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Enomoto N, Nakamura Y, Suda T, Nakamura H: Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis. Intern Med 61(3):395-400, 2022.
Nakayasu H, Shirai T, Hirai K, Suzuki T, Akamatsu T, Sakurai S, Asada K: Impaired cough-related quality of life in patients with nontuberculous mycobacteriosis. Respir Investig S2212-5345(22)00121-6, 2022.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T: Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis. Thorax 77(7):727-730, 2022.
Suda T, Kondoh Y, Hongo Y, Yoshida M, Hiroi S, Iwasaki K, Takeshima T, Homma S: Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis. Respir Investig 60(6):806-814, 2022.
Suzuki T, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis. BMC Pulm Med 22(1):290, 2022.
Suzuki Y, Aono Y, Akiyama N, Horiike Y, Naoi H, Horiguchi R, Shibata K, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma. Autophagy 18(9):2216-2228, 2022.
Tanaka Y, Suzuki Y, Hasegawa H, Yokomura K, Fukada A, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis. Respir Res 23(1):142, 2022.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T: Transient leukocytopenia following combination therapy for COVID-19. Respir Investig 60(1):158-161, 2022.
Tsuchiya K, Yoshimura K, Iwashita Y, Inoue Y, Ohta T, Watanabe H, Yamada H, Kawase A, Tanahashi M, Ogawa H, Funai K, Shinmura K, Suda T, Sugimura H: m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer. Cancer Gene Ther 29(10):1355-1372, 2022.
Watanabe H, Karayama M, Yasui H, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T: Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide. Cancer Treat Res Commun 29:100493, 2021.
Watanabe H, Shirai T, Hirai K, Akamatsu T, Nakayasu H, Tamura K, Masuda T, Takahashi S, Tanaka Y, Kishimoto Y, Oishi K, Saigusa M, Yamamoto A, Morita S, Asada K: Blood eosinophil count and FeNO to predict benralizumab effectiveness in real-life severe asthma patients. J Asthma 59:1796-1804, 2022.
英文掲載 (症例報告)
Arai K, Matsuda M, Nakayasu H, Meguro S, Kurokami T, Kubota A, Iwasaki T, Suzuki M, Kawaguchi S, Iwashita T: Nivolumab-induced liver injury with a steroid-refractory increase in biliary enzymes, in a patient with malignant mesothelioma: An autopsy case report. Clin Case Rep 9(12):e05174, 2021.
Endo Y, Inoue Y, Karayama M, Nagata Y, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report. JTO Clin Res Rep 3(1):100263, 2021.
Hirama R, Kono M, Kobayashi T, Oshima Y, Takeda K, Miyashita K, Miwa H, Tsutsumi A, Miki Y, Hashimoto D, Otsuki Y, Nakamura H: Intra-abdominal Hemorrhage due to Splenic Vein Aneurysm Rupture Caused by Invasive Aspergillosis During Treatment for Advanced Non-small-cell Lung Cancer.Intern Med. 2022 Jun 21.
Hiramatsu T, Murano M, Nakai S, Murakami Y, Nishimoto K, Matsushima S, Harada M, Uto T, Sato J, Imokawa S, Suda T: Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies. Respir Med Case Rep 36: 101606, 2021.
Ito Y, Miwa S, Hayakawa H, Oshima T, Eihuku T, Iwaizumi E, Ohba H, Fujita K, Kanai M, Shirai M: Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis. Respir Med Case Rep 39:101737, 2022.
Kawamura A, Tanaka Y, Inoue Y, Ysuchida T, Katsumata M, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, SudaT: EGFR-mutated, metastatic pulmonary pleomorphic carcinoma successfully treated with afatinib. Current Problems in Cancer: Case Reports 6: 100160, 2022.
Mochizuka Y, Fujisawa T, Inoue Y, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T: Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report. Respir Med Case Rep 37:101632, 2022.
Morikawa MM, Harada M, Kishimoto E, Suzuki K, Nakagawa E, Hiramatsu T, Nakai S, Murakami Y, Nishimoto K, Matsushima S, Uto T, Imokawa S: BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report. Medicine 101(39):e30806, 2022.
Takuma S, Inoue Y, Karayama M, Tsuchiya K, Tsukui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report. JTO Clin Res Rep 3(1):100264., 2021.
Watanabe H, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation. Respir Med Case Repv36:101608, 2022.
Endo Y, Inoue Y, Karayama M, Nagata Y, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report. JTO Clin Res Rep 3(1):100263, 2021.
Hirama R, Kono M, Kobayashi T, Oshima Y, Takeda K, Miyashita K, Miwa H, Tsutsumi A, Miki Y, Hashimoto D, Otsuki Y, Nakamura H: Intra-abdominal Hemorrhage due to Splenic Vein Aneurysm Rupture Caused by Invasive Aspergillosis During Treatment for Advanced Non-small-cell Lung Cancer.Intern Med. 2022 Jun 21.
Hiramatsu T, Murano M, Nakai S, Murakami Y, Nishimoto K, Matsushima S, Harada M, Uto T, Sato J, Imokawa S, Suda T: Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies. Respir Med Case Rep 36: 101606, 2021.
Ito Y, Miwa S, Hayakawa H, Oshima T, Eihuku T, Iwaizumi E, Ohba H, Fujita K, Kanai M, Shirai M: Antigen avoidance and environmental inhalation challenge for successful diagnosis of fibrotic hypersensitivity pneumonitis mimicking idiopathic pulmonary fibrosis. Respir Med Case Rep 39:101737, 2022.
Kawamura A, Tanaka Y, Inoue Y, Ysuchida T, Katsumata M, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, SudaT: EGFR-mutated, metastatic pulmonary pleomorphic carcinoma successfully treated with afatinib. Current Problems in Cancer: Case Reports 6: 100160, 2022.
Mochizuka Y, Fujisawa T, Inoue Y, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T: Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report. Respir Med Case Rep 37:101632, 2022.
Morikawa MM, Harada M, Kishimoto E, Suzuki K, Nakagawa E, Hiramatsu T, Nakai S, Murakami Y, Nishimoto K, Matsushima S, Uto T, Imokawa S: BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report. Medicine 101(39):e30806, 2022.
Takuma S, Inoue Y, Karayama M, Tsuchiya K, Tsukui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: EGFR-Mutated Lung Adenocarcinoma Successfully Treated With Osimertinib After Spontaneous Transformation to SCLC and Adenocarcinoma With Neuroendocrine Differentiation: Case Report. JTO Clin Res Rep 3(1):100264., 2021.
Watanabe H, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the BRAF mutation. Respir Med Case Repv36:101608, 2022.
2021年
英文掲載 (総説)
Fujisawa T：Management of Myositis-Associated Interstitial Lung Disease. Medicina (Kaunas) Apr 3;57(4):347, 2021.
英文掲載 (原著論文)
Aoshima Y, Enomoto Y, Muto S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T：Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis. Lung 199(3):289-98, 2021.
Aoshima Y, Karayama M, Horiike Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival. BMC Pulm Med 21(1):63, 2021.
Aoshima Y, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Mikamo M, Matsuura S, Kusagaya H, Kaida Y, Uto T, Hashimoto D, Matsui T, Asada K, Suda T：Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Invest New Drugs 39(1):210-6, 2021.
Akahori D, Inoue Y, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Suda T：Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas. Sci Rep 11(1):14999, 2021.
Enomoto N, Suzuki S, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Nakamura Y, Odagiri K, Ishikawa T, Kataoka K, Kondoh Y, Maekawa M, Inui N, Watanabe H, Suda T： Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension. Sci Rep 11(1):15502, 2021.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T：Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 216263, 2021.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial. Respirology 26(4):370-7, 2021.
Fujisawa T, Horiike Y, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Kataoka K, Hashisako M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias. Respir Res Nov 11;22(1):290, 2021.
Hozumi H, Kataoka K, Kondoh Y, Isayama T, Okada J, Sugiura K, Mori K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T：Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis. Chest S0012-3692(21)01317-9, 2021.
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T：Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis. Chest Jun;159(6):2334-2345, 2021.
Inoue Y, A Nikolic, D Farnsworth, R Shi, FD Johnson , A Liu , M Ladanyi , R Somwar , M Gallo , WW Lockwood：Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer. eLife 10: e66524, 2021.
Inoue Y, Suda T, Kitamura H, Okamoto M, Azuma A, Inase N, Kuwana M, Makino S, Nishioka Y, Ogura T, Takizawa A, Ugai H, Stowasser S, Schlenker-Herceg R, Takeuchi T：Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. Respir Med Oct;187:106574, 2021.
Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Suda T：Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 2021.
Karayama M, Aoshima Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray. Sci Rep 11(1):7669, 2021.
Karayama M, Inoue Y, Yoshimura K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy. J Immunother Oct 14, 2021.
Karayama M, Masuda J, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Maekawa M, Sugimura H, Takada A：Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer. Clin Transl Oncol Feb;23(2):418-423, 2021.
Koda K, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T：Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease. Sci Rep 11(1):1682, 2021.
Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M; joint committee of Japanese Respiratory Society and Japan College of Rheumatology：2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig Nov;59(6):709-740, 2021.
Kondoh Y, Kataoka K, Ando M, Awaya Y, Ichikado K, Kataoka M, Komase Y, Mineshita M, Ohno Y, Okamoto H, Ooki T, Tasaka Y, Tomioka H, Suda T：COVID-19 and acute exacerbation of interstitial lung disease. Respir Investig Sep;59(5):675-678, 2021.
Kono M, Miyashita K, Hirama R, Oshima Y, Takeda K, Mochizuka Y, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Suda T, Nakamura H : Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.Respir Med. 2021 Sep;186:106534. doi: 10.1016/j.rmed.2021.106534. Epub 2021 Jul 7.PMID: 34260978
Kono M, Nakamura Y, Enomoto Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Nakamura H, Suda T : Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis : Incidence, Clinical Features, and Risk Factors. Respiration 100(1):19-26, 2021
Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T：Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study. Thorax 76(3):248-55, 2021.
Miyashita K, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kono M, Matsui T, Niwa M, Koda K, Toyoshima M, Matsushima S, Matsuura S, Asada K, Fujii M, Kusagaya H, Matsuda H, Inui N, Suda T：Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis. BMC Pulm Med 21(1):309, 2021.
Miyashita K, Kono M, Saito G, Koyanagi Y, Tsutsumi A, Kobayashi T, Miki Y, Hashimoto D, Nakamura Y, Suda T, Nakamura H : Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis. Clin Respir J 15(3):336-44, 2020.
Miyashita K, Nakatani E, Hozumi H, Sato Y, Miyachi Y, Suda T：Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study. Open Forum Infect Dis 8(3):ofab068, 2021.
Naito Y, Enomoto N, Kameno Y, Yamasue H, Suda T, Hotta Y：Kessler Psychological Distress (K6) Questionnaire Scores Can Predict Autistic Traits and the Current and Prospective Suicidal Ideation in Medical University Students : A Prospective Study. SAGE Open : 1-10, 2021.
Nakamura Y, Mori K, Enomoto Y, Kono M, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Nakamura H, Hayakawa H, Suda T：Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes. J Clin Med Apr 4;10(7):1498, 2021.
Ota Y, Furuhashi K, Hirai N, Ishikawa J, Nagura O, Yamanaka K, Maekawa M. Evaluation of MBT STAR-Cepha and MBT STAR-Carba kits for the detection of extended-spectrum β-lactamases and carbapenemase producing microorganisms using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Microbiol Methods. 183: 106166, 2021.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan：Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J Jan 5;57(1):2000348, 2021.
Sakaue S, Yamaguchi E, Inoue Y, Takahashi M, Hirata J, Suzuki K, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Miyawaki S, Dofuku S, Maeda Y, Nii T, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Sonehara K, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Watanabe M, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Hizawa N, Mochizuki H, Kumanogoh A, Matsuda F, Nakata K, Hirota T, Tamari M, Okada Y：Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nat Commun Feb 15;12(1):1032, 2021.
Saku A, Fujisawa T, Nishimoto K, Yoshimura K, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease. Respir Med 182:106420, 2021.
Sakurai S, Furuhashi K, Horiguchi R, Nihashi F, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T：Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung. Allergol Int 70(3):351-9, 2021.
Suzuki T, Hozumi H, Miyashita K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Hasegawa H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Nakamura H, Suda T：Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study. Sci Rep 11(1):9120, 2021.
Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis. Sci Rep 11(1):18579, 2021.
Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study. BMC Pulm Med 21(1):221, 2021.
Suzuki Y, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy. Respirology 26(2):171-9, 2021.
Tahara M, Fujino Y, Yamasaki K, Oda K, Kido T, Sakamoto N, Kawanami T, Kataoka K, Egashira R, Hashisako M, Suzuki Y, Fujisawa T, Mukae H, Suda T, Yatera K：Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study. Respir Res Mar 12;22(1):80, 2021.
Takahashi S, Karayama M, Takahashi M, Watanabe J, Minami H, Yamamoto N, Kinoshita I, Lin CC, Im YH, Achiwa I, Kamiyama E, Okuda Y, Lee C, Bang YJ：Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors. Clin Cancer Res Aug 23, 2021.
Tanaka K, Enomoto N, Hozumi H, Isayama T, Naoi H, Aono Y, Katsumata M, Yasui H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T：Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis. Respir Investig S2212-5345(21)00089-7, 2021.
Tsuchiya K, Yoshimura K, Inoue Y, Iwashita Y, Yamada H, Kawase A, Watanabe T, Tanahashi M, Ogawa H, Funai K, Shinmura K, Suda T, Sugimura H：YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer. Oncoimmunology 10(1):1962656, 2021.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Transient leukocytopenia following combination therapy for COVID-19. Respir Investig Oct 9:S2212-5345(21)00162-3, 2021.
Ueda-Hayakawa I, Fujimoto M, Sato S, Murakami A, Kawakami A, Mishima M, Seishima M, Suda T, Takehara K, Mimori T, Kuwana M：Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort. J Dermatol Sci Jul;103(1):53-56, 2021.
Yamagata A, Arita M, Tachibana H, Tokioka F, Sugimoto C, Sumikawa H, Tanaka T, Yasui H, Fujisawa T, Nakamura Y, Suda T, Ishida T：Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res Apr 20;22(1):115, 2021.
Yamamoto S, Iihara H, Uozumi R, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige KI, Inui N：Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials. BMC Cancer 21(1):832, 2021.
Yoshimura K, Inoue Y, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Sugimura H, Suda T：MET Amplification and Efficacy of Nivolumab in Patients With NSCLC. JTO Clin Res Rep Oct 8;2(11):100239, 2021.
Aoshima Y, Karayama M, Horiike Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival. BMC Pulm Med 21(1):63, 2021.
Aoshima Y, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Mikamo M, Matsuura S, Kusagaya H, Kaida Y, Uto T, Hashimoto D, Matsui T, Asada K, Suda T：Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Invest New Drugs 39(1):210-6, 2021.
Akahori D, Inoue Y, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Suda T：Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas. Sci Rep 11(1):14999, 2021.
Enomoto N, Suzuki S, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Nakamura Y, Odagiri K, Ishikawa T, Kataoka K, Kondoh Y, Maekawa M, Inui N, Watanabe H, Suda T： Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension. Sci Rep 11(1):15502, 2021.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T：Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias. Thorax 216263, 2021.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial. Respirology 26(4):370-7, 2021.
Fujisawa T, Horiike Y, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Kataoka K, Hashisako M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias. Respir Res Nov 11;22(1):290, 2021.
Hozumi H, Kataoka K, Kondoh Y, Isayama T, Okada J, Sugiura K, Mori K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T：Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis. Chest S0012-3692(21)01317-9, 2021.
Hozumi H, Kono M, Hasegawa H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T：Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis. Chest Jun;159(6):2334-2345, 2021.
Inoue Y, A Nikolic, D Farnsworth, R Shi, FD Johnson , A Liu , M Ladanyi , R Somwar , M Gallo , WW Lockwood：Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer. eLife 10: e66524, 2021.
Inoue Y, Suda T, Kitamura H, Okamoto M, Azuma A, Inase N, Kuwana M, Makino S, Nishioka Y, Ogura T, Takizawa A, Ugai H, Stowasser S, Schlenker-Herceg R, Takeuchi T：Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. Respir Med Oct;187:106574, 2021.
Karayama M, Inui N, Inoue Y, Yoshimura K, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Suda T：Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer. Cancer Immunol Immunother 2021.
Karayama M, Aoshima Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray. Sci Rep 11(1):7669, 2021.
Karayama M, Inoue Y, Yoshimura K, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T：Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy. J Immunother Oct 14, 2021.
Karayama M, Masuda J, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T, Maekawa M, Sugimura H, Takada A：Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer. Clin Transl Oncol Feb;23(2):418-423, 2021.
Koda K, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T：Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease. Sci Rep 11(1):1682, 2021.
Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M; joint committee of Japanese Respiratory Society and Japan College of Rheumatology：2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig Nov;59(6):709-740, 2021.
Kondoh Y, Kataoka K, Ando M, Awaya Y, Ichikado K, Kataoka M, Komase Y, Mineshita M, Ohno Y, Okamoto H, Ooki T, Tasaka Y, Tomioka H, Suda T：COVID-19 and acute exacerbation of interstitial lung disease. Respir Investig Sep;59(5):675-678, 2021.
Kono M, Miyashita K, Hirama R, Oshima Y, Takeda K, Mochizuka Y, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Suda T, Nakamura H : Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.Respir Med. 2021 Sep;186:106534. doi: 10.1016/j.rmed.2021.106534. Epub 2021 Jul 7.PMID: 34260978
Kono M, Nakamura Y, Enomoto Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Nakamura H, Suda T : Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis : Incidence, Clinical Features, and Risk Factors. Respiration 100(1):19-26, 2021
Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T：Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study. Thorax 76(3):248-55, 2021.
Miyashita K, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kono M, Matsui T, Niwa M, Koda K, Toyoshima M, Matsushima S, Matsuura S, Asada K, Fujii M, Kusagaya H, Matsuda H, Inui N, Suda T：Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis. BMC Pulm Med 21(1):309, 2021.
Miyashita K, Kono M, Saito G, Koyanagi Y, Tsutsumi A, Kobayashi T, Miki Y, Hashimoto D, Nakamura Y, Suda T, Nakamura H : Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis. Clin Respir J 15(3):336-44, 2020.
Miyashita K, Nakatani E, Hozumi H, Sato Y, Miyachi Y, Suda T：Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study. Open Forum Infect Dis 8(3):ofab068, 2021.
Naito Y, Enomoto N, Kameno Y, Yamasue H, Suda T, Hotta Y：Kessler Psychological Distress (K6) Questionnaire Scores Can Predict Autistic Traits and the Current and Prospective Suicidal Ideation in Medical University Students : A Prospective Study. SAGE Open : 1-10, 2021.
Nakamura Y, Mori K, Enomoto Y, Kono M, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Nakamura H, Hayakawa H, Suda T：Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes. J Clin Med Apr 4;10(7):1498, 2021.
Ota Y, Furuhashi K, Hirai N, Ishikawa J, Nagura O, Yamanaka K, Maekawa M. Evaluation of MBT STAR-Cepha and MBT STAR-Carba kits for the detection of extended-spectrum β-lactamases and carbapenemase producing microorganisms using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Microbiol Methods. 183: 106166, 2021.
Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan：Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial. Eur Respir J Jan 5;57(1):2000348, 2021.
Sakaue S, Yamaguchi E, Inoue Y, Takahashi M, Hirata J, Suzuki K, Ito S, Arai T, Hirose M, Tanino Y, Nikaido T, Ichiwata T, Ohkouchi S, Hirano T, Takada T, Miyawaki S, Dofuku S, Maeda Y, Nii T, Kishikawa T, Ogawa K, Masuda T, Yamamoto K, Sonehara K, Tazawa R, Morimoto K, Takaki M, Konno S, Suzuki M, Tomii K, Nakagawa A, Handa T, Tanizawa K, Ishii H, Ishida M, Kato T, Takeda N, Yokomura K, Matsui T, Watanabe M, Inoue H, Imaizumi K, Goto Y, Kida H, Fujisawa T, Suda T, Yamada T, Satake Y, Ibata H, Hizawa N, Mochizuki H, Kumanogoh A, Matsuda F, Nakata K, Hirota T, Tamari M, Okada Y：Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nat Commun Feb 15;12(1):1032, 2021.
Saku A, Fujisawa T, Nishimoto K, Yoshimura K, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease. Respir Med 182:106420, 2021.
Sakurai S, Furuhashi K, Horiguchi R, Nihashi F, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T：Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung. Allergol Int 70(3):351-9, 2021.
Suzuki T, Hozumi H, Miyashita K, Kono M, Suzuki Y, Karayama M, Furuhashi K, Hasegawa H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Nakamura H, Suda T：Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study. Sci Rep 11(1):9120, 2021.
Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis. Sci Rep 11(1):18579, 2021.
Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study. BMC Pulm Med 21(1):221, 2021.
Suzuki Y, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T：Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy. Respirology 26(2):171-9, 2021.
Tahara M, Fujino Y, Yamasaki K, Oda K, Kido T, Sakamoto N, Kawanami T, Kataoka K, Egashira R, Hashisako M, Suzuki Y, Fujisawa T, Mukae H, Suda T, Yatera K：Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study. Respir Res Mar 12;22(1):80, 2021.
Takahashi S, Karayama M, Takahashi M, Watanabe J, Minami H, Yamamoto N, Kinoshita I, Lin CC, Im YH, Achiwa I, Kamiyama E, Okuda Y, Lee C, Bang YJ：Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors. Clin Cancer Res Aug 23, 2021.
Tanaka K, Enomoto N, Hozumi H, Isayama T, Naoi H, Aono Y, Katsumata M, Yasui H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T：Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis. Respir Investig S2212-5345(21)00089-7, 2021.
Tsuchiya K, Yoshimura K, Inoue Y, Iwashita Y, Yamada H, Kawase A, Watanabe T, Tanahashi M, Ogawa H, Funai K, Shinmura K, Suda T, Sugimura H：YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer. Oncoimmunology 10(1):1962656, 2021.
Tsuchiya K, Fujisawa T, Mochizuka Y, Takuma S, Oishi K, Endo Y, Tanaka Y, Fukada A, Watanabe H, Katsumata M, Aoshima Y, Inoue Y, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T：Transient leukocytopenia following combination therapy for COVID-19. Respir Investig Oct 9:S2212-5345(21)00162-3, 2021.
Ueda-Hayakawa I, Fujimoto M, Sato S, Murakami A, Kawakami A, Mishima M, Seishima M, Suda T, Takehara K, Mimori T, Kuwana M：Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort. J Dermatol Sci Jul;103(1):53-56, 2021.
Yamagata A, Arita M, Tachibana H, Tokioka F, Sugimoto C, Sumikawa H, Tanaka T, Yasui H, Fujisawa T, Nakamura Y, Suda T, Ishida T：Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res Apr 20;22(1):115, 2021.
Yamamoto S, Iihara H, Uozumi R, Kawazoe H, Tanaka K, Fujita Y, Abe M, Imai H, Karayama M, Hayasaki Y, Hirose C, Suda T, Nakamura K, Suzuki A, Ohno Y, Morishige KI, Inui N：Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials. BMC Cancer 21(1):832, 2021.
Yoshimura K, Inoue Y, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Sugimura H, Suda T：MET Amplification and Efficacy of Nivolumab in Patients With NSCLC. JTO Clin Res Rep Oct 8;2(11):100239, 2021.
英文掲載 (症例報告)
Koda K, Toyoshima M, Yazawa S, Fukada A, Sugimura H, Suda T. CD8-positive peripheral T cell lymphoma in a patient following long-term nivolumab for advanced lung adenocarcinoma: A case report. Thorac Cancer 12(11):1765-9, 2021.
Mochizuka Y, Kono M, Katsumata M, Hirama R, Watanuki M, Oshima Y, Takeda K, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Enomoto N, Nakamura Y, Suda T, Nakamura H :A Case of Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis. Intern Med. 2021 Jul 30.
Nakai S, Murano M, Hiramatsu T, Matsushima S, Uto T, Sato J, Imokawa S, Suda T. Multicentric Castleman disease with infiltration of eosinophils to the lung. Respir Med Case Rep 2021; 34: 101458.
Takuma S, Kusagaya H, Nakamura S, Mori R, Oyama Y, Ikeda M, Suda T: Systemic Air Embolism and Mediastinal Emphysema after Pneumonia. Am J Respir Crit Care Med. 2021; 204(1): 95-96
Yazawa S, Toyoshima M, Koda K, Suda T. Benralizumab as initial treatment for chronic eosinophilic pneumonia. Allergol Int 70(1):140-2.2021．
Mochizuka Y, Kono M, Katsumata M, Hirama R, Watanuki M, Oshima Y, Takeda K, Tsutsumi A, Miwa H, Miki Y, Hashimoto D, Enomoto N, Nakamura Y, Suda T, Nakamura H :A Case of Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis. Intern Med. 2021 Jul 30.
Nakai S, Murano M, Hiramatsu T, Matsushima S, Uto T, Sato J, Imokawa S, Suda T. Multicentric Castleman disease with infiltration of eosinophils to the lung. Respir Med Case Rep 2021; 34: 101458.
Takuma S, Kusagaya H, Nakamura S, Mori R, Oyama Y, Ikeda M, Suda T: Systemic Air Embolism and Mediastinal Emphysema after Pneumonia. Am J Respir Crit Care Med. 2021; 204(1): 95-96
Yazawa S, Toyoshima M, Koda K, Suda T. Benralizumab as initial treatment for chronic eosinophilic pneumonia. Allergol Int 70(1):140-2.2021．
2020年
英文掲載（原著）
- Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study. Thorax. 2021 Mar;76(3):248-255. doi: 10.1136/thoraxjnl-2020-215917. Epub 2020 Dec 9. PMID: 33298580.
- Miyashita K, Kono M, Saito G, Koyanagi Y, Tsutsumi A, Kobayashi T, Miki Y, Hashimoto D, Nakamura Y, Suda T, Nakamura H. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis. Clin Respir J. 2021 Mar;15(3):336-344. doi: 10.1111/crj.13304. Epub 2020 Dec 10. PMID: 33197284.
- Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial. Respirology. 2021 Apr;26(4):370-377. doi: 10.1111/resp.13978. Epub 2020 Nov 11. PMID: 33179395.
- Enomoto N, Sumikawa H, Sugiura H, Kitani M, Tanaka T, Hozumi H, Fujisawa T, Suda T. Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias. Respir Med. 2020 Nov-Dec;174:106201. doi: 10.1016/j.rmed.2020.106201. Epub 2020 Oct 21. PMID: 33120192.
- Kamiya Y, Fujisawa T, Katsumata M, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Setou M, Ito M, Suzuki T, Ikegami K, Suda T. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium. Respir Res. 2020 Oct 27;21(1):282. doi: 10.1186/s12931-020-01555-1. PMID: 33109186; PMCID: PMC7590254.
- Suzuki Y, Aono Y, Kono M, Hasegawa H, Yokomura K, Naoi H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy. Respirology. 2021 Feb;26(2):171-179. doi: 10.1111/resp.13943. Epub 2020 Sep 23. PMID: 32969124.
- Inoue Y, Yoshimura K, Nishimoto K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Asada K, Uto T, Fujii M, Matsui T, Matsuura S, Hashimoto D, Toyoshima M, Kusagaya H, Matsuda H, Inami N, Kaida Y, Niwa M, Ito Y, Sugimura H, Suda T. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer. JAMA Netw Open. 2020 Sep 1;3(9):e2011818. doi: 10.1001/jamanetworkopen.2020.11818. PMID: 32955570; PMCID: PMC7506518.
- Aono Y, Nakamura Y, Kono M, Nakamura H, Yokomura K, Imokawa S, Toyoshima M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620953783. doi: 10.1177/1753466620953783. PMID: 32928050; PMCID: PMC7495940.
- Suzuki Y, Fujisawa T, Sumikawa H, Tanaka T, Sugimoto C, Kono M, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis. Respir Med. 2020 Sep;171:106078. doi: 10.1016/j.rmed.2020.106078. Epub 2020 Jul 11. PMID: 32917352.
- Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, Kolek V, Benicka A, Yamane T, Shibuya E, Yoshino A, Isomoto A, Ota M, Yatsu K, Shijubo N, Nagai S, Yamaguchi E, Yamaguchi T, Namba K, Kaburaki T, Takase H, Morimoto SI, Hori J, Kono K, Goto H, Suda T, Ikushima S, Ando Y, Takenaka S, Takeuchi M, Yuasa T, Sugisaki K, Ohguro N, Hiraoka M, Kitaichi N, Sugiyama Y, Horita N, Asukata Y, Kawagoe T, Kimura I, Ishido M, Inoko H, Mochizuki M, Ohno S, Bahram S, Remmers EF, Kastner DL, Mizuki N. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis. Commun Biol. 2020 Aug 21;3(1):465. doi: 10.1038/s42003-020-01185-9. PMID: 32826979; PMCID: PMC7442816.
- Aoshima Y, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Mikamo M, Matsuura S, Kusagaya H, Kaida Y, Uto T, Hashimoto D, Matsui T, Asada K, Suda T. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Invest New Drugs. 2021 Feb;39(1):210-216. doi: 10.1007/s10637-020-00988-1. Epub 2020 Aug 17. PMID: 32803701.
- Tanaka K, Enomoto N, Uehara M, Furuhashi K, Sakurai S, Yasui H, Karayama M, Hozumi H, Suzuki Y, Fujisawa T, Inui N, Nakamura Y, Nagata T, Suda T. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium. Microbiol Immunol. 2020 Oct;64(10):666-678. doi: 10.1111/1348-0421.12836. Epub 2020 Oct 5. PMID: 32786043.
- Ito K, Murotani K, Kubo A, Kunii E, Taniguchi H, Shindoh J, Asada K, Imaizumi K, Takahashi K, Karayama M, Okuno M, Inui N, Hataji O, Morikawa S, Hayai S, Suda T, Abe T, Tsuda T, Yamagichi T, Kimura T, Oya Y, Yoshida T, Hida T. Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data. Cancer Sci. 2020 Oct;111(10):3705-3713. doi: 10.1111/cas.14560. Epub 2020 Aug 5. PMID: 32639668; PMCID: PMC7541013.
- Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Suda T. Pneumothorax in connective tissue disease-associated interstitial lung disease. PLoS One. 2020 Jul 7;15(7):e0235624. doi: 10.1371/journal.pone.0235624. PMID: 32634173; PMCID: PMC7340294.
- Enomoto N, Naoi H, Aono Y, Katsumata M, Horiike Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620935774. doi: 10.1177/1753466620935774. PMID: 32600180; PMCID: PMC7328360.
- Akiyama N, Fujisawa T, Morita T, Mori K, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View. J Pain Symptom Manage. 2020 Nov;60(5):933-940. doi: 10.1016/j.jpainsymman.2020.06.012. Epub 2020 Jun 20. PMID: 32569830.
- Nishimoto K, Niida H, Uchida C, Ohhata T, Kitagawa K, Motegi A, Suda T, Kitagawa M. HDAC3 Is Required for XPC Recruitment and Nucleotide Excision Repair of DNA Damage Induced by UV Irradiation. Mol Cancer Res. 2020 Sep;18(9):1367-1378. doi: 10.1158/1541-7786.MCR-20-0214. Epub 2020 Jun 11. PMID: 32527949.
- Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, Iwaizumi E, Oshima T, Kojima S, Suda T, Hayakawa H. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy. Respir Med. 2020 Aug;169:106025. doi: 10.1016/j.rmed.2020.106025. Epub 2020 May 15. PMID: 32442113.
- Yoshimura K, Suzuki Y, Inoue Y, Tsuchiya K, Karayama M, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Sugimura H, Suda T. CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer. Oncoimmunology. 2020 Apr 7;9(1):1746554. doi: 10.1080/2162402X.2020.1746554. PMID: 32395395; PMCID: PMC7204521.
- Yoshimura K, Saku A, Karayama M, Inui N, Sugimura H, Suda T. Leucine-Rich α2-Glycoprotein as a Potential Biomarker for Immune-related Colitis After Anti-PD-L1 Therapy: A Report of a Case Series. Clin Lung Cancer. 2020 Nov;21(6):e516-e522. doi: 10.1016/j.cllc.2020.04.005. Epub 2020 Apr 13. PMID: 32389505.
- Matsuda T, Suzuki Y, Fujisawa T, Suga Y, Saito N, Suda T, Yao I. Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice. Anal Bioanal Chem. 2020 Jul;412(18):4327-4341. doi: 10.1007/s00216-020-02670-0. Epub 2020 May 4. PMID: 32367293; PMCID: PMC7320054.
- Suzuki Y, Karayama M, Uto T, Fujii M, Matsui T, Asada K, Kusagaya H, Kato M, Matsuda H, Matsuura S, Toyoshima M, Mori K, Ito Y, Koyauchi T, Yasui H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study. J Thorac Oncol. 2020 Aug;15(8):1317-1327. doi: 10.1016/j.jtho.2020.04.002. Epub 2020 Apr 11. PMID: 32289515.
- Kishaba T, Hozumi H, Fujisawa T, Nei Y, Enomoto N, Sugiura H, Kitani M, Suda T. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis. Respir Investig. 2020 May;58(3):177-184. doi: 10.1016/j.resinv.2020.02.004. Epub 2020 Mar 20. PMID: 32205147.
- Karayama M, Yoshizawa N, Sugiyama M, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Goshima S, Suda T, Takehara Y. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer. Lung Cancer. 2020 May;143:47-54. doi: 10.1016/j.lungcan.2020.03.013. Epub 2020 Mar 18. PMID: 32203770.
- Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia. Sci Rep. 2020 Feb 19;10(1):3324. doi: 10.1038/s41598-020-58958-9. Erratum for: Sci Rep. 2019 Dec 10;9(1):18750. PMID: 32075990; PMCID: PMC7031333.
- Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327. PMID: 32046604; PMCID: PMC7016313.
- Matsushima S, Aoshima Y, Akamatsu T, Enomoto Y, Meguro S, Kosugi I, Kawasaki H, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Funai K, Suda T, Iwashita T. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes. BMC Pulm Med. 2020 Jan 21;20(1):21. doi: 10.1186/s12890-020-1054-9. PMID: 31964365; PMCID: PMC6975017.
- Yoshimura K, Inoue Y, Tsuchiya K, Karayama M, Yamada H, Iwashita Y, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H. Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer. Lung Cancer. 2020 Mar;141:21-31. doi: 10.1016/j.lungcan.2020.01.005. Epub 2020 Jan 7. PMID: 31931443.
- Kondoh Y, Azuma A, Inoue Y, Ogura T, Sakamoto S, Tsushima K, Johkoh T, Fujimoto K, Ichikado K, Matsuzawa Y, Saito T, Kishi K, Tomii K, Sakamoto N, Aoshima M, Araya J, Izumi S, Arita M, Abe M, Yamauchi H, Shindoh J, Suda T, Okamoto M, Ebina M, Yamada Y, Tohda Y, Kawamura T, Taguchi Y, Ishii H, Hashimoto N, Abe S, Taniguchi H, Tagawa J, Bessho K, Yamamori N, Homma S. Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial. Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC. PMID: 31917621.
英文掲載（症例報告）
- Harada M, Furuhashi K, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection. J Infect Chemother. 2021 Feb;27(2):373-378. doi: 10.1016/j.jiac.2020.09.031. Epub 2020 Oct 16. PMID: 33071037.
- Yazawa S, Toyoshima M, Koda K, Suda T. Benralizumab as initial treatment for chronic eosinophilic pneumonia. Allergol Int. 2021 Jan;70(1):140-142. doi: 10.1016/j.alit.2020.07.005. Epub 2020 Aug 14. PMID: 32807690.
- Murakami Y, Kitahara Y, Uto T, Sato J, Imokawa S, Suda T. Localized circumferential narrowed bronchial wall lesions in allergic bronchopulmonary aspergillosis. Respirol Case Rep. 2020 Jul 7;8(6):e00612. doi: 10.1002/rcr2.612. PMID: 32670585; PMCID: PMC7340868.
- Koda K, Toyoshima M, Nozue T, Suda T. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature. Intern Med. 2020 Aug 15;59(16):2015-2021. doi: 10.2169/internalmedicine.4275-19. Epub 2020 May 8. PMID: 32389943; PMCID: PMC7492107.
- Suzuki T, Enomoto N, Horiike Y, Asada K, Shirai T, Suda T. Longitudinal lung involvement of systemic lupus erythematosus-related vasculitis and alveolar proteinosis-like reaction. Respirol Case Rep. 2020 Apr 17;8(5):e00559. doi: 10.1002/rcr2.559. PMID: 32313654; PMCID: PMC7163719.
- Tsuchiya K, Sagisaka S, Suda T. Mediastinal Emphysema with Electrocardiogram Abnormality. Intern Med. 2020 Jul 15;59(14):1783-1784. doi: 10.2169/internalmedicine.4460-20. Epub 2020 Apr 23. PMID: 32321894; PMCID: PMC7434552.
- Koda K, Toyoshima M, Fukada A, Nozue T, Ishikawa R, Baba S, Sugimura H, Suda T. Pulmonary Malignant Peripheral Nerve Sheath Tumor in a Patient With Rheumatoid Arthritis-Associated Interstitial Pneumonia. JTO Clin Res Rep. 2020 Feb 11;1(2):100004. doi: 10.1016/j.jtocrr.2020.100004. PMID: 34589919; PMCID: PMC8474222.
- Nihashi F, Hiramatsu T, Uto T, Sato J, Imokawa S, Suda T. Endobronchial mucosal nodular lesions in allergic bronchopulmonary aspergillosis. Respir Med Case Rep. 2019 Dec 4;29:100975. doi: 10.1016/j.rmcr.2019.100975. PMID: 31886124; PMCID: PMC6921207.
- Watanabe H, Kitahara Y, Murakami Y, Nihashi F, Matsushima S, Eifuku T, Uto T, Sato J, Imokawa S, Suda T. Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy. Intern Med. 2020 Apr 1;59(7):987-990. doi: 10.2169/internalmedicine.3907-19. Epub 2019 Dec 13. PMID: 31839658; PMCID: PMC7184075.
- Kitahara Y, Murakami Y, Nakai S, Hiramatsu T, Kishimoto Y, Nihashi F, Aono Y, Eifuku T, Uto T, Sato J, Imokawa S, Suda T. Endobronchial Small-cell Lung Cancer with Intraluminal Growth Pattern Showing "Finger-in-glove" Appearance. Intern Med. 2020 Mar 1;59(5):701-704. doi: 10.2169/internalmedicine.3438-19. Epub 2019 Nov 8. PMID: 31708544; PMCID: PMC7086333.
2019年
英文掲載（著書）
- Toshihiro Shirai, ：Chapter 8. Clinical application of the forced oscillation technique (FOT)．Advances in asthma. Pathophysiology and treatment．2019.
英文掲載（総説）
- Suzuki Y, Suda T.：Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.. Allergol Int 68(4): 413-9, 2019.
英文掲載（原著）
- Akahori D, Suzuki Y, Yokomura K, Shirai M, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Hayakawa H, Suda T.：Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.. J Infect 79(4): 341-8, 2019.
- Akiyama N, Hozumi H, Isayama T, Okada J, Sugiura K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.：Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.. Respirology : , 2019.
- Akiyama N, Inui N, Mori K, Nakamura Y, Hayakawa H, Tanaka S, Uchida S, Namiki N, Watanabe H, Suda T.：Effect of rifampicin and clarithromycin on the CYP3A activity in patients with Mycobacterium avium complex.. J Thorac Dis 11(9): 3814-21, 2019.
- Akiyama N, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Uto T, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Suda T：Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.. Invest New Drugs 37(3): 531-7, 2019.
- Enomoto N, Egashira R, Tabata K, Hashisako M, Kitani M, Waseda Y, Ishizuka T, Watanabe S, Kasahara K, Izumi S, Shiraki A, Miyamoto A, Kishi K, Kishaba T, Sugimoto C, Inoue Y, Kataoka K, Kondoh Y, Tsuchiya Y, Baba T, Sugiura H, Tanaka T, Sumikawa H, Suda T.：Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.. Sci Rep 9(1): , 2019.
- Enomoto N, Oyama Y, Enomoto Y, Yasui H, Karayama M, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.：Differences in clinical features of acute interstitial pneumonia and idiopathic pulmonary fibrosis. Chron Respir Dis 16: , 2019.
- Enomoto N, Oyama Y, Yasui H, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T.：Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.. Sci Rep 9(1): , 2019.
- Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T, Inoue Y, Hasegawa Y, Inase N, Homma S, Suda T：Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion. . Eur Respir J 17: , 2019.
- Fujisawa T, Hozumi H, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.：Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.. J Rheumatol 46(8): 935-42, 2019.
- Furuhashi K, Fujisawa T, Hashimoto D, Kamiya Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T.：Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.. J Asthma Allergy 12: 253-61, 2019.
- Hashimoto T, Mogami H, Tsuriya D, Morita H, Sasaki S, Kumada T, Suzuki Y, Urano T, Oki Y, Suda T.：G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells.. PLoS One 14(9): , 2019.
- Hirai K, Shirai T, Rachi Y, Uehara S, Ueda M, Nakatani E, Itoh K：Impact of gene expression associated with glucocorticoid-induced transcript 1 (GLCCI1) on severe asthma and future exacerbation. Biol Pharm Bull 42: 1746-52, 2019.
- Hirai K, Shirai T, Suzuki Y, Shimmomura T, Itoh K：Compariosn of the association between circulating vitamin D3 levels and clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a prospective observational study. Biol Pharm Bull 42: 1861-6, 2019.
- Horiike Y, Suzuki Y, Fujisawa T, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Ogawa N, Suda T.：Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.. Rheumatology (Oxford) : , 2019.
- Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T.：Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.. J Rheumatol 15: , 2019.
- Hozumi H, Hasegawa H, Miyashita K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T. ：Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.. Respirology 25: , 2019.
- Kamiya C, Inui N, Hakamata A, Miyakawa S, Tanaka S, Uchida S, Namiki N, Odagiri K, Watanabe H.：Effect of co-administered inducer or inhibitor on omeprazole pharmacokinetics based on CYP2C19 genotype. J Pharmacol Sci 139(4): 361-6, 2019.
- Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Sumikawa H, Johkoh T, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T.：Prognostic factors for primary Sj gren's syndrome-associated interstitial lung diseases.. Respir Med 159: , 2019.
- Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T：Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.. Int J Chron Obstruct Pulmon Dis 14: 1333-42, 2019.
- Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T：Physiological and morphological differences of airways between COPD and asthma-COPD overlap.. Sci Rep 9(1): , 2019.
- Katayama N, Odagiri K, Hakamata A, Inui N, Yamauchi K, Watanabe H.：Transient Laterality of Cerebral Oxygenation Changes in Response to Head-of-Bed. J Clin Med 19(10): E1739, 2019.
- Katsumata M, Hozumi H, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T.：Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.. Respir Med 154: 102-8, 2019.
- Kono M, Fujita Y, Takeda K, Miyashita K, Tsutsumi A, Kobayashi T, Miki Y, Hashimoto D, Enomoto N, Nakamura Y, Suda T, Nakamura H：Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis. Respir Med 154: 122-6, 2019.
- Kono M, Nakamura Y, Enomoto N, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Kobayashi T, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Inui N, Suda T, Nakamura H：Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone. Respir Investig 57(6): 552-60, 2019.
- Miura M, Uchida S, Tanaka S, Inui N, Kawakami J, Watanabe H, Namiki N.：The Prediction of the Area under the Curve and Clearance of Midazolam from Single-Point Plasma Concentration and Urinary Excretion in Healthy Volunteers.. Biol Pharm Bull 42(9): 1590-5, 2019.
- Ota Y, Furuhashi K, Nagao T, Nanba T, Yamanaka K, Ishikawa J, Nagura O, Iwaizumi M, Hamada E, Maekawa M：Detection of extended-spectrum β-lactamases producing Enterobacteriaceae using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry based MBT STAR-BL software module with β-lactamase inhibition assay depends on the bacterial strains.. J Microbiol Methods 167: 105734, 2019.
- Ota Y, Furuhashi K, Nanba T, Yamanaka K, Ishikawa J, Nagura O, Hamada E, Maekawa M：A rapid and simple detection method for phenotypic antimicrobial resistance in Escherichia coli by loop-mediated isothermal amplification.. J Med Microbiol 68(2): 169-77, 2019.
- Ozawa Y, Amano Y, Kanata K, Hasegwa H, Matsui T, Kakutani T, Koyauchi T,Tanahashi M, Niwa H, Yokomura K, Suda T：Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer. Med Oncol 36(4): 33, 2019.
- Saigusa M, Asada K, Akamatsu T, Tanaka Y, Endo Y, Yamamoto A, Morita S, Shirai T：Forced oscillation technique may identify severe asthma. J Allergy Clin Immunol Pract 42: 52-6, 2019.
- Satake Y, Furuhashi K, Yasui H, Karayama K, Suzuki Y, Hozumi H, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Imokawa S, Yokomura K, Hayakawa H, Harada M, Koshimizu N, Suda T：Intravenous to oral levofloxacin switch therapy in patients with moderate community-acquired pneumonia; a pilot study.. 新薬と臨牀 68: 1519-31, 2019.
- Shinmura K, Kato H, Kawanishi Y, Goto M, Tao H, Yoshimura K, Nakamura S, Misawa K, Sugimura H：Defective repair capacity of variant proteins of the DNA glycosylase NTHL1 for 5-hydroxyuracil, an oxidation product of cytosine. Free Radic Biol Med 131: 264-73, 2019.
- Shinmura K, Kato H, Kawanishi Y, Yoshimura K, Tsuchiya K, Takahara Y, Hosokawa S, Kawase A, Funai K, Sugimura H：POLQ Overexpression Is Associated with an Increased Somatic Mutation Load and PLK4 Overexpression in Lung Adenocarcinoma. Cancers (Basel) 11(5): , 2019.
- Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Holweg C, Itoh K, Inoue H, Hashimoto S：Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol Pract 7: 134-45, 2019.
- Shirai T, Hirai K, Gon Y, Maruoka S, Mizumura K, Hikichi M, Itoh K, Hashimoto S：Forced oscillation technique may identify asthma-COPD overlap. Allergol Int 68: 385-7, 2019.
- Sotoyama M, Uchida S, Kamiya C, Tanaka S, Kashiwagura Y, Hakamata A, Odagiri K, Inui N, Watanabe H, Namiki N：Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.. Chem Pharm Bull 67(6): 540-5, 2019.
- Sugawara S, Inui N, Kanehara M, Morise M, Yoshimori K, Kumagai T, Fukui T, Minato K, Iwashima A, Takeda Y, Kubota K, Saeki T, Tamura T.：Multicenter,placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea vand vomiting in patients receiving highly emetogenic chemotherapy. . Cancer 125(22): 4076-83, 2019.
- Sugimura H, Yoshimura K：Lymph node metastasis matters. J Thorac Dis 11: 331-3, 2019.
- Suzuki T, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Saigusa M, Akamatsu T, Yamamoto A, Morita S, Asada K, Shirai T：Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis. Respir Investig 57: 252-9, 2019.
- Suzuki Y, Inui N, Karayama M, Imokawa S, Yamada T, Yokomura K, Asada K, Kusagaya H, Kaida Y, Matsuda H, Koshimizu N, Toyoshima M, Masuda M, Hayakawa H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Suda T.：Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.. Int J Chron Obstruct Pulmon Dis 21(14): 1867-77, 2019.
- Takano H,, Uchida S, Kashiwagura Y, Tanaka S, Hakamata A, Odagiri K, Inui N, Watanabe H, Namiki N：Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.. Chem Pharm Bull 67(2): 112-9, 2019.
- Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T.：Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.. Cancer Chemother Pharmacol 84(1): 147-53, 2019.
- Watanabe H, Shirai T, Akamatsu T, Asada K, Hirai K：Forced oscillatory parameters in reversibility testing as predictors for chronic cough responsive to inhaled corticosteroid/long-acting β2 agonist. Ann Allergy Asthma Immunol 122: 345-6, 2019.
- Watanabe K, Ishii H, Kiyomi F, Terasaki Y, Hebisawa A, Kawabata Y, Johkoh T, Sakai F, Kondoh Y, Inoue Y, Azuma A, Suda T, Ogura T, Inase N, Homma S; Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases in Japan.：Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.. Respir Investig 57(4): 312-20, 2019.
- Yasui H, Inui N, Karayama M, Mori K, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T：Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.．．、2019、76-80.
- Yoshimura K, Inoue Y, Karayama M, Tsuchiya K, Mori K, Suzuki Y, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Yokomura K, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H.：Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.. Lung Cancer 134: 202-9, 2019.
- Maazi H, Hartiala J, Suzuki Y, Crow A, Jahani PS, Lam J, Patel N, Rigas D, Han Y, Huang P, Eskin E, Lusis AJ, Gilliland FD, Akbari O, Allayee H：A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity. Plos Genetics : , 2019.
- Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T：Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia. Sci Rep : , 2019.
英文掲載（症例報告）
- Fukada A, Toyoshima M, Nozue T, Suda T.：Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature - Reply.. Intern Med 58(23): 3499, 2019.
- Karayama M, Aoshima Y, Sagisaka S, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T.：Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should be Treated with Low-dose Prednisolone During Pembrolizumab Therapy: The Author's Reply.. Intern Med : , 2019.
- Kitahara Y, Murakami Y, Nakai S, Hiramatsu T, Kishimoto Y, Nihashi F, Aono Y, Eifuku T, Uto T, Sato J, Imokawa S, Suda T：Endobronchial Small-cell Lung Cancer with Intraluminal Growth Pattern Showing "Finger-in-glove" Appearance. Intern Med 58: , 2019.
- Aoshima Y, Karayama M, Sagisaka S, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T：Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.. Intern Med : , 2019.
- Fukada A, Toyoshima M, Nozue T, Suda T.：Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature.. Intern Med 58(15): 2207-11, 2019.
- Harada M, Aono Y, Yasui H, Uto T, Sato J, Imokawa S, Suzuki S, Tanioka F, Suda T.：Minute Pulmonary Meningothelial-like Nodules Showing Multiple Ring-shaped Opacities.. Intern Med 58: 3149-52, 2019.
- Harada M, Imokawa S, Miwa S, Nihashi F, Aono Y, Amano Y, Uto T, Sato J, Suda T.：Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis.. Oxf Med Case Reports 2: , 2019.
- Mochizuki E, Matsuura S, Kubota T, Mochizuka Y, Oishi K, Naoi H, Uehara M, Mikura S, Nagaoka M, Tsukui M, Koshimizu N, Nameki I：Sinobronchial allergic mycosis syndrome in an elderly male. Allergy Asthma Clin Immunol 15(35): , 2019.
- Nakayasu H, Shirai T, Tanaka Y, Muro H：Neurosarcoidosis presenting with obstructive hydrocephalus successfully treated with endoscopic third ventriculostomy. Intern Med 58: 105-10, 2019.
- Nozue T, Toyoshima M, Fukada A, Suda T.：Anti-Jo-1 Antibody-positive Interstitial Pneumonia in an Elderly Patient with Congenital Rubella Syndrome.. Intern Med 58(14): 2063-66, 2019.
- Tanaka Y, Matubara O, Muramatsu A, Suzuki M, Shirai T：Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: an autopsy case study. Respir Med Case Rep 28: , 2019.
- Tanaka Y, Shirai T, Asada K, Muramatsu A, Katsumata M, Suda T：Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis. Clin Case Rep 7: 731-4, 2019.
- Tsuchiya K, Karayama M, Sato T, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sugimura H, Yasuda H, Suda T：Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.. Intern Med : , 2019.
- Tsuchiya K, Suzuki Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Baba S, Suda T.：Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.. Am J Respir Crit Care Med 199(8): 1031-3, 2019.
- Nihashi F, Hiramatsu T, Uto T, Sato J, Imokawa S, Suda T：Endobronchial mucosal nodular lesions in allergic bronchopulmonary aspergillosis. Respir Med Case Rep 29: , 2019.
和文掲載（著書）
- 古橋一樹, 前川真人：4章各腫瘍での臨床検査の使い方 4.肺癌．がんの臨床検査ハンドブック．、2019、162-8.
- 佐藤篤彦, 須田隆文：全身性疾患・他臓器疾患に伴う呼吸器障害 サルコイドーシス、Langerhans細胞組織球症．内科学書 改訂第9版 vol.2．中山書店、2019、553-9.
- 須田隆文, ：間質性肺疾患 非特異性間質性肺炎（NSIP）．呼吸器疾患最新の治療2019-2020．南江堂、2019、312-5.
和文掲載（総説）
- 横村光司, ：【既存のガイドラインを透析患者にどう活用するか】肺炎(解説/特集). 臨床透析 35(8): 1017-23, 2019.
- 安井秀樹, 須田隆文：成人喘息におけるロイコトリエン受容体拮抗薬（LTRA）と長時間作用性抗コリン薬（LAMA）の有用性. アレルギーの臨床 38(514): 94-98, 2018.
- 榎本紀之, 須田隆文：特発性間質性肺炎：臨床診断の現状と課題 IPAFを考える. 呼吸器内科 36(2): 137-42, 2019.
- 榎本紀之, 須田隆文：IPAFは全身疾患であるか？. 呼吸器内科 36(6): 563-7, 2019.
- 中村祐太郎, 須田隆文：生物学的製剤と呼吸器疾患. 内科 124(1): 1471－4, 2019.
- 中村祐太郎, ：特発性肺線維症の新たなガイドラインについて. 臨床画像 35(7): 826－9, 2019.
- 平井啓太, 白井敏博，伊藤邦彦：成人喘息における増悪発現予測バイオマーカー. アレルギー 68: 942-7, 2019.
- 穗積宏尚, 須田隆文：膠原病関連びまん性肺疾患. 臨床と研究 96(10): 1189-97, 2019.
- 白井敏博, ：4.最新の気管支喘息治療戦略 ②GINA2019改訂のポイント 気管支喘息―最新の戦略的・継続的マネジメント―. 薬局 70: 32-7, 2019.
- 白井敏博, ：アレルギー検査の最新情報 重症喘息における気流閉塞. アレルギーの臨床 39: 720-3, 2019.
- 白井敏博, ：喘息診療における強制オシレーション法の有用性. Medical Practice 12: 1883-5, 2019.
- 白井敏博, ：喘息診療Update 2019 モストグラフを喘息診療でどう使うか. Pharma Medica 37: 37-40, 2019.
和文掲載（原著）
- 太田悠介, 古橋一樹, 長尾侑紀, 山中勝正, 濱田悦子, 前川真人：全自動尿中有形成分分析装置UF-5000によるEscherichia coliを対象とした迅速な薬剤感受性検査法の構築. 臨床病理 67: 569-76, 2019.
和文掲載（研究報告）
- 藤澤朋幸, 近藤康博, 稲瀬直彦, 福岡順也, 小倉高志, 上甲剛, 井上義一, 長谷川好規, 本間栄, 須田隆文：特発性間質性肺炎におけるクラウド型臨床・画像・病理統合データベースを用いた遠隔MDDの有用性. 分子呼吸器病 24(1): 66-69, 2020.
和文掲載（症例報告）
- 角谷 拓哉, 横村 光司, 明石 拓郎, 矢澤 秀介, 杉山 未紗, 金田 桂, 天野 雄介, 長谷川 浩嗣, 松井 隆, 須田 隆文：非結核性抗酸菌感染症疑いの気管支鏡検査で同菌が検出されなかった症例の経過について. 日本呼吸器学会誌 8(2): 91-6, 2019.
- 幸田 敬悟, 横村 光司, 後藤 彩乃, 赤堀 大介, 小谷内 敬史, 佐藤 慈子, 長谷川 浩嗣, 小澤 雄一, 松井 隆, 須田 隆文：気管支腔内超音波断層法(EBUS)で病変を観察した孤立性末梢性肺動脈瘤の1例. 気管支学 40(6): 596-600, 2018.
- 清水真也, 足立史郎，後藤康洋，伊藤茂樹，嶋野祐之，長瀬通隆，伊藤雅文，伊藤藍，吉富淳，春田純一，坂上祐司，鋪野紀好，須永眞司：CPC～何が起きていたのか？最終病理診断からのメッセージ～ 肺野病変，多発リンパ節腫脹，肺高血圧を伴い呼吸不全で死亡した1例. 日本内科学会雑誌 108(9): 1985-2004, 2019.
- 赤堀 大介, 横村 光司, 金田 桂, 後藤 彩乃, 小谷内 敬史, 天野 雄介, 角谷 拓哉, 須田 隆文：特発性脊柱側彎症による気道狭窄に対して胸椎後方矯正固定術が有効であった1例. 気管支学 41(2): 117-2, 2019.
- 大山吉幸, 森利枝，中村匠吾，田熊翔，池田政輝，草ヶ谷英樹：難治性気瘻に対しEWS（Endobronchial Watanabe Spigot）と自己血癒着の併用が有効であった有瘻性膿胸の一例. 気管支学 : , 2019.
- 田熊翔, 草ヶ谷英樹，中村匠吾，森利枝，大山吉幸，池田政輝：鼻中隔生検により診断に至った気管支壁肥厚を呈するIgG4関連疾患の1例. 気管支学 : , 2019.
- 田熊翔, 中村匠吾，森利枝，大山吉幸，池田政輝，草ヶ谷英樹：ペムブロリズマブによる感染後器質化肺炎増悪を来した1例. 肺癌 : , 2019.
- 深田充輝, 豊嶋幹生：シリーズ：一目瞭然！目で診る症例．日本内科学会雑誌. 日本内科学会雑誌 108(7): 1475-7, 2019.
- 穗積宏尚, 須田隆文：皮疹とともに進行性の呼吸困難・胸部異常陰影を呈した1例. 内科 123(4): 511-2, 2019.
- 吉富淳, 春田純一，北川順一，榛葉誠，中村一平，中村真潮，鈴木大介，森田浩之：診断に苦慮した症例. 日本内科学会雑誌 108(4): 805-10, 2019.
2018年
英文掲載（著書）
Takafumi Suda. Pulmonary Fibrosis: Hereditary and Non-hereditary- What are the Role of Genetic Factors in Pathogenesis of Pulmonary Fibrosis? Clinical Relevance of genetic factors I Pulmonary Disease. Springer 107-133, 2018.
英文掲載（総説）
- Suzuki Y, Suda T: Long-term management and persistent impairment of pulmonary function in chronic eosinophilic pneumonia: A review of the previous literature. Allergol Int. 23. (17), 2018.
- Takafumi Suda : Terapeutic Strategies for interstitial lung Diseases in Rheumatoid Arthritis. Lung Diseases Associated with Rheumatoid Arthritis.141-148, 2018.
英文掲載（原著）
- Akamatsu T, Shirai T, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Suzuki T, Noguchi R, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K. Usefulness of fractional exhaled nitric oxide-guided treatment in patients with asthma-COPD overlap. Open J Respir Dis 8:1-12. 2018.
- Enomoto N, Oyama Y, Enomoto Y, Mikamo M, Karayama M, Hozumi H, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis. Clin Respir J. 12(8):2378-2389, 2018.
- Enomoto N, Oyama Y, Enomoto Y, Yasui H, Karayama M, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. Chron Respir Dis. Jan-Dec;16, 2019
- Enomoto Y, Matsushima S, Shibata K, Aoshima Y, Yagi H, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T : LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis. Clin Sci (Lond). 31;132(14):1565-80, 2018.
- Enomoto Y, Oyama Y, Enomoto N, Yasui H, Karayama M, Kono M, Hozumi H, Suzuki Enomoto Y, Matsushima S, Meguro S, Kawasaki H, Kosugi I, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T, Iwashita T : Podoplanin-positive myofibroblasts: a pathological hallmark of pleuroparenchymal fibroelastosis.: Histopathology. 2018.
- Hirai K, Shirai T, Suzuki M, Itoh K. Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations. J Allergy Clin Immunol 142:663-5. 2018.
- Hozumi H, Oyama Y, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Suda T : Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. PLoS One. 21;13(6):e0199659, 2018.
- Imatoh T, Sai K, Takeyama M, Hori K, Karayama M, Furuhashi K, Segawa K, Kimura M, Kawakami J, Saito Y. Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia. J Clin Pharm Ther. 2018.
- Inoue Y, Matsuura S, Yoshimura K, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Maeda M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H. Characterization of V-set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cells. Cancer Sci. 108(8):1701-1714, 2017.
- Ishihara T, Yamada K, Harada A, Yukiue H, Tanahashi M, Niwa H, Matsui T, Yokomura K, Ejima Y, Sasaki R: Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratoryfunction. Acta Oncol57(9):1232-9, 2018.
- Ishii H, Watanabe K, Kushima H, Baba T, Watanabe S, Yamada Y, Arai T, Tsushima K, Kondoh Y, Nakamura Y, Terasaki Y, Hebisawa A, Johkoh T, Sakai F, Takemura T, Kawabata Y, Ogura T; Tokyo Diffuse Lung Disease Study Group. Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan. Respir Med. 141: 190-7, 2018 .
- Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T : Respiratory impedance is correlated with airway narrowing in asthma using three-dimensional computed tomography. Clin Exp Allergy.48(3):278-287, 2018.
- Karayama M, Inui N, Tanaka K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Suda T. Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis. Med Oncol. 35: 139, 2018.
- Kato S, Inui N, Hakamata A, Suzuki Y, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T : Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis. Respir Res. 26;19(1):127, 2018.
- Kato S, Inui N, Hozumi H, Inoue Y, Yasui H, Karayama M, Kono M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T : Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis. Respir Med. 138S:S20-3, 2018.
- Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Shintani A, Fujisawa T, Suda T, Arita M, Baba T, Ichikado K, Inoue Y, Kishi K, Kishaba T, Nishiyama O, Ogura T, Tomii K, Homma S: Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy. PLoS One. 13(3) 2018.
- Koyauchi T, Hasegawa H, Kanata K, Kakutani T, Amano Y, Ozawa Y, Matsui T, Yokomura K, Suda T: Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study. Respiration 96(4):323-9, 2018.
- Lee DCP, Tay NQ, Thian M, Prabhu N, Furuhashi K, Kemeny DM. Prior exposure to inhaled allergen enhances anti-viral immunity and T cell priming by dendritic cells. Plos One. 13: e0190063, 2018.
- Mikamo M, Kitagawa K, Sakai S, Uchida C, Ohhata T, Nishimoto K, Niida H, Suzuki S, Nakayama KI, Inui N, Suda T, Kitagawa M : Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis. Int J Mol Sci. 6;19(2), 2018.
- Mochizuki E, Matsuura S, Oishi K, Miyashita K, Ichijyo K, Furukawa S, Nagaoka M, Mikura S, Tsukui M, Koshimizu N, Sakurai S, Asada K, Shirai T. Surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung. World J Surg Oncol. 16(1): 33, 2018.
- Nishimoto K, Fujisawa 1, Yoshimura 1, Enomoto 1, Enomoto 1, Nakamura 1, Inui N, Sumikawa H, Johkoh T, Colby TV, Suda T. The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis.Respirology. 23(5):519-525, 2018.
- Nishimoto K, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Imokawa S, Suda T. Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study. Med Oncol. 16;35(7):108, 2018.
- Niwa M, Fujisawa T, Karayama M, Furuhashi K, Mori K, Hashimoto D, Yasui H, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suzuki T, Maekawa M, Suda T : Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma-chronic obstructive pulmonary disease overlap. Ann Allergy Asthma Immunol. S1081-1206(18)30666-5, 2018.
- Niwa M, Fujisawa T, Mori K, Yamanaka K, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suzuki T, Maekawa M, Suda T : IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium. J Immunol. 15;201(8):2392-2402, 2018.
- Ozawa Y, Koda K, Akahori D, Matsui T, Hasegawa H, Kakutani T, Amano T, Tanahashi M, Niwa H, Kunimoto Y, Yamada K, Yokomura K, Suda T: Preexisting Interstitial Lung Disease and Lung Injury Associated with Irinotecan in Patients with Neoplasms. Anticancer Res 38(10):5937-41, 2018.
- Shirai T. Is R5-R20 a marker of small airway function? Respir Investig 56:199-200. 2018
- Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shirai T, Hayakawa H, Suda T. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis. Sci Rep. 8(1):13129, 2018.
- Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci Rep. 8:14074, 2018. Yamanaka K, Fujisawa T, Kusagaya H, Mori K, Niwa M, Furuhashi K, Kono M, Hamada E, Suda T, Maekawa M. IL-13 regulates IL-17C expression by suppressing NF-κB-mediated transcriptional activation in airway epithelial cells. Biochem Biophys Res Commun. 1;495(1):1534-40, 2018.
- Yasui H, Inui N, Fujisawa T, Karayama M, Enomoto N, Nakamura Y, Kuroishi S, Ohba H, Yokomura K, Sato J, Sato M, Koshimizu N, Toyoshima M, Yamada T, Masuda M, Shirai T, Suda T : Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease. Clin Med Insights Circ Respir Pulm Med. 7;12, 2018.
- Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Sugimura H, Suda T : Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia. Respir Med.137:167-75, 2018.
- Yoshimura K, Suzuki Y, Inoue Y, Nishimoto K, Mori K, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Imokawa S, Suda T. Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. PLoS One. 5;13(6), 2018.
英文掲載（症例報告）
- Aono Y, Eifuku T, Uto T, Sato J, Imokawa S, Suda T. Non-specific interstitial pneumonia associated with clinically amyopathic dermatomyositis showing “crazy paving” appearance on thin-section lung CT. Respirology Case Rep:6; e00326, 2018.
- Fukada A, Toyoshima M, Akahori D, Suda T. Pulmonary Aspergilloma with Oxalosis. Intern Med 57(18): 2765-6, 2018.
- Fukada A,Yasui H, Uto T, Suzuki S, Sato J, Imokawa S, Suda T. Direct pulmonary infiltrates as an initial manifestation of chronic lymphocytic leukemia. Respir Med Case Rep 25; 282-5, 2018.
- Kono M, Nakamura Y, Oyama Y, Saito G, Koyanagi Y, Miyashita K, Tsutsumi A, Enomoto Y, Kobayashi T, Miki Y, Hashimoto D, Enomoto N, Colby TV, Suda T, Nakamura H：IgG4-related disease presenting with combined pulmonary fibrosis and emphysema (CPFE). Respir Med Case Rep 3(25):257-260, 2018.
- Saito G, Kono M, Tsutsumi A, Koyanagi Y, Miyashita K, Kobayashi T, Hozumi H, Miki Y, Arai Y, Otsuki Y, Hashimoto D, Fujisawa T, Nakamura T, Suda T, Nakamura H：Anti-PL-7 Antisynthetase Syndrome with Eosinophilic Pleural Effusion. Intern Med 57(15):2227-2232, 2018.
- Masuda T, Shirai T, Saigusa M, Asada K, Muro H. Metastatic pulmonary malignant melanoma showing a ring-shaped and the halo sign. Respirology Case Reports 6, e00370, 2018.
- Miyashita K, Matsuura S, Naoi H, Tsukui M, Koshimizu N and Suda T. Successful treatment by tolvaptan of the syndrome of inappropriate antidiuretic hormone secretion that may be associated with chemotherapy-induced tumor lysis in a patient with small-cell lung carcinoma. Respiratory Case Reports. 6 (3): e00296, 2018.
- Miyashita K, Matsuura S, Tajima K, Tajima S, Aoki A, Sakagami T, Koshimizu N, Toyoshima M, Suda T. Disseminated Mycobacterium avium Infection Presenting with Bladder Lesions in a Patient with Interferon-γ-neutralizing Autoantibodies. Intern Med. 57(20): 3041-3045, 2018.
- Tamura K, Shirai T, Matsubara A. Laryngomalacia presenting as severe uncontrolled asthma. Respirology Case Reports 6 (5), e00316, 2018.
- Tsuchiya K, Masato K, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T. ：An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases . Intern Med 57 (23), 2018.
- Tsuchiya K, Toyoshima M, Fukada A, Akahori D, Funai K, Suda T. Lupus Pleuritis with Silicotic Nodules in the Parietal Pleura. Intern Med 57(9): 1277-80, 2018.
- Yasui H, Arima H, Hozumi H, Suda T : Neurogenic Pulmonary Edema without Norepinephrine Elevation. Intern Med. 15;57(14):2097-98, 2018.
- Yoshimura K, Karayama M, Inoue Y, Kahyo T, Inui N, Maekawa M, Sugimura H, Suda T: Heterogeneous MET gene copy number and EGFR mutation elicit discordant responses to crizotinib between primary and metastatic lesions in erlotinib-resistant lung adenocarcinoma. Lung Cancer. S0169-5002(18)30305-2, 2018.
和文掲載（著書）
- 大山吉幸, 須田隆文：膠原病肺の画像所見の特徴は？ 呼吸器ジャーナル 呼吸器画像診断-エキスパートの視点- 医学書院 65, 82-92, 2018.
- 白井敏博．第4章 管理・治療：薬物による長期管理（重症度，コントール状態の評価を含めて）．診断と治療のABC 135：喘息（新実彰男監修），最新医学社，大阪，2018.
- 須田隆文 : Pleuroparenchymal fibroelastosis(PPFE). 呼吸器疾患：CRPアプローチ. 南江堂. 136-9, 2017
- 中村祐太郎．リンパ球性間質性肺炎（LIP）．呼吸器疾患 診断治療アプローチ第４巻 間質性肺炎・肺線維症と類縁疾患 214-218，中山書店，2018．
- 安井秀樹, 須田隆文：抗MAC抗体 透析患者検査値のみかた,考えかた ver.2 中外医学社 206-209,2018.
和文掲載（総説）
- 榎本紀之 : 特発性肺線維症に対する個別化医療-免疫抑制療法と抗線維化薬の役割について- THE LUNG perspectives. 26(2) :142-5, 2018.
- 榎本紀之, 須田隆文 : IPAFを考える. 間質性肺炎・肺線維症と類縁疾患 : 274-80, 2018.
- 榎本紀之, 須田隆文 : IPAFを考える:膠原病との異同. 呼吸器内科学 34(3) : 252-8, 2018.
- 榎本紀之, 須田隆文 : 膠原病関連の間質性肺炎におけるMDD診断-問題点と今後の課題. 医学のあゆみ 260(8): 667-72, 2017
- 須田隆文 : COPDに合併する呼吸器疾患-肺癌,肺線維症・間質性肺炎- 日本内科学会誌. 107(6), 2018
- 須田隆文 : 抗リウマチ薬による薬剤性肺障害. 最新医学 73(7): 932-940, 2018.
- 中村祐太郎, 須田隆文 : 呼吸器内科. 膠原病の細気管支炎 科学評論社 33(4): 367-371, 2018.
- 中村祐太郎，須田隆文：肺線維症合併肺癌の現状と課題 免疫療法の可能性を中心に. Medical Science Digest 44(1): 40-44, 2018.
- 藤澤朋幸, 須田隆文 : 呼吸器内科. 呼吸器疾患の主な治療薬・治療手技 1.主な治療薬の使い方 12)免疫抑制薬. 科学評論社 34(Suppl. 1): 235-40, 2018.
- 藤澤朋幸, 須田隆文 : 膠原病肺・血管炎. Medical Practice. 文光堂. 34(4):595-603, 2017.
- 福沢嘉孝，吉富淳，岩田健太郎，中村敦，早川啓史：第 24 回東海支部専門医部会セミナーまとめ 内科疾患と感染症．日本内科学会雑誌 107(11): 2354-61, 2018.
- 穗積宏尚, 須田隆文 : 呼吸器内科. 顕微鏡的多発血管炎の肺病変：診断と治療. 科学評論社 32(4): 314-24, 2017.
- 穗積宏尚，須田隆文 : 呼吸器疾患におけるステロイド薬の適応と意義. 成人病と生活習慣病, 48(11) : 1211-23, 2018.
- 穗積宏尚，須田隆文 : 多発性筋炎・皮膚筋炎の間質性肺疾患における新規バイオマーカーの探索－YKL-40の臨床的有用性―. リウマチ科, 60(4) : 418-26, 2018.
- 穗積宏尚，須田隆文 : 膠原病の匂いのする間質性肺疾患 : IPAFを中心に. 呼吸臨床. 2(8), 2018.
- 三輪清一，早川啓史：【NTM(非結核性抗酸菌)症の治療は今のままでよいのか?－パラダイムシフトを探る! 】リファンピシンによるクラリスロマイシンの不活化にどう対処するか?感染と抗菌薬21(1):46-51, 2018
- 安井秀樹, 須田隆文：呼吸器内科. CQ2 IPF患者にステロイドと免疫抑制剤の併用療法を行うべきか？科学評論社33(5): 451-8, 2018
- 安井秀樹，須田隆文：気管支喘息治療におけるロイコトリエン受容体拮抗薬(LTRA)と長時間作用性抗コリン薬(LAMA)の有用性:アレルギーの臨床 38 (4);346-50, 2018
和文掲載（原著）
- 伏見華奈，土屋憲，池ヶ谷佳寿子，加瀬澤友梨，齋藤敦子，更谷和真，徳濱潤一，原田晴司，髙森康次，柴田洋，増田昌文：当院におけるレジオネラ定期環境調査とLegionella pneumophila serogroup 5による給水汚染対策．日本環境感染学会誌 33(2): 56-61, 2018.
- 伏見華奈，齋藤敦子，更谷和真，土屋憲，池ヶ谷佳寿子，加瀬澤友梨，徳濱潤一，原田晴司，柴田洋，髙森康次，増田昌文：歯科用ユニットに潜在するレジオネラ感染のリスク．日本環境感染学会誌 33(4): 136-42, 2018.
- 村田支優, 河野雅人, 齋藤合, 小柳悠, 宮下晃一，堤あかり, 小林健, 三木良浩, 橋本大, 中村秀範：肺癌患者における喫煙に関する自己申告の正確性．聖隷浜松病院医学雑誌 18(1): 8-13, 2018.
和文掲載（研究報告）
須田隆文，榎本紀之：膠原病的背景を有する特発性間質性肺炎の多施設共同コホート研究〜中間解析2017〜;平成30年度厚生労働科学研究費補助金 難治性疾患等政策研究事業（難治性疾患政策研究事業）びまん性肺疾患に関する調査研究班 総会報告書
和文掲載（症例報告）
- 赤堀大介, 豊嶋幹生, 深田充輝, 須田隆文：ジクロロメタン吸入による肺障害の1例．職業・環境アレルギー誌 25(2): 71-76, 2018.
- 小谷内 敬史, 横村 光司, 杉山 未紗, 金田 桂, 天野 雄介, 須田 隆文 投与開始から3年後に発症したアダリムマブによる薬剤性肺障害の1例．日呼吸誌，7(2): 114-118，2018.
- 小谷内 敬史, 長谷川 浩嗣, 金田 桂, 後藤 彩乃, 天野 雄介, 角谷 拓哉, 小澤 雄一, 松井 隆, 横村 光司, 須田 隆文． 気管支サーモプラスティが有効であった高度の閉塞性換気障害を有する難治性喘息の1例 気管支学，40(5)： 479-483，2018.
- 二橋文哉、北原佳泰、村上有里奈、岸本祐太郎、青野祐也、永福建、右藤智啓、佐藤潤、妹川史朗、須田隆文. 呼吸不全を呈した加湿器肺３例の臨床的検討. 日本サルコイドーシス/肉芽腫性疾患学会雑誌 38: 80-3, 2018
- 松田慈, 齋藤合, 小柳悠, 宮下晃一, 堤あかり, 小林健, 河野雅人, 三木良浩, 橋本大, 中村秀範, 新井義文, 大月寛郎, 小林寛：明らかなアスベスト曝露歴を認めなかった高齢女性の悪性胸膜中皮腫の一剖検例．聖隷浜松病院医学雑誌 17(2): 47-54, 2017.（査読あり）
- 渡邉裕文，宍戸雄一郎，鈴木貴人，野口理絵，三枝美香，赤松泰介，山本輝人，森田悟，朝田和博，白井敏博．リファンピシンおよびエタンブトールにより急性汎発性発疹性膿疱症を発症した肺結核の１例．結核 93:41-46，2018.
- 渡邉裕文，田中悠子，遠藤慶成，鈴木貴人，野口理絵，三枝美香，赤松泰介，山本輝人，宍戸雄一郎，秋田剛史，森田悟，朝田和博，白井敏博．呼吸困難を主症状としたサルコイドーシスの1例．サルコイドーシス 38:60-65，2018.
和文掲載（その他）
- 稲瀬直彦，田坂定智，須田隆文，西岡安彦 : 日常診療に潜むIPF. 日経メディカル.10 38-40, 2017.
- 白井敏博．呼吸抵抗測定（強制オシレーション法）．アレルギー 67；1035-36, 2018.
- 須田隆文：肺線維症と治療～とくに特発性肺線維症について～. 難病と在宅ケア24(2), 2018
- 須田隆文 : 新専門医制度について. 静岡県医師会報 5,7-9,2018
- 福沢嘉孝，吉富淳，牧信行，徳永あゆみ，中村勝己：内科診療とリスクマネジメント．日本内科学会雑誌 107(5): 944-50, 2018.
- 福沢嘉孝，吉富淳，岩田健太郎，中村敦，早川啓史：内科疾患と感染症．日本内科学会雑誌 107(11): 2354-61, 2018.
2017年
英文掲載（総説）
Inui N ：Antiemetic therapy for non-antracycline and cyclophosphamide moderately emetogenic chemotherapy. Med Oncol 34(5): 77, 2017.
英文掲載（原著）
- Akamatsu T, Shirai T, Shimoda Y, Suzuki T, Hayashi I, Noguchi R, Mochizuki E, Sakurai S, Saigusa M, Yamamoto A, Shishido Y, Morita S, Asada K. Forced oscillation technique as a predictor of FEV1 improvement in asthma. Respir Physiol Neurobiol 236: 78-83, 2017.
- Akita T, Shirai T, Akamatsu T, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K. Long-term change in reactance by forced oscillation technique correlates FEV1 decline in moderate COPD patients. Eur Respir J 49 (4) : 1601534, 2017.
- Inoue Y, Yoshimura K, Kurabe N, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H：Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Oncotarget 31 (8): 8738-51, 2017.
- Inoue Y, Matsuura S, Yoshimura K, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Maeda M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H：Characterization of V-set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cells. Cancer Sci：108(8)：1701-14, 2017.
- Uehara M, Enomoto N, Oyama Y, Suzuki Y, Kono M, Furuhashi K, Fujisawa T, Inui N, Nakamura Y, Suda T：Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia. Respirology : doi:10.111/resp.13145, 2017.
- Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Iwashita T, Kuroishi S, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T：Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study. Respir Med 133: 1-5, 2017.
- Enomoto Y, Nakamura Y, Enomoto N, Fujisawa T, Inui N, Suda T：Japanese herbal medicine-induced pneumonitis: A review of 73 patients. Respiratory Investigation 55(2): 138-44, 2017.
- Enomoto Y, Nakamura Y, Colby TV, Johkoh T, Sumikawa H, Nishimoto K, Yoshimura K, Matsushima S, Oyama Y, Hozumi H, Kono M, Fujisawa T, Enomoto N, Inui N, Iwashita T, Suda T：Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease. PLoS One 12(6): e0180283, 2017.
- Enomoto Y, Suzuki Y, Hozumi H, Mori K, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Yutaro N, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T：Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis Research & Therapy 19(1):9, 2017.
- Enomoto Y, Inui N, Yoshimura K, Nishimoto K, Mori K, Kono M, Fujisawa T, Enomoto N, Nakamura Y, Iwashita T, Suda T：Lung cancer development in patients with connective tissue disease-related interstitial lung disease. Medicine 95(50): e5716, 2016.
- Enomoto Y, Inui N, Kato T, Baba T, Karayama M, Nakamura Y, Ogura T, Suda T：Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer. Lung Cancer (96): 63-7, 2016.
- Endo Y, Shirai T, Akamatsu T, Asada K. Comparison of fractional exhaled nitric oxide levels measured using the NIOX VERO and NOA 280i. Ann Allergy Asthma Immunol 119 (4): 383-5, 2017.
- Oyama Y, Enomoto N, Suzuki Y, Kono M, Fujisawa T, Inui N, Nakamura Y, Kuroishi S, Yokomura K, Toyoshima M, Imokawa S, Oishi K, Watanabe S, Kasahara K, Baba T, Ogura T, Ishii H, Watanabe K, Nishioka Y, Suda T：Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE)．Respir Med. 123: 63-70, 2017.
- Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Hashimoto Dai, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T：Respiratory impedance is correlated with morphological changes in the lungs on threee-dimensional CT in patients with COPD. Scientific Reports 8(7): 41709, 2017.
- Satake Y, Nakamura Y, Kono M, Hozumi H, Nagata T, Tsujimura K, Enomoto N, Fujisawa T, Inui N,Fujiyama T, Tokura Y, Matsui T, Yokomura K, Shirai M, Hayakawa H, Suda T：Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis. Int J Tuberc Lung Dis 21(5): 523-530, 2017.
- Suzuki Y, Oyama Y, Hozumi H, Imokawa S, Toyoshima M, Yokomura K, Nalamura H, kuroishi S, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Koshimizu N, Yamada T, Mori K, Masuda M, Shirai T, Hayakawa H, Sumikawa M, Johkoh T, Suda T：Persistent impairment on spirometry in chronic eosinophilic pneumonia: a longitudinal observation study (Shizuoka-CEP study). Ann Allergy Asthma Immunol : in press, 2017.
- Tokuda H, Harigai M, Kameda H, Tomono K, Takayanagi N, Watanabe A, Tasaka S, Suda T, Tateda K, Kadota J：Consensus statements for medical practice: Biological agents and lung disease Respir Investig. 55(3):229-251, 2017.
- Nishimoto K, Karayama M, Inui N, Mori K, kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Watanabe H, Suda T：Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma. Scientific Reports 7: 10187, 2017.
- Nishimoto K, Fujisawa T, Yoshimura K, Enomoto Y, Enomoto N, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Suda T：The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis. Respirology : doi: 10.1111/resp.13219, 2017.
- Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, Tsuji D, Inoue K, Itoh K. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype. Clin Exp Allergy 47 (11): 1374-82, 2017.
- Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T：Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. Respiratory Investigation 55(2): 130-137, 2017.
- Furuhashi K, Chua YL, Wong KHS, Zhou Q, Liong KH, Teo GH, Hutchinson PE, Kemeny DM：Priming with high and low respiratory allergen dose induces differential CD4+T helper type 2 cells and IgE/IgG1 antibody responses in mice. Immunology 151(2): 227-238, 2017.
- Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T：Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease. J Rheumatol 44(9): 1394-1401, 2017.
- Yoshimura K, Inoue Y, Mori K, Iwashita Y, Kahyo T, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H：Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer. Genes Chromosomes Cancer 56(7): 570-581, 2017.
- Yamanaka K, Fujisawa T, Kusagaya H, Mori K, Niwa M, Furuhashi K, Kono M, Hamada E, Suda T, Maekawa M.：IL-13 regulates IL-17C expression by suppressing NF-κB-mediated transcriptional activation in airway epithelial cells.Biochem Biophys Res Commun. (17)32384-7, 2017.
- Wong KH, Zhou Q, Prabhu N, Furuhashi K, Chua YL, Grotenbreg GM, Kemeny DM.：Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response. Immunology. 152(2):344-355, 2017.
英文掲載（症例報告）
- Aono Y, Imokawa S, Uto T, Sato J, Tanioka F, Suda T. Granulomatosis with polyangiitis involving the epiglottis. Respirology Case trport 5; e00226, 2017.
- Akiyama N, Karayama M, Iwaizumi M, Kusama Y, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T：Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Pral Fluoropyrimidine. Intern Med 56: 2367-71, 2017.
- Ikeda M, Inoue KI, Kusagaya H：A case of supernumerary intrathoracic rib. Asian Cardiovasc Thorac Ann 25(5): 400, 2017.
- Enomoto Y, Nakamura Y, Colby TV, Inui N, Suda T：Pirfenidone for primary Sjögren's syndrome-related fibrotic interstitial pneumonia. Sarcoidosis Vasculitis and Diffuse Lung Diseases 34(1): 91-6, 2017.
- Endo Y, Shirai T, Mika Saigusa, Mochizuki E. Severe acute asthma caused by Chlamydophila pneumoniae infection. Respirology Case Reports 5: e00239, 2017.
- Goto A, Ozawa Y, Koda K, Akahori D, Koyauchi T, Amano Y, Kakutani T, Sato Y, Hasegawa H, Matsui T, Yokomura K, Suda T．Clinical impact of minocycline on afatinib-related rash in patients with epidermal growth factor receptor-mutated non-small cell lung cancer．Respiratory Investigation, in press.
- Tsuchiya K, Toyoshima M, Kamiya Y, Nakamura Y, Baba S, Suda T：Non-smoking Chronic Obstructive Pulmonary Disease Attributed to Occupational Exposure to Silica Dust. Intern Med 56(13): 1701-1704, 2017.
- Tsuchiya K, Toyoshima M, Akiyama N, Kono M, Nakamura Y, Funai K, Baba S, Sugimura H, Kanayama H, Suda T：Rapid Radiologic Progression of Silicosis. Am J Respir Crit Care Med 195(10): e39-e42, 2017.
- Tsuchiya K, Toyoshima M, Suda T：Penumonitis with Diffuse Alveolar Hemorrhage Induced by Sho-seiryu-to. Intern Med 56(19): 2623-26, 2017.
- Nakayasu H, Shirai T, Tanaka Y, Saigusa M. Chronic eosinophilic pneumonia after radiation therapy for squamous cell lung cancer. Respir Med Case Reports 22:147-9, 2017.
- Matsuura S, Mochizuka Y, Oishi K, Miyashita K, Naoi H, Mochizuki E, Mikura S, Tsukui M, Koshimizu N, Ohata A, Suda T. Sarcoidosis with Pancreatic Mass, Endobronchial Nodules, and Miliary Opacities in the Lung. Intern Med 56(22): 3083-3087, 2017.
- Yoshimura K, Inui N, Karayama M, Inoue Y, Enomoto N, Fujisawa T, Nakamura Y, Takeuchi K, Sugimura H, Suda T：Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acuired MET amplification after erlotinib therapy. Respir Med Case Rep 17(20): 160-163, 2017.
和文掲載（総説）
- 川史朗. 忘れてはいけない、よく遭遇する呼吸器症状からみた鑑別診断について. 日内会誌 106: 1494-7, 2017.
- 榎本紀之，須田隆文：膠原病関連の間質性肺炎におけるMDD診断-問題点と今後の課題. 医学のあゆみ 260(2): 667-72, 2017./li>
- 須田隆文，大山吉幸：膠原病肺の画像所見の特徴は？. 呼吸器ジャーナル 65(1): 82-92, 2017./li>
- 須田隆文：膠原病に伴う肺病変．内科学 第11版 朝倉書店, 2017./li>
- 須田隆文：特発性間質性肺炎 診断と治療の手引き（改訂第３版）．編集：日本呼吸器学 会びまん性肺疾患診断・治療ガイドライン作成委員会．非特異性間質性肺炎（NSIP）, 2017./li>
- 藤澤朋幸：多発性筋炎/皮膚筋炎に合併する間質性肺炎における筋炎特異的自己抗体の臨床的意義. 日本医事新報 (4879): 55, 2017./li>
- 藤澤朋幸，須田隆文：膠原病肺・血管炎. Medical Practice 34(4): 595-603, 2017./li>
- 穂積宏尚，須田隆文：顕微鏡的多発血管炎の肺病変：診断と治療. 呼吸器内科 32(4): 314-324, 2017./li>
- 中村祐太郎，須田隆文：肺線維症合併肺癌-免疫療法の可能性も含めて-. Bio Clinica 6(1): 114-20, 2017./li>
- 中村祐太郎，須田隆文：医窓通信Vol.53 浜松医科大学内科学第二講座. 月刊新医療 507(3): 68-70, 2017./li>
- 中村祐太郎，須田隆文：Pleuroparenchymal fibroelastosis (PPFE)．呼吸器疾患：Clinical-Radiological-Pathologicalアプローチ．藤田次郎（編）．南江堂、2017，136-39./li>
- 増田昌文，伊波奈穂，芦澤洋喜，吉富淳，須田隆文：肺胞微石症②診断後約30年の経過で呼吸不全を呈した肺胞微石症の一例．難治性びまん性肺疾患診療の手引き 日本呼吸器学会（監修）．南江堂12-15，2017./li>
- 福沢嘉孝，吉富淳，森田純仁，白木亮，加藤明彦，春田純一，村上雅子，多久佳成：内科疾患と栄養療法．日本内科学会雑誌 106(1): 133-142, 2017./li>
- 福沢嘉孝，吉富淳，妹川史朗，久保田知希：内科診療のTips: Dos & Don’ts．日本内科学会雑誌 106(7): 1491-1499, 2017./li>
和文掲載（症例報告）
- 大杉浩一，峯田健司，高山 晋，土手 尚，渥美生弘，田中 茂，齋藤 合，橋本 大：持続的腎代替療法中に不適切な体位による腹臥位療法にて高アミラーゼ血症を来したと考えられた一例. 人工呼吸 34(2): , 2017.
- 角谷拓哉，小澤雄一，長谷川浩嗣，松井隆，横村光司，須田隆文：脳転移再発に対して定位放射線照射施行後9年間完全寛解が維持されている小細胞肺癌の1例．肺癌 57 (6)：775-80，2017
- 角谷拓哉，横村光司，後藤彩乃，小谷内敬史，丹羽 宏，須田隆文：下気道感染の合併により増大し，肺野に多彩な陰影を伴った気管支原性嚢胞の1 例． 日呼吸誌， 6(1): 49-52， 2017
- 神谷陽輔，豊嶋幹生，土屋一夫，秋山訓通，河野雅人，中村祐太郎，須田隆文：超硬合金暴露歴のない巨細胞性間質性肺炎の1例. 職業・環境アレルギー誌 24(2): 35-40, 2017.
- 小谷内敬文，横村光司，金田桂，後藤彩乃，赤堀大介，天野雄介，角谷拓哉，鈴木恵理子，棚橋雅幸，丹羽宏，須田隆文：EBUS-TBNAにより診断した縦隔リンパ節炎を伴う播種性クリプトコッカス症．気管支学，in press
- 下村 巌，橋本 大，設楽将之，棚橋雅幸，丹羽 宏，中村秀範：内視鏡的治療に加え外科的治療介入を要した気管支グロムス腫瘍の1例. 日本呼吸器学会雑誌 6(1): 18-21, 2017.
- 三輪聖、右藤智啓、安井秀樹、佐藤潤、妹川史朗、須田隆文. レーザー焼灼が治療に有効であった気管支型平滑筋腫の1例. 日呼吸誌 6: 337-40, 2017.
2016年
英文掲載（総説）
- Suda T: Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease. Clin Med Insights Circ Respir Pulm Med. 9(Suppl 1):155-162, 2016.
- Nakamura Y, Suda T: Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations. Clin Med Insights Circ Respir Pulm Med. 9(Suppl 1):163-171, 2016.
- Mori S, Furukawa H, Kawaguchi Y, Suda T, Tasaka S: Current Developments in Interstitial Lung Disease. Clin Med Insights Circ Respir Pulm Med. 9(Suppl 1):173-177, 2016.
英文掲載（原著）
- Akita T, Shirai T, Mori K, Shimoda Y, Suzuki T, Hayashi I, Noguchi R, Mochizuki E, Sakurai S, Saigusa M, Akamatsu T, Yamamoto A, Shishido Y, Morita S, Asada K, Suda T: Association of the forced oscillation technique with negative expiratory pressure in COPD. Respir Physiol Neurobiol 220:62-68, 2016.
- Enomoto N, Chida K, Suda T, Kaida Y, Taniguchi M, Azuma A, Hayashi H, Ogura T, Kitamura H, Yamaguchi O, Ando M, Sato A, Kudo S: An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter report. Clin Respir J. 10(6):746-755, 2016.
- Enomoto Y, Inui N, Kato T, Baba T, Karayama M, Nakamura Y, Ogura T, Suda T: Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer. Lung Cancer 96:63-67, 2016.
- Enomoto Y, Inui N, Yoshimura K, Nishimoto K, Mori K, Kono M, Fujisawa T, Enomoto N, Nakamura Y, Iwashita T, Suda T: Lung cancer development in patients with connective tissue disease-related interstitial lung disease: A retrospective observational study. Medicine (Baltimore) 95(50):e5716, 2016.
- Enomoto Y, Yokomura K, Hasegawa H, Ozawa Y, Matsui T, Suda T: Healthcare- associated pneumonia with positive respiratory methicillin-resistant Staphylococcus aureus culture: Predictors of the true pathogenicity. Geriatr Gerontol Int. [Epub ahead of print] 2016.
- Galle-Treger L, Suzuki Y, Patel N, Sankaranarayanan I, Aron JL, Maazi H, Chen L, Akbari O: Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. Nat Commun. 7:13202, 2016.
- Hiramatsu M, Chida K, Suda T, Hashimoto D, Takamoto H, Honozawa K, Okada H, Nakamura K, Takagi K: Possibility of using salivary ultra-weak chemiluminescence as a biomarker for feelings of anxiety in hospital settings. Luminescence 31:1395-1399, 2016.
- Hojo M, Shirai T, Hirashima J, Iikura M, Sugiyama H. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler. Pulm Pharmacol Ther. 37:43-8, 2016.
- Hozumi H, Enomoto N, Oyama Y, Kono M, Fujisawa T, Inui N, Nakamura Y, Suda T: Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias. Lung 194(2):235-242, 2016.
- Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T: Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis- associated interstitial lung disease. Respir Med. 121:91-99, 2016.
- Inoue Y, Yoshimura K, Mori K, Kurabe N, Kahyo T, Mori H, Kawase A, Tanahashi M, Ogawa H, Inui N, Funai K, Shinmura K, Niwa H, Suda T, Sugimura H: Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer. Oncotarget 7(22):32113-32128, 2016.
- Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Koshimizu N, Sato M, Toyoshima M, Shirai T, Masuda M, Yamada T, Imokawa S, Suda T: Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer. Eur J Cancer. 58:30-37, 2016.
- Karayama M, Inui N, Kusagaya H, Suzuki S, Inoue Y, Enomoto N, Fujisawa T, Nakamura Y, Suda T: Changes in cross-sectional area of pulmonary vessels on chest computed tomography after chemotherapy in patients with advanced non-squamous non-small-cell lung cancer. Cancer Chemother Pharmacol. 77(5):1011-1018, 2016.
- Kono M, Nakamura Y, Oyama Y, Mori K, Hozumi H, Karayama M, Hashimoto D,Enomoto N, Fujisawa T, Inui N, Yamada M, Hamada E, Colby TV, Maekawa M, Suda T: Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis. Respir Med. 115:46-52, 2016.
- Kono M, Nakamura Y, Yoshimura K, Enomoto Y, Oyama Y, Hozumi H, Enomoto N,Fujisawa T, Inui N, Hamada E, Colby TV, Maekawa M, Suda T: Nonspecificinterstitial pneumonia preceding diagnosis of collagen vascular disease. Respir Med. 117:40-47, 2016.
- Kurabe N, Igarashi H, Ohnishi I, Tajima S, Inoue Y, Takahashi Y, Setou M, Sugimura H. Visualization of sphingolipids and phospholipids in the fundic gland mucosa of human stomach using imaging mass spectrometry. World J Gastrointest Pathophysiol. 2016 May 15;7(2):235-41.
- Maazi H, Suzuki Y, Jung J, Akbari O: Reply. J Allergy Clin Immunol. Nov 12. [Epub ahead of print] 2016.
- Mikamo M, Fujisawa T, Oyama Y, Kono M, Enomoto N, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Suda T: Clinical Significance of Forced Oscillation Technique for Evaluation of Small Airway Disease in Interstitial Lung Diseases. Lung 194(6):975-983, 2016.
- Mochizuki E, Shirai T, Hayashi I, Noguchi R, Sakurai S, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K, Fujii M: Undiagnosed COPD in hospitalized patients with pneumonia in Japan. Respir Investig 54:369-371, 2016.
- Mori K, Fujisawa T, Inui N, Hashimoto D, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Toyoshima M, Imokawa S, Yamada T, Shirai T, Masuda M, Hayakawa H, Chida K, Suda T: Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma. Respir Med. 119:1-6, 2016.
- Nishimoto K, Karayama M, Akiyama N, Suzuki S, Inoue Y, Kono M, Hozumi H, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy. J Clin Gastroenterol. 50(8):689-690, 2016.
- Odagiri K, Inui N, Hakamata A, Inoue Y, Suda T, Takehara Y, Sakahara H, Sugiyama M, Alley MT, Wakayama T, Watanabe H: Non-invasive evaluation of pulmonary arterial blood flow and wall shear stress in pulmonary arterial hypertension with 3D phase contrast magnetic resonance imaging. Springerplus 5(1):1071, 2016.
- Ozawa Y, Akahori D, Koda K, Abe T, Hasegawa H, Matsui T, Tanahashi M, Niwa H, Yamada K, Yokomura K, Suda T: Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer．Cancer Chemother Pharmacol. 77(5):1031-1038, 2016.
- Sakurai S, Shirai T, Akamatsu T, Hayashi I, Noguchi R, Mochizuki E, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K, Fujii M: Endobronchial lesions as a predictor of impaired cough-related quality of life in lung cancer. Lung Cancer 96:25-26, 2016.
- Shinmura K, Kato H, Kawanishi Y, Yoshimura K, Igarashi H, Goto M, Tao H, Inoue Y, Sugiyama T, Furuse H, Ozono S, Sugimura H. Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma. Mol Carcinog. 2016 Jun 2.
- Shinmura K, Kato H, Kawanishi Y, Igarashi H, Goto M, Tao H, Inoue Y, Nakamura S, Misawa K, Mineta H, Sugimura H. Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer. Oxid Med Cell Longev. 2016.1546392.
- Shirai T, Kurosawa H: Clinical application of the forced oscillation technique. Intern Med 55:559-566, 2016.
- Suzuki S, Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Asada K, Masuda M, Yamada T, Watanabe H, Suda T: Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer. Invest New Drugs. 34(4):490-496, 2016.
- Suzuki S, Karayama M, Inui N, Kuroishi S, Fujisawa T, Enomoto N, Nakamura Y, Yokomura K, Toyoshima M, Imokawa S, Asada K, Masuda M, Yamada T, Watanabe H, Hayakawa H, Suda T: Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy. Med Oncol. 33(7):65, 2016.
- Suzuki Y, Enomoto Y, Yokomura K, Hozumi H, Kono M, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Suda T: Soluble hemoglobin scavenger receptor CD163 (sCD163) predicts mortality of community-acquired pneumonia. J Infect. 73(4):375-377, 2016.
- Suzuki Y, Imokawa S, Sato J, Uto T, Suda T: Cumulative incidence of tuberculosis in lung cancer patients in Japan: A 6-year observational study. Respir Investig. 54(3):179-183, 2016.
- Suzuki Y, Maazi H, Sankaranarayanan I, Lam J, Khoo B, Soroosh P, Barbers RG, James Ou JH, Jung JU, Akbari O: Lack of autophagy induces steroid-resistant airway inflammation. J Allergy Clin Immunol. 137(5):1382-1389, 2016.
- Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T: Utility of Macrophage Activated Marker, CD163, for Diagnosis and Prognosis in Pulmonary Tuberculosis. Ann Am Thorac Soc. Sep 29, [Epub ahead of print] 2016.
- Uehara M, Enomoto N, Mikamo M, Oyama Y, Kono M, Fujisawa T, Inui N, Nakamura Y, Suda T: Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis. Respir Med. 114:18-26, 2016.
- Yasui H, Donahue DL, Walsh M, Castellino FJ, Ploplis VA: Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury. Am J Physiol Lung Cell Mol Physiol. 311(1):L74-86, 2016.
- Yoshimura K, Osman M, Inoue Y, Suda T, Sugimura H: A novel prognostic marker of non-small cell lung cancer: chromosome 9 open reading frame 86 (C9orf86). J Thorac Dis. 8(9):2284-2286, 2016.
- Yoshimura K, Suzuki Y, Uto T, Sato J, Imokawa S, Suda T: Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016:11:1435-1445, 2016.
英文掲載（症例報告）
- Kamiya Y, Toyoshima M, Akiyama N, Suda T: Combined pulmonary fibrosis and emphysema preceding lupus pleuritis. Intern Med 55(7): 783-786, 2016.
- Kamiya Y, Toyoshima M, Suda T: Endobronchial Involvement in Methotrexate- associated Lymphoproliferative Disease. Am J Respir Crit Care Med 193(11):1304-1306, 2016.
- Tanaka Y, Shirai T, Asada K, Oyama Y, Enomoto N, Suda T: Occupational hypersensitivity pneumonitis in a green tea manufacturer. Respirology Case Reports 4:e00152, 2016.
- Yasui H, Yokomura K, Suda T: A severe case of acute exogenous lipoid pneumonia treated with systemic corticosteroid. Respir Med Case Rep. 17:64-67, 2016.
- Yasui H, Yokomura K, Suda T: Idiopathic Nonsurgical Pneumoperitoneum Accompanied by a Pneumomediastinum. Intern Med. 55(15):2125-2126, 2016.
和文掲載（総説）
- 小澤雄一：免疫チェックポイント阻害薬と抗体医薬の併用Combination of immune checkpoint inhibitors and monoclonal antibody therapy．がん分子標的治療14（2）：53-57, 2016
- 須田隆文、徳田均：診療ガイドラインat a glance 生物学的製剤と呼吸器疾患・診療の手引き. 日本内科学会雑誌 105(8): 1414-1421, 2016
- 須田隆文：IPAFと特発性間質性肺炎. 最新醫學 71(7): 1298-1305, 2016.
- 須田隆文：さまざまなびまん性肺疾患の診断・治療 膠原病肺. 内科 117(2): 249-253, 2016.
- 須田隆文：呼吸器疾患：症例から病態生理学/分子病態学へ 間質性肺炎．呼吸と循環．医学書院 64(10):947-954, 2016.
- 須田隆文：膠原病関連肺の診断と管理. 呼吸器内科 30(2): 171-177, 2016.
- 中村祐太郎、千田金吾、須田隆文：関節リウマチに伴うUIPの臨床的病理学的特徴. 分子呼吸器病 20(1): 12-16, 2016.
和文掲載（原著）
- 阿部岳文，横村 光司，後藤 彩乃，赤堀 大介，幸田 敬悟，小谷内 敬史，角谷 拓哉，榎本 泰典，松井 隆，須田 隆文：特発性肺線維症の急性増悪に対するリコンビナントトロンボモデュリンの有用性．日呼吸誌, 5(2): 57-63, 2016
和文掲載（症例報告）
- 秋山 訓通，横村 光司，野末 剛史，阿部 岳文，松井 隆，須田 隆文：メサラジンによる薬剤性肺炎の3例．アレルギー 64(10):1334-1340, 2015.
- 大嶋智子，土屋一夫，山田孝，玉里滋幸，千原幸司，森木利昭：気管支中心性肉芽腫像を呈した肺Mycobacterium avium症の1例．日本呼吸器学会誌 5 (2):106-109, 2016.
- 幸田 敬悟，榎本 泰典，大前 美奈子，赤堀 大介， 阿部 岳文，長谷川 浩嗣，松井 隆，横村 光司，須田 隆文：真性皮膚結核が先行した粟粒結核の1例．結核 91(2):59-63, 2016.
- 柴田洋，草ケ谷英樹，土屋一夫，大山吉幸，山田孝，江河勇樹：シェーグレン症候群に合併した肺軽鎖沈着症の1例．日本呼吸器学会誌 5 (5):245-249, 2016.
- 土屋一夫，小谷内敬史，野末剛史，大嶋智子，柴田洋，藤井雅人，山田孝，西川滋人：術前気管支鏡で観察できた気管支進展縦隔成熟奇形腫の1例．気管支学 38 (6):494-499, 2016.
和文掲載（その他）
- 秋山訓通, 豊嶋幹生：左第IV弓とのシルエットサイン陰性の結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 193-194.
- 榎本紀之：気管支鏡の適応と結果の解釈，外科的肺生検について．気づきと対応がわかる びまん性肺疾患の診かた治しかた．喜舎場朝雄（編）．南江堂、2016, 79-89.
- 小澤雄一：小さな結節影にもかかわらず全身転移していた進行肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 131-132.
- 小澤雄一：前年との比較読影が有用であった肺気腫合併肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 163-164.
- 勝又峰生, 中村秀範：脳転移を伴うⅣ期扁平上皮癌．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 87-88.
- 勝又峰生, 中村秀範：対側肺転移を認めたⅣ期肺腺癌．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 89-90.
- 勝又峰生, 中村秀範：左中肺野の淡い結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 95-96.
- 神谷陽輔, 豊嶋幹生：陳旧性陰影と鑑別を要する充実性腫瘤影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 123-124.
- 鈴木清一郎, 豊嶋幹生：縦隔リンパ節に転移していた25mmの肺腺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 133-134.
- 鈴木清一郎、豊嶋幹生：左第IV弓とのシルエットサインイン陰性の腫瘤影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 235-236.
- 須田隆文：膠原病的背景をもった間質性肺炎（UCTD,LD-CTD,AIF-ILDなど）はどう治療し管理すべきか？ EBM呼吸器疾患の治療2016-2017edition．永井厚志（編）．中外医学社、2016, 202-210.
- 須田隆文：膠原病の肺病変．呼吸器疾患最新の治療2016-2018．南江堂、2016, 365-368.
- 豊嶋幹生：どんな所見が肺がんを疑う所見か．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 20-24.
- 豊嶋幹生：右下肺野結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 39-40.
- 豊嶋幹生：右上肺野の肋骨、肩甲骨と重なる淡い結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 63-64.
- 豊嶋幹生：右上肺野結節影の指摘により発見された右中肺野結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版2016, 109-110.
- 豊嶋幹生：気腫合併肺線維症と肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 167-168.
- 豊嶋幹生：左上肺野結節影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 41-42.
- 豊嶋幹生：心臓の裏側に注目．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 229-230.
- 豊嶋幹生：他の呼吸器疾患にマスクされた肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 157-158.
- 豊嶋幹生：特徴的なサインを呈した肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 181-182.
- 豊嶋幹生：別部位の異常陰影指摘により偶然発見された肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 101-102.
- 長谷川浩嗣・横村光司：下葉原発で肺門リンパ節に転移した小細胞肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 155-156.
- 橋本大：右肺門と重なる陰影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 45-46.
- 橋本大：右肺門索状影（左側のペースメーカーを気にせず読影することが必要）．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 47-48.
- 橋本大：7年間の経過を追えた緩徐に発育するⅠ期肺腺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016,137-138.
- 福沢嘉孝，吉富淳，大生定義，宮田靖志，吉嶺文俊，井口清太郎，吉永治彦：新内科専門医による地域医療の実践～地域包括ケア実現に向かう地域社会へのコミットメント～．日本内科学会雑誌 105(1): 119-125, 2016.
- 古橋一樹，須田隆文：喀痰（P痰・M痰）．透析患者診療に役立つ診断と重症度判定のためのアプローチ．加藤明彦,小松康宏,中山昌明（編）．日本メディカルセンター、2016, 102-103.
- 松井隆：塵肺と肺がん．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 165-166.
- 松井隆：大動脈弓と重なりシルエットサイン陰性の腫瘤影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 189-190.
- 横村光司：側面写真のほうが指摘しやすい右下肺野背側の腫瘤影．検診胸部X線写真の読影－肺がんの発見から治療、予後までを追う－浜松市医師会 肺結核・肺がん検診委員会（編）．国際医学出版 2016, 227-228.
2015年
英文掲載（原著）
- Akamatsu T, Inui N, Kusagaya H, Nakamura Y, Suda T, Chida K.：Evaluation of antibody levels over 3years after 23-valent pneumococcal polysaccharide vaccination in patients with pulmonary diseases receiving steroids and immunosuppressive agents.. Clin Biochem 48(3): 125-9, 2015.
- Enomoto N, Mikamo M, Oyama Y, Kono M, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Yasuda H, Kato A, Mimuro S, Doi M, Sato S, Suda T：Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival. BMC Pulm Med 15: 15, 2015.
- Enomoto Y， Inui N， Imokawa S， Karayama M， Hasegawa H， Ozawa Y， Matsui T， Yokomura K， Suda T：Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease. Cancer Chemother Pharmacol 76(3): 499-505, 2015.
- Enomoto Y, Kenmotsu H, Watanabe N, Baba T, Murakami H, Yoh K, Ogura T, Takahashi T, Goto K, Kato T：Efficacy and Safety of Combined Carboplatin, Paclitaxel, and Bevacizumab for Patients with Advanced Non-squamous Non-small Cell Lung Cancer with Pre-existing Interstitial Lung Disease: A Retrospective Multi-institutional Study. Anticancer Res 35(7): 4259-63, 2015.
- Fujii M, Shirai T, Mori K, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Suda T：Inspiratory resonant frequency as a predictor of the composite physiologic index in interstitial lung disease. Respir Physiol Neurobiol 207: 22-7, 2015.
- Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T：Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS One 10(3): e0120313, 2015.
- Ikeda M, Enomoto N, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Suda T, Nagata T：Nontypeable Haemophilus influenzae exploits the interaction between protein-E and vitronectin for the adherence and invasion to bronchial epithelial cells. BMC Microbiol. 15(1): 263, 2015.
- Inoue Y, Inui N, Asada K, Karayama M, Matsuda H, Yokomura K, Koshimizu N, Imokawa S, Yamada T, Shirai T, Kasamatsu N, Suda T：Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Cancer Chemother Pharmacol 76(1): 155-61, 2015.
- Inoue Y, Inui N, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Suda T：Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis. PLoS One 10(11): e0143371, 2015.
- Inoue Y, Matsuura S, Kurabe N, Kahyo T, Mori H, Kawase A, Karayama M, Inui N, Funai K, Shinmura K, Suda T, Sugimura H：Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification. J Thorac Oncol 10(11): 1590-600, 2015.
- Inui N, Matsushima S, Kato S, Yasui H, Kono M, Fujisawa T, Enomoto N, Nakamura Y, Toyoshima M, Suda T：Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 10: 1139-46, 2015.
- Maazi H, Patel N, Sankaranarayanan I, Suzuki Y, Rigas D, Soroosh P, Freeman GJ, Sharpe AH, Akbari O：ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42(3): 538-51, 2015.
- Matsushima S, Inui N, Yasui H, Kono M, Nakamura Y, Toyoshima M, Shirai T, Suda T：Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 30: 11-5, 2015.
- Mori K, Fujisawa T, Kusagaya H, Yamanaka K, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Maekawa M, Suda T：Synergistic Proinflammatory Responses by IL-17A and Toll-Like Receptor 3 in Human Airway Epithelial Cells. PLoS One 10(9): e0139491, 2015.
- Oda T, Ogura T, Kitamura H, Hagiwara E, Baba T, Enomoto Y, Iwasawa T, Okudela K, Takemura T, Sakai F, Hasegawa Y：Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Chest 146(5): 1248-55, 2014.
- Ogura T, Azuma A, Inoue Y, Taniguchi H, Chida K, Bando M, Niimi Y, Kakutani S, Suga M, Sugiyama Y, Kudoh S, Nukiwa T：All-case post marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis. Respir Investig 53(5): 232-41, 2015.
- Oyama Y, Fujisawa T, Hashimoto D, Enomoto N, Nakamura Y, Inui N, Kuroishi S, Yokomura K, Toyoshima M, Yamada T, Shirai T, Masuda M, Yasuda K, Hayakawa H, Chida K, Suda T：Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia. Eur Respir J 45(6): 1624-31, 2015.
- Ozawa Y， Abe T， Omae M， Matsui T， Kato M， Hasegawa H， Enomoto Y， Ishihara T， Inui N， Yamada K， Yokomura K， Suda T：Impact of preexisting interstitial lung disease on acute， extensive radiation pneumonitis: retrospective analysis of patients with lung cancer. PLoS One 10(10): e0140437, 2015.
- Ozawa Y， Omae M， Fujii M， Matsui T， Kato M， Sagisaka S， Asada K， Karayama M， Shirai T， Yasuda K， Nakamura Y， Inui N， Yamada K， Yokomura K， Suda T：Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. BMC Cancer 15(1): 589, 2015.
- Shinmura K, Igarashi H, Kato H, Kawanishi Y, Inoue Y, Nakamura S, Ogawa H, Yamashita T, Kawase A, Funai K, Sugimura H：CLCA2 as a novel immunohistochemical marker for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the lung. Dis Markers 2014: 619273, 2014.
- Shinmura K, Kato H, Igarashi H, Inoue Y, Nakamura S, Du C, Kurachi K, Nakamura T, Ogawa H, Tanahashi M, Niwa H, Sugimura H：CD44-SLC1A2 fusion transcripts in primary colorectal cancer. Pathol Oncol Res 21(3): 759-64, 2015.
- Shinmura K, Kato H, Kawanishi Y, Goto M, Tao H, Inoue Y, Nakamura S, Sugimura H：NEIL1 p.Gln282Stop variant is predominantly localized in the cytoplasm and exhibits reduced activity in suppressing mutations. Gene 571(1): 33-42, 2015.
- Shinmura K, Kato H, Kawanishi Y, Nagura K, Kamo T, Okubo Y, Inoue Y, Kurabe N, Du C, Iwaizumi M, Kurachi K, Nakamura T, Sugimura H：SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer. Oncol Rep 34(2): 727-38, 2015.
- Shirai T, Mikamo M, Tsuchiya T, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T：Real-world effect of gastroesophageal reflux disease on cough-related quality of life and disease status in asthma and COPD. Allergol Int 64: 79-83, 2015.
- Shirai T, Mori K, Tsuchiya T, Suda T：Resonant frequency as a predictor of phase III slope of nitrogen single-breath washout in asthma. Ann Allergy Asthma Immunol 115: 73-4, 2015.
英文掲載（症例報告）
- Akiyama N, Toyoshima M, Kono M, Nakamura Y, Funai K, Suda T：Methotrexate-induced accelerated pulmonary nodulosis. Am J Respir Crit Care Med 192(2): 252-3, 2015.
- Enomoto Y， Oba M， Ishii N， Nakanaga K， Yagi Y， Hasegawa H， Ozawa Y， Matsui T， Yokomura K， Suda T：Rhinosinusitis and disseminated cutaneous infection caused by Mycobacterium chelonae in an immunocompromised patient. J Infect Chemother 21(9): 691-4, 2015.
- Enomoto Y， Yokomura K， Suda T ：Bilateral pleural effusion associated with miliary sarcoidosis. Am J Respir Crit Care Med 191(4): 474-5, 2015.
- Imokawa S, Uehara M, Uto T, Sato J, Suda T：Organaizing pneumonia associated with myeloperoxidase anti-neutrophil cytoplasmic antibody. Respirology Case Reports 3(4): 122-4, 2015.
- Kasuya A, Kaneko Y, Enomoto N, Suda T, Tokura Y：Simultaneous reactivation of cytomegalovirus in an adult patient with varicella. J Dermatol 42(6): 658-9, 2015.
- Kato S, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T：Severe respiratory failure associated with influenza B virus infection. Respirol Case Rep 3(2): 61-3, 2015.
- Kusagaya H, Fujisawa T, Enomoto N, Inui N, Nakamura Y, Suda T：Co-occurrence of Pneumoperitoneum and Pneumothorax in a Patient with Pleuroparenchymal Fibroelastosis. Am J Respir Crit Care Med 191(10): 1200-1, 2015.
- Mochizuki E, Shirai T, Noguchi R, Mitsui C, Taniguchi M, Suda T：Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug. Resprol Case Rep 3: 3-5, 2015.
- Nakamura Y, Miura K, Yasumizu R, Sato M, Suda T：Dendriform pulmonary ossification visualised by scanning acoustic microscope. Thorax 70(5): 512-3, 2015.
- Suzuki Y, Imokawa S, Nihashi F, Uto T, Sato J, Suda T：Diffuse alveolar hemorrhage caused by exposure to organic dust. Respiratory Medicine Case Reports 15: 59-61, 2015.
- Yasui H, Nakamura Y, Hasegawa H, Fujisawa T, Enomoto N, Inui N, Fukuoka J, Suda T：A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjögren's syndrome treated with methotrexate for rheumatoid arthritis. Respir Med Case Rep 15: 4-6, 2015.
- Yasui H, Nakamura Y, Hasegawa H, Fujisawa T, Enomoto N, Inui N, Fukuoka J, Suda：A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjogren's syndrome treated with methotrexate for rheumatoid arthritis. Respiratory Medicine Case Reports 15: 4-6, 2015.
- Yoshimura K, Sato J, Imokawa S, Kageyama H, Tokura Y, Suda T：Organaizing pneumonia associated with multicentric reticulohistiocytosis. Respirology Case Reports 3(4): 125-7, 2015.
和文掲載（総説）
- 妹川史朗：感染症(1) インフルエンザ．デジタルハイジーン別冊 診療室・多職種協働の現場で活きる！歯科衛生士のための全身疾患ハンドブック．橋本賢二・増本一真（編）．医歯薬出版株式会社、2015
- 榎本泰典, 須田隆文：IPF併存症としての糖尿病. 呼吸器内科 28(5): 347-9, 2015.
- 白井敏博：喘息予防・管理ガイドライン」2015改訂のポイントと今後の展望 トピックス2) 呼気NO測定装置NIOX VERO. Progress in Medicine 35: 1625-9, 2015.
- 須田隆文：膠原病関連間質性肺炎の診断・治療. 医学と薬学 72(6): 1037-46, 2015.
- 須田隆文：膠原病関連：呼吸器疾患の鑑別と治療. 呼吸器内科 27(2): 164-70, 2015.
- 須田隆文：膠原病関連：呼吸器疾患の鑑別と治療. 呼吸器内科 27(2): 164-70, 2015.
- 豊嶋幹生：慢性閉塞性肺疾患（COPD）．デンタルハイジーン別冊、2015、65-6.
- 穂積宏尚，須田隆文：間質性肺疾患におけるUCTD診断の臨床的意義. 呼吸器内科 27(4): 298-303, 2015.
- 穂積宏尚, 須田隆文：【ステロイド薬(含吸入薬)の基礎と呼吸器疾患への臨床応用】 間質性肺炎 膠原病に合併した間質性肺疾患に対する治療戦略. 日本胸部臨床 74(4): 411-25, 2015.
- 三輪清一：PK-PD理論に基づく非結核性抗酸菌症治療. 呼吸器内科 27(1): 58-62, 2015.
- 横村光司：知っておきたい!全身疾患の基礎知識と歯科診療における注意点 呼吸器疾患 肺炎(解説/特集)．デンタルハイジーン 【診療室・多職種協働の現場で活きる!歯科衛生士のための全身疾患ハンドブック】．医歯薬出版株式会社、2015、58-61.
- 横村光司，須田隆文：【今さらきけない呼吸器外来診療】 膿性痰が出ます(解説/特集). 成人と生活習慣病 45(6): 703-7, 2015.
- 福沢嘉孝，吉富淳，中森史朗，村上大輔，美甘真史，伊吹恵里，牛越博昭，濱村啓介：第20回東海支部専門医部会教育セミナーまとめ 内科医が遭遇する救急疾患. 日本内科学会雑誌 104(11): 2436-44, 2015.
- 福沢嘉孝，吉富淳，山内雅裕，石川英二，伊吹恵里，佐竹康臣，春田純一，恒川幸司：内科疾患と臨床推論. 日本内科学会雑誌 104(8): 1672-9, 2015.
和文掲載（原著）
- 上原正裕, 藤澤朋幸, 森和貴, 井上裕介, 橋本大, 榎本紀之, 中村祐太郎, 乾直輝, 須田隆文：成人気管支喘息における増悪予測因子の検討. アレルギーの臨床 35(8): 774-6, 2015.
- 原田雅教，古橋一樹，早川啓史，安田和雅，増田昌文，白井敏博，山田孝，菅沼秀基，豊嶋幹生，黒石重城，中村祐太郎，乾直輝，須田隆文，千田金吾：成人院内肺炎に対するdoripenem(DRPM)の有効性と安全性の検討. 新薬と臨床 64: 996-1005, 2015.
和文掲載（研究報告）
- 須田隆文，渡辺憲太朗：慢性進行肺線維化症例の疫学・治療法検討分科会. 厚生労働科学研究委託業務難治性疾患実用化研究事業 びまん性肺疾患に対するエビデンスを構築する新規戦略的研究班, 2014.
- 榎本紀之，美甘真史，大山吉幸，河野雅人，藤澤朋，乾直輝，中村祐太郎，須田隆文：膠原病的背景を有する特発性間質肺炎の多施設共同コホート研究〜中間報告2014〜. 厚生労働科学研究委託業務難治性疾患実用化研究事業 びまん性肺疾患に対するエビデンスを構築する新規戦略的研究班, 2014.
和文掲載（症例報告）
- 秋山訓通, 横村光司, 野末剛史, 阿部岳文, 松井隆, 須田隆文：メサラジンによる薬剤性肺炎の3例. アレルギー 64(10): 1334, 2015.
- 右藤智啓，青野祐也，天野雄介，青島洋一郎，神谷陽輔，吉村克洋，匂坂伸也，佐藤潤，妹川史朗，安田和雅：レーザー焼灼治療前後で気道抵抗の変化を確認し得た気管原発腺様嚢胞癌の1例. 気管支学 37(1): 94-8, 2015.
- 浦野聖子, 鈴木陽子, 安澤数史, 大石強, 黒石重城, 伊藤尚美, 岡田宇史, 望月隆：関節リウマチおよび肺癌罹患患者に生じたExophiala xenobioticaによるphaeomycotic cyst. Medical Mycology Journal 55(4): J151-6, 2014.
- 大前美奈子，横村光司，阿部岳文，秋山訓通，野末剛史，須田隆文：小細胞肺癌・間質性肺炎の治療中に播種性水痘を発症し死亡した1例. 日本呼吸器学会雑誌 4(5): 403-7, 2015.
- 加藤慎平, 笠松紀雄, 松田周一, 杉本俊介, 矢野利章, 小笠原隆：陽陰圧体外式人工呼吸器を併用し全肺洗浄を行った自己免疫性肺胞蛋白症の1例. 日本呼吸器学会雑誌 4(2): 185-8, 2015.
- 上沼康範，榎本泰典，幸田敬悟，阿部岳文，横村光司，須田隆文：グルコサミン製剤に含有された漢方成分が原因と考えられた薬剤性肺炎の1例. 日本呼吸器学会雑誌 4(4): 323-6, 2015.
- 近藤あかり, 松田宏幸, 堀池安意, 丹羽充, 平田健雄, 須田隆文：CT画像が診断の契機となったアミオダロン肺障害の1例. 日本呼吸器学会雑誌 4(1): 125-28, 2015.
- 二橋文哉, 豊嶋幹生, 秋山訓通, 鈴木清一郎, 須田隆文：養蜂業者にみられたミツバチ刺傷後に発症した間質性肺炎の1例. 日本職業・環境アレルギー学会雑誌 22(2): 73-7, 2015.
- 野末剛史，横村光司，赤堀大介，阿部岳文，秋山訓通，須田隆文：胃胸腔瘻による膿気胸で発症した胃原発びまん性大細胞型B細胞性リンパ腫の1例. 日本呼吸器学会雑誌 4(3): 235-9, 2015.
- 松島紗代実, 藤澤朋幸, 原田雅教, 河野雅人, 榎本紀之, 中村祐太郎, 乾直輝, 目黒史織, 岩下寿秀, 馬場聡, 須田隆文：CPC日常臨床から学ぶ この症例の新しい意義は? 腎移植後に多剤耐性緑膿菌感染をきたした1例. THE LUNG-perspectives 23(4): 318-22, 2015.
- 吉村克洋， 深田充輝， 青野祐也， 天野雄介， 神谷陽輔， 鈴木勇三， 右藤智啓， 佐藤潤， 妹川史朗， 須田隆文：スネアループが摘出に有用であった歯冠補綴物による気道異物の2例. 気管支学 37: 550-5, 2015.
和文掲載（その他）
- 白井敏博：一般社団法人日本アレルギー学会喘息ガイドライン専門部会 「喘息予防・管理ガイドライン2015」（協和企画、2015）作成委員
- 須田隆文：免疫症候群(第2版)-その他の免疫疾患を含めて- Ⅰ. 臓器特異的自己免疫疾患 自己免疫性呼吸器疾患 特発性間質性肺炎．別冊日本臨床 新領域別症候群シリーズ．宮坂信之（編）．日本臨床社、2015、406-10.
- 須田隆文：Case16 肺炎を疑われ, 当院に紹介となった56歳女性．New 専門医を目指すケース・メソッド・アプローチ 呼吸器疾患第3版．永井厚志（編）．日本医事新報社、2015、148-159.
- 白井敏博：免疫疾患・膠原病 (1) アレルギー．デンタルハイジーン別冊 歯科衛生士のための全身疾患ハンドブック、2015、82-4.
- 横村光司，須田隆文：透析患者における結核，非結核性抗酸菌章の特徴，抗菌薬の使いかたを教えてください．いまさら訊けない！透析患者薬剤の考え方、使いかた．加藤明彦（編）．中外医薬社、2015、53-9.
2014年
英文掲載（原著）
- Enomoto N, Kusagaya H, Oyama Y, Kono M, Kaida Y, Kuroishi S, Hashimoto D, Fujisawa T, Yokomura K, Inui N, Nakamura Y, Suda T：Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF). BMC Pulm Med 14: 91, 2014.
- Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, Inui N, Yokomura K, Koshimizu N, Toyoshima M, Shirai T, Yasuda K, Hayakawa H, Suda T：Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9(6): e98824, 2014.
- Fujiyama T, Ito T, Ogawa N, Suda T, Tokura Y, Hashizume H：Preferential infiltration of IL-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis. Clin Exp Immuol 177(1): 110-20, 2014.
- Harada M, Kotake Y, Ohhata T, Kitagawa K, Niida H, Matsuura S, Funai K, Sugimura H, Suda T, Kitagawa M.：YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers. Genes Cells 19(6): 504-16, 2014.
- Inui N, Akamatsu T, Uchida S, Tanaka S, Namiki N, Karayama M, Chida K, Watanabe H：Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method. Clin Pharmacol Ther 94(6): 702-8, 2013.
- Irisawa H, Takeuchi K, Inui N, Miyakawa S, Morishima Y, Mizushima T, Watanabe H：Incremental shuttle walk test as a valuable assessment of exercise performance in patients with pulmonary arterial hypertension. Circ J 78(1): 215-21, 2014.
- Ito Y, Karayama M, Inui N, Kuroishi S, Nakano H, Nakamura Y, Yokomura K, Toyoshima M, Shirai T, Masuda M, Yamada T, Yasuda K, Hayakawa H, Suda T, Chida K：Aprepitant in patients with advanced non-small-cell lung cancer receiving carboplatin-based chemotherapy. Lung Cancer 84(3): 259-64, 2014.
- Kato M, Fujisawa T, Hashimoto D, Kono M, Enomoto N, Nakamura Y, Inui N, Hamada E, Miyazaki O, Kurashita S, Maekawa M, Suda T：Plasma connective tissue growth factor levels as potential biomarkers of airway obstruction in patients with asthma. Ann Allergy Asthma Immunol 113(3): 295-300, 2014.
- Kono M, Nakamura Y, Enomoto N, Hashimoto D, Fujisawa T, Inui N, Maekawa M, Suda T, Colby TV, Chida K：Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 9(4): e94775, 2014.
- Kusagaya H, Fujisawa T, Yamanaka K, Mori K, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Wu R, Maekawa M, Suda T, Chida K：TLR-Mediated Airway IL-17C Enhances Epithelial Host Defense in an Autocrine/Paracrine Manner. Am J Respir Cell Mol Biol 50(1): 30-9, 2014.
- Matsushima S, Inui N, Yasui H, Kono M, Nakamura Y, Toyoshima M, Shirai T, Suda T：Indacaterol and tiotropium combination therapy in patients with chronicobstructive pulmonary disease. Pulm Pharmacol Ther 30(1): 11-5, 2014.
- Mikamo M, Shirai T, Mori K, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T：Predictors of expiratory flow limitation measured by forced oscillation technique in COPD. BMC Pulm Med 14:23, 2014.
- Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H：Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease: A Preliminary Study. Ann Am Thorac Soc 11(1): 23-9, 2014.
- Nakashima R, Imura Y, Hosono Y, Seto M, Murakami A, Watanabe K, Handa T, Mishima M, Hirakata M, Takeuchi T, Fujio K, Yamamoto K, Kohsaka H, Takasaki Y, Enomoto N, Suda T, Chida K, Hisata S, Nukiwa T, Mimori T：The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia. PLoS One 9(1): e85062, 2014.
- Odagiri K, Inui N, Miyakawa S, Hakamata A, Wei J, Takehara Y, Sakahara H, Sugiyama M, Alley MT, Tran QK, Watanabe H：Abnormal hemodynamics in the pulmonary artery seen on time-resolved 3-dimensional phase-contrast magnetic resonance imaging (4D-flow) in a young patient with idiopathic pulmonary arterial hypertension. Circ J 78(7): 1770-2, 2014.
- Shirai T, Kawayama T, Nagase T, Inoue H, Sato S, Asano K, Kume H：Exhaled nitric oxide measurement may predict asthma exacerbation after stepping down formoterol/budesonide combination therapy in adult astma. J Allergy Ther 5: 173, 2014.
- Tanaka S, Uchida S, Inui N, Takeuchi K, Watanabe H, Namiki N：Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites. Biol Pharm Bull 37(1): 18-25, 2014.
- Tanaka S, Uchida S, Miyakawa S, Inui N, Takeuchi K, Watanabe H, Namiki N：Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome P450 3A4. Biol Pharm Bull 36(12): 1936-41, 2013.
- Tsuchiya T：Risk of performing multiple logistic regression analysis without considering multiplicity: an overview for clinicians and practitioners. J Med Stat Inform 2:7, 2014.
- Uto T, Yasuda K, Sagisaka S, Sato J, Imokawa S, Uemura N, Suda T, Chida K：Serial QuantiFERON TB-2G testing over a four-year period in healthcare workers at a city hospital. Intern Med 53(11): 1119-24, 2014.
- Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H：Overview of Green Tea Interaction with Cardiovascular Drugs. Curr Pharm Des 21(9) : 1213-9, 2015.
- Yamamoto Y, Ohmichi M, Watanabe A, Niki Y, Aoki N, Kawai S, Chida K, Mikasa K, Seki M, Ishida T, Kadota J, Matsuse H, Fujita J, Kohno S：A study on the management of acute respiratory tract infection in adults. The Japanese journal of antibiotics 67(4): 223-32, 2014.
英文掲載（症例報告）
- Fujii M, Shirai T, Asada K, Saito Y, Hirose M, Suda T：Synchronous diffuselarge B-cell lymphoma and squamous cell lung carcinoma. Respirol Case Rep 2(1): 33-5, 2014.
- Furuhashi K, Enomoto N, Fujisawa T, Hashimoto D, Inui N, Nakamura Y, Suda T：Hermansky-Pudlak syndrome with nonspecific interstitial pneumonia. Intern Med 53(5): 449-53, 2014.
- Morita S, Shirai T, Asada K, Fujii M, Suzuki M, Suda T：Pulmonary cryptococcosis presenting with a large cavity. Respirol Case Rep 2(2): 61-3, 2014.
- Shirai T, Mochizuki E, Asada K, Suda T：Pollen count and exhaled nitric oxide levels in a seasonal allergic rhinitis patient.. Respirol Case Rep 2(3): 113-5, 2014.
- Suzuki S, Toyoshima M, Nihashi F, Tsukui H, Baba S, Sugimura H, Suda T：An autopsy case of malignant pleural mesothelioma associated with nephrotic syndrome. Intern Med 53(3): 243-6, 2014.
- Suzuki S, Toyoshima M, Yamashita S, Suda T：Pulmonary arteriovenous fistula occurring within a pulmonary cyst. Intern Med 53(4): 333-4, 2014.
- Toyoshima M, Suzuki S, Kono M, Nakamura Y, Suda T：Mildly progressive pulmonary lymphangiectasis diagnosed in a young adult. Am J Respir Crit Care Med 189(7): 860-2, 2014.
和文掲載（総説）
- 豊嶋幹生，秋山訓通，鈴木清一郎，須田隆文：メトトレキサートによる薬剤性肺炎の臨床病理学的検討. アレルギーの臨床 34: 971-3, 2014.
- 河野雅人，須田隆文：特集 特発性間質性肺炎に関する最新の話題 非特異性間質性肺炎－診断と治療，UCTDの意義を含めて－. Respiratory Medical Research 2(2): 104-10, 2014.
- 白井敏博：最新の吸入ステロイド療法7 吸入指導の現状と問題点. 月刊アレルギーの臨床 (463): 962-5, 2014.
- 須田隆文：間質性肺炎と樹状細胞. 呼吸 33(5): 425-34, 2014.
- 須田隆文：肺サルコイドーシス/最新の話題. 呼吸器内科 25(2): 147-55, 2014.
- 須田隆文：特集 かかりつけ医のための間質性肺炎の手引き 鑑別が難しい類縁疾患 -肺病変先行型の膠原病肺と膠原病疑診例. 日本医師会雑誌 143(5): 986-90, 2014.
- 千田金吾：特集 びまん性肺疾患の最新情報 間質性肺炎にステロイド薬をどのように役立てるか？. 呼吸器内科 25(2): 98-104, 2014.
- 中村祐太郎，須田隆文：特集：呼吸器病学TOPICS 2013-2014 5.びまん性肺疾患 Idiopathic pleuroparenchymal fibroelastosis. 分子呼吸器病 18(1): 47-9, 2014.
- 藤澤朋幸：I型アレルギーのバイオマーカー. 臨床検査 58(2): 253-8, 2014.
- 穂積宏尚，須田隆文：特集 肺血管炎の基礎と臨床 顕微鏡多発血管炎の病態，肺病変の特徴，治療. 呼吸器内科 25(4): 294-302, 2014.
和文掲載（研究報告）
- 須田隆文，榎本紀之：膠原病的背景を有する特発性間質性肺炎の多施設共同コホート研究～中間解析～. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 : 89-93, 2014.
- 須田隆文，河野雅人，大山吉幸，榎本紀之，藤澤朋幸，中村祐太郎，乾直輝：特発性肺線維症（IPF）における肺病変先行型膠原病関連間質性肺炎（CVD-IP）. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 : 223-32, 2014.
和文掲載（症例報告）
- 近藤あかり，松田宏幸，土屋一夫，丹羽充，平田健雄，須田隆文：重度の肝機能障害を合併しステロイド剤の併用が奏効した粟粒結核の1例. 日本呼吸器学会雑誌 3(4): 590-3, 2014.
- 西本幸司，鈴木清一郎，右藤智啓，匂坂伸也，佐藤潤，妹川史朗，安田和雅，影山葉月，須田隆文：器質化肺炎の所見を呈したSweet病に伴う肺病変の1例. アレルギー 63(7): 938-44, 2014.
- 西本幸司，鈴木清一郎，右藤智啓，匂坂伸也，佐藤潤，妹川史朗，安田和雅，須田隆文，千田金吾：気管支肺胞洗浄液のリンパ球刺激試験が陽性を示した柴苓湯による薬剤性肺炎の1例. 気管支学 36(1): 68-72, 2014.
- 西本幸司，小清水直樹，長岡深雪，津久井賢，須田隆文：気管支肺胞洗浄が有効であった軽油肺炎の１例. 気管支学 36(6): 656-60, 2014.
和文掲載（その他）
- 須田隆文：膠原病と肺病変 関節リウマチ．最新医学 別冊 新しい診断と治療のABC．最新医学社、2014、15-23.
- 須田隆文, 千田金吾：II．1 呼吸器病変について．サルコイドーシス診療 Q & A 集. 2014、 51-5.
- 須田隆文, 千田金吾：III．診断の進歩 4．IIPs とUCTD, Lung-dominant CTD, Autoimmune-featured ILD. Annual Review 呼吸器 2014．中外医学社、2014、151-8.
- 千田金吾：IV-A 特発性間質性肺炎 3 非特異性間質性肺炎（NSIP）．間質性肺疾患 診療マニュアル 改訂第2版．南江堂、2014、236-40.
- 中村祐太郎，須田隆文：特発性間質性肺炎（IIPs）各疾患の診断と治療 8)リンパ球性間質性肺炎（LIP）とIPPFE．インフォームドコンセントのための図説シリーズ びまん性肺疾患と特発性間質性肺炎．医薬ジャーナル社、2014、128-33.
- 穂積宏尚，須田隆文：IV-A 特発性間質性肺炎 4 非特異性間質性肺炎（NSIP）の急性増悪．間質性肺疾患 診療マニュアル 改訂第2版．南江堂、2014、241-4.
- 乾直輝：呼吸器抄読会 浜松医科大学呼吸器内科. 呼吸 33(4): 417, 2014.
- 東田有智，田中裕士，白井敏博，長谷川隆志：喘息管理におけるアンダートリートメントへの挑戦. 吸入療法 6(2): 6-15, 2014.
2013年
英文掲載（原著）
- Akamatsu T, Arai Y, Kosugi I, Kawasaki H, Meguro S, Sakao M, Shibata K, Suda T, Chida K, Iwashita T：Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences. Fibrogenesis Tissue Repair 6(1): 15, 2013.
- Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.：Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Pulm Pharmacol Ther 27(1): 52-6, 2014.
- Enomoto N, Suda T, Kono M, Kaida Y, Hashimoto D, Fujisawa T, Inui N, Nakamura Y, Imokawa S, Funai K, Chida K：Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir Med 107(10): 1608-16, 2013.
- Fujisawa T, Yasui H, Akamatsu T, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Maekawa M, Suda T, Chida K.：Alveolar nitric oxide concentration reflects peripheral airway obstruction in stable asthma. Respirology. 18(3): 522-7, 2013.
- Harada M, Inui N, Suda T, Nakamura Y, Wajima T, Matsuo Y, Chida K：Pharmacokinetic analysis of doripenem in elderly patients with nosocomial pneumonia. Int J Antimicrob Agents 42(2): 149-54, 2013.
- Hozumi H, Tsujimura K, Yamamura Y, Seto S, Uchijima M, Nagata T, Miwa S, Hayakawa H, Fujisawa T, Hashimoto D, Inui N, Suda T, Chida K, Koide Y：Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan. Int J Tuberc Lung Dis 17(6): 818-24, 2013.
- Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Kono M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Suda T, Chida K：Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 3(9): 2013.
- Karayama M, Inui N, Kuroishi S, Yokomura K, Toyoshima M, Shirai T, Masuda M, Yamada T, Yasuda K, Suda T, Chida K：Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study. Cancer Chemother Pharmacol 72(2): 445-52, 2013.
- Kotake Y, Ozawa Y, Harada M, Kitagawa K, Niida H, Morita Y, Tanaka K, Suda T, Kitagawa M：YB1 binds to and represses the p16 tumor suppressor gene. Genes Cells 18(11): 999-1006, 2013.
- Kurabe N, Hayasaka T, Igarashi H, Mori H, Sekihara K, Tao H, Yamada H, Kahyo T, Onishi I, Tsukui H, Kawase A, Matsuura S, Inoue Y, Shinmura K, Funai K, Setou M, Sugimura H：Visualization of phosphatidylcholine (16:0/16:0) in type II alveolar epithelial cells in the human lung using imaging mass spectrometry. Pathol Int. 63(4): 195-200, 2013.
- Matsuura S, Shinmura K, Kamo T, Igarashi H, Maruyama K, Tajima M, Ogawa H, Tanahashi M, Niwa H, Funai K, Kohno T, Suda T, Sugimura H：CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma. Oncol Rep 30(4): 1675-80, 2013.
- Matsuura S, Kahyo T, Shinmura K, Iwaizumi M, Yamada H, Funai K, Kobayashi J, Tanahashi M, Niwa H, Ogawa H, Takahashi T, Inui N, Suda T, Chida K, Watanabe Y, Sugimura H：SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers. Sci Rep 3: 3012, 2013.
- Mikamo M, Shirai T, Mori K, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Tsuchiya T, Suda T：Predictors of phase III slope of nitrogen single-breath washout in COPD. Respir Physiol Neurobiol 189(1): 42-6, 2013.
- Miwa S, Suzuki Y, Shirai M, Ohba H, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K.：Assessment of serum KL-6 as a prognostic marker in pulmonary tuberculosis patients. Int J Tuberc Lung Dis 17(2): 240-2, 2013.
- Mori K, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Hozumi H, Suda T, Chida K：Respiratory mechanics measured by forced oscillation technique in combined pulmonary fibrosis and emphysema. Respir Physiol Neurobiol 185(2): 235-40, 2013.
- Shirai T, Mori K, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T, Chida K：Respiratory mechanics and peripheral airway inflammation and dysfunction in asthma．Clin Exp Allergy 43(5): 521-6, 2013.
- Shirai T, Mori K, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T, Chida K：Usefulness of Colored 3D Imaging of Respiratory Impedance in Asthma. Allergy Asthma Immunol Res 5(5): 322-8, 2013.
- Suzuki Y, Miwa S, Akamatsu T, Suzuki M, Fujie M, Nakamura Y, Inui N, Hayakawa H, Chida K, Suda T：Indoleamine 2,3-dioxygenase in the pathogenesis of tuberculous pleurisy. Int J Tuberc Lung Dis 17(11): 1501-6, 2013.
- Okamoto T, Miyazaki Y, Ogura T, Chida K et al：A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig 51(3): 191-9, 2013.
- Yasui H, Inui N, Furuhashi K, Nakamura Y, Uto T, Sato J, Yasuda K, Takehara Y,Suda T, Chida K.：Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 26(3): 336-41, 2013.
- Yasui H, Suzuki Y, Sano H, Suda T, Chda K, Dan T, Miyata T, Urano T：TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Thromb Res 132(1): 100-5, 2013.
英文掲載（症例報告）
- Imokawa S, Uehara M, Uto T, Sagisaka S, Sato J, Yasuda K, Matsushita K, Oi S, Tanioka F, Suda T, Chida K：Pulmonary metastasis from urothelial carcinoma showing progressive multiple cystic lesions. Am J Respir Crit Care Med 188(10): 1267-8, 2013.
- Takeuchi Y, Shirai T, Sakurai S, Mikamo M, Fujii M, Suda T：Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirology Case Reports 1(1): 5-7, 2013.
- Yoshida Y, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T：Development of allergic bronchopulmonary aspergillosis with central bronchiectasis over a 10-year period: the need to recheck allergen sensitization. Intern Med 52(18): 2135-8, 2013.
和文掲載（総説）
- 池ヶ谷佳寿子，加瀬澤友梨，土屋憲，濱田敦子，難波真奈美，明貝路子，小路毅，丸尾啓敏，増田昌文：菌種を限定しないリアルタイムアウトブレイク監視およびラウンド記録管理のシステム化. 日本環境感染学会誌 28(2): 101-8, 2013.
- 白井敏博，野口理絵，望月栄佑，櫻井章吾，美甘真史，宍戸雄一郎，秋田剛史，森田悟，朝田和博，藤井雅人，須田隆文，千田金吾：成人喘息における血清ペリオスチンとeosinophil cationic protein(ECP)の関連. 呼吸 32(5): 479, 2013.
- 安井秀樹，横村光司，松島紗代実，大山吉幸，草ヶ谷英樹，河野雅人，松井隆，須田隆文，千田金吾：Ⅱ型呼吸不全を伴う慢性閉塞性肺疾患増悪に対する非侵襲的陽圧換気療法の有用性について－当院における治療成績－. 日本呼吸器学会雑誌 2(3): 163-8, 2013.
- 赤松泰介，千田金吾：【呼吸器疾患の診断と治療（Ⅲ）】肺胞蛋白症. 医学と薬学 69(3): 343-8, 2013.
- 池田政輝，千田金吾：【サルコイドーシスの合併症】アジュバント病としてのサルコイドーシス. 日本胸部臨床 72(8): 866-74, 2013.
- 妹川史朗，中村祐太郎，須田隆文，千田金吾：【特発性間質性肺炎-この10年の進歩と今後の展望-】膠原病と関連した間質性肺炎 関節リウマチ（RA）/シェーグレン症候群（SjS）にみられる間質性肺炎. 日本胸部臨床 72(増刊号): S256-62, 2013.
- 佐藤潤，千田金吾：職業性過敏性肺炎. 呼吸器内科 23(5): 472-9, 2013.
- 白井敏博，野口理絵，望月栄佑，櫻井章吾，美甘真史，宍戸雄一郎，秋田剛史，森田悟，朝田和博，藤井雅人，須田隆文，千田金吾：成人喘息における血清ペリオスチンとeosinophil cationic protein(ECP)の関連. 呼吸 32(5): 479, 2013.
- 白井敏博：【もっと知りたい!吸入療法-喘息・COPD治療の新たな展開-】もっと知りたい!吸入療法のトレンド ICS使用中の喘息患者に対するロイコトリエン受容体拮抗薬・テオフィリン徐放製剤の活用法. 薬局 64(1): 94-9, 2013.
- 白井敏博：【呼吸機能検査Update】呼気NOと閉塞性指標との関連. 医学のあゆみ 244(11): 977-80, 2013.
- 須田隆文：（第4章）主要疾患 病態・診断・治療 全身性疾患の肺病変 膠原病の肺病変．医学のあゆみ 別冊呼吸器疾患-state of arts ver.6．医歯薬出版株式会社，2013，409-11.
- 須田隆文：【特発性間質性肺炎-この10年の進歩と今後の展望-】膠原病と関連した間質性肺炎 IIPsとUCTD/Lung-dominant CTD/Autoimmune-featured ILD. 日本胸部臨床 72(増刊号): S222-8, 2013.
- 藤澤朋幸，千田金吾：膠原病に伴う肺病変. 呼吸 32(6): 497-505, 2013.
- 穂積宏尚，千田金吾：【特集 特発性間質性肺炎を見直す】 -特発性間質性肺炎臨床の最新知見-. 呼吸と循環 61(2): 123-31, 2013.
- 穂積宏尚，須田隆文，千田金吾：【2次性間質性肺炎の画像診断をめぐって】膠原病的特徴を持つ間質性肺炎の臨床像と画像所見 NSIP，UCTD，lung dominant CTD，膠原病の肺病変をめぐって. 日本胸部臨床 72(9): 934-48, 2013.
- 森和貴，須田隆文，千田金吾：【間質性肺炎と周辺疾患 -感染症から薬剤性まで-】膠原病に合併する間質性肺炎. 化学療法の領域 29(4): 640-7, 2013.
- 横村光司，千田金吾：Ⅳ 間質性肺炎 6.慢性好酸球性肺炎．呼吸器疾患 最新の治療 2013-2015．南江堂，2013，329-30.
- 横村光司，千田金吾：稀な肺疾患 肺肉腫. 呼吸 32(3): 259-265, 2013.
和文掲載（研究報告）
- 千田金吾，須田隆文：膠原病との関連が疑われるIIPs症例の前向き調査. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成24年度研究報告書 : 105-8, 2013.
- 千田金吾，榎本紀之，草ヶ谷英樹， 大山吉幸，河野雅人， 中村祐太郎，橋本大，藤澤朋之，乾直輝，横村光治，須田隆文：Idiopathic pleuroparenchymal fibroelastosis (IPPFE) 3症例におけるピルフェニドンの使用経験. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成24年度研究報告書 : 155-62, 2013.
- 千田金吾，榎本紀之，須田隆文，貝田勇介，谷口正実，吾妻安良太，林宏紀，山口央，小倉高志，北村英也，安藤正幸，佐藤篤彦，工藤翔二：特発性肺線維症 (IPF) に対する乾燥スルホ化免疫グロブリン療法に関する前向き多施設共同治療研究. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成24年度研究報告書 : 251-9, 2013.
- 田口善夫，橋本成修，石井芳樹，海老名雅仁，岸一馬，谷口博之，千田金吾，本間栄：急性増悪部会（田口善夫） 急性増悪治療に関する二次アンケート調査. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成24年度研究報告書 : 93-7, 2013.
- 立石知也，上甲剛，酒井文和，宮崎泰成，小倉高志，一門和哉，千田金吾，田口善夫．井上義一，武村民子，Thomas V. Colby，澄川裕充，藤本公則，荒川浩明，稲瀬直彦：慢性過敏性肺炎のUIPパターンとIPF/UIPのHRCT画像比較検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成24年度研究報告書 : 185-9, 2013.
和文掲載（症例報告）
- 井上裕介，吉村克洋，大前美奈子，佐藤慈子，横村光司，須田隆文，千田金吾：気管支喘息発作の治療中に侵襲性肺アスペルギルス症を発症した1例. 日本呼吸器学会雑誌 2(1): 53-8, 2013.
- 吉村克洋，横村光司，大前美奈子，佐藤慈子，大谷速人，須田隆文，千田金吾：間質性肺炎に合併したplatypnea-orthodeoxia syndromeの1例. 日本呼吸器学会雑誌 2(5): 593-7, 2013.
- 大前美奈子，横村光司，吉村克洋，佐藤慈子，須田隆文，千田金吾：Mycobacterium shimoideiによる非結核性抗酸菌症の1例. 日本呼吸器学会雑誌 2(5): 622-6, 2013.
- 藤田総文，伊波奈穂，芦澤洋喜，土屋智義，吉富淳，増田昌文，須田隆文，千田金吾：ダビガトランエテキシラートによる薬剤性好酸球性肺炎の1例. 日本呼吸器学会雑誌 2(4): 414-8, 2013.
和文掲載（その他）
- 榎本紀之，乾直輝，須田隆文，千田金吾：28 サルコイドーシスの臨床経過・予後．皮膚科臨床アセット 14 肉芽腫生皮膚疾患 サルコイドーシス・他の肉芽腫．中山書店，2013，162-8.
- 千田金吾，須田隆文，乾直輝，中村祐太郎：．Q & Aでわかる呼吸器疾患ガイドライン実践ブック．南江堂，2013.
- 千田金吾，中野豊：4 呼吸器．ナースの内科学．奈良信雄（編）．中外医学社，2013，171-226.
- 千田金吾：各種疾患の治療と看護 呼吸器疾患 薬剤性肺障害．今日の治療と看護．永井良三（編）．南江堂，2013，420-2.
- 千田金吾：膠原病にみられる肺病変．内科学 第10版．朝倉書店，2013，790-3.
- 千田金吾：【胸部画像を読み解く】 胸部単純X線写真の診かた. 月刊レジデント．医学出版，6(11): 6-10, 2013.
- 中村祐太郎，千田金吾：第Ⅷ章 3．上葉優位型肺線維症．特発性間質性肺炎の治療と管理．杉山幸比古（編）．克誠堂出版，2013，212-6.
2012年
英文掲載
- Akamatsu T, Shirai T, Kato M, Hashimoto D, Yasui H, Inui N, Suda T, Yokomura K, Hayakawa H, Ide K, Toyoshima M, Kuroishi S, Yasuda K, Suganuma H, Yamada T, Masuda M, Chida K：Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma．Allergol Int 61(2)：323-329,2012
- Enomoto N, Hyde E, Ma JZ, Yang J, Forbes-Blom E, Delahunt B, Le Gros G, Ronchese F：Allergen-specific CTL require perforin expression to suppress allergic airway inflammation．J Immunol 188(4)：1734-1741,2012
- Furuhashi K, Shirai T, Suda T, Chida K：Inflammatory Markers in Active pulmonary Tuberculosis: Association with Th1/Th2 and Tc1/Tc2 Balance．Kekkaku 87(1)：1-7,2012
- Hozumi H, Fujisawa T, Kuroishi S, Inui N, Nakamura Y, Suda T, Chida K：Ulcerating Bronchitis Caused by Cytomegalovirus in a Patient with Polymyositis．Intern Med51：2933-2936，2012
- Inui N, Hasegawa H, Suda T, Chida Nakamura Y, Watanabe H, Chida K, ：Expression and Function of Multidrug Resistance Protein 1 and Multidrug Resistance Associated Protein 1 in Lung Dendritic Cells From Aging Mice．J Gerontol A Biol Sci Med Sci 67(10)：1049-55,2012
- Inui N, Kato T, Uchida S, Chida K, Takeuchi K, Kimura T, Watanabe H：Novel patch for transdermal administration of morphine patch for transdermal administration of morphine．J Pain Symptom Manage 44(4)：479-85,2012
- Karayama M, Inui N, Suda T, Nakamura Y, Enomoto N, Chida K：Pulmonary dendritic cell accumulation in usual interstitial pneumonia and nonspecific interstitial pneumonia．Sarcoidosis Vasc Diffuse Lung Dis 29：69-73,2012
- Kono M, Nakamura Y, Suda T, Uchijima M, Tsujimura K, Nagata T, Giermasz A, Kalinski P, Nakamura H, Chida K：Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine．Vaccine 30：2633-2639,2012
- Kusagaya H, Inui N, Karayama M, Nakamura Y, Kuroishi S, Yokomura K, Toyoshima, M, Shirai T, Masuda M, Yamada T, Yasuda K, Suda T, Chida K：Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study．Lung Cancer 77(3)：550-5,2012
- Kusagaya H, Nakamura Y, Kono M, Kaida Y, Kuroishi S, Enomoto N, Fujisawa T, Koshimizu N, Yokomura K, Inui N, Suda T, Colby TV, Chida K：Idiopathic Pleuroparenchymal Fibroelastosis: Consideration of a Clinicopathological Entity in a Series of Japanese Patients. BMC Pulm Med 12(1): 72, 2012
- Miwa S, Suzuki Y, Shirai M, Ohba H, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K：Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing．Int J Tuberc Lung Dis 16(9)：1265-9,2012
- Nakamura Y, Suda T, Kaida Y, Kono M, Hozumi H, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Imokawa S, Yasuda K, Shirai T, Suganuma H, Morita S, Hayakawa H, Takehara Y, Thomas V.Colby, Chida K：Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases．Respir Med 106：1164-1169,2012
- Ohba H, Miwa S, Shirai M, Kanai M, Eifuku T, Suda T, Hayakawa H, Chida K：Clinical characteristics and prognosis of chronic pulmonary aspergillosis．Respir Med 106(5)：724-729,2012
- Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Mori K, Suda T, Chida K.：Impaired cough-related quality of life in patients with controlled asthma with gastroesophageal reflux disease．Ann Allergy Asthma Immunol 108(5)：379,2012
- Shirai T, Yasueda H, Saito A, Taniguchi M, Akiyama K, Tsuchiya T, Suda T, Chida K：Effect of Exposure and Sensitization to Indoor Allergens on asthma Control Level．Allergol Int 61(1)：51-56,2012
- Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, Fujie M, Furuhashi K, Nakamura Y, Inui N, Shirai T, HatakawaH, Nakamura H, Chida K：Serum Indoleamine 2,3-Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis．Clin Vaccine Immunol 19(3)：436-442,2012
- Suzuki Y, Suda T, Furuhashi K, Shibata K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Chida K.：Mouse CD11bhigh lung dendritic cells have more potent capability to induce IgA than CD103+ lung dendritic cells in vitro．Am J Respir Cell Mol Biol 46(6)：773-80,2012
- Toyoshima M, Chida K, Suda T, Sato M：Methotrexate might increase mortality from interstitial lung disease in rheumatoid arthritis．Am J Respir Crit Care Med185(9)：1024, 2012
- Toyoshima M, Chida K, Suda T, Sugimura H, Sato M：Endobronchial metastasis from gastrinoma of the pancreas．Am J Respir Crit Care Med185(5)：590-591, 2012
- Toyoshima M, Suda T, Chida K：Asymptomatic congenital lobar emphysema in a young adult．Intern Med51(19)：2839-40, 2012
- Toyoshima M, Suda T, Chida K：Tracheobronchial Involvement in Chronic Eosinophilic Pneumonia. Am J Respir Crit Care Med 186(10): 1057, 2012.
- Yasui H, Fujisawa T, Inui N, Kato M, Hashimoto D, Enomoto N, Nakamura Y, Shirai T, Suda T, Nakamura H, Chida K：Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation．Respir Med 106(4)：508-514,2012
和文掲載
- 田口善夫、橋本成修、杉山幸比古、石井芳樹、海老名雅仁、岸一馬、谷口博之、千田金吾、本間栄：急性増悪治療に関する一次アンケート調査．厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成23年度研究報告書：67-69，2012
- 千田金吾、須田隆文：膠原病肺部会報告．厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成23年度研究報告書：75-77，2012
- 千田金吾、中村祐太郎、草ヶ谷英樹、河野雅人、榎本紀之、藤澤朋幸、乾直輝、須田隆文：Idiopathic pleuroparenchymal fibroelastosis症例の検討．厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患に関する調査研究 平成23年度研究報告書：111-115，2012
- 須田隆文：非特異性間質性肺炎．間質性肺炎を究めるマジカルビュー社，2012
- 須田隆文：呼吸器疾患．MTX使いこなし自由自在 -関節リウマチ-南江堂，2012
- 須田隆文：第3章 診断 気管支肺胞洗浄液検査所見．最新医学 別冊 新しい診断と治療のABC3 サルコイドーシス 改訂第2版最新医学社，2012
- 千田金吾：急性間質性肺炎．今日の治療指針，2012
- 藤澤朋幸, 千田金吾：第2章 病理・病態生理 病態生理．最新医学 別冊 新しい診断と治療のABC3 サルコイドーシス 改訂第2版最新医学社，2012
- 妹川史朗，安田和雅，佐藤潤，匂坂伸也，右藤 智啓：浸水性肺水腫(Immersion Pulmonary Edema:IPE)の提唱 事例からみたスクーバダイビングにおける浸水性肺水腫．日本臨床高気圧酸素・潜水医学会雑誌9(1)：43-46．2012．
- 白井敏博，小川喜子，美甘真史，宍戸雄一郎，秋田剛史，森田悟，朝田和博，藤井雅人，森 和貴，須田隆文，千田 金吾：成人喘息における呼吸インピーダンスの3Dカラー画像解析 ―気道炎症マーカー, 末梢気道病変との関連―．呼吸31(5)：482．2012．
- 河野雅人、千田金吾：第９章：呼吸器系疾患の医療ニーズ 第１節 特発性間質性肺炎．希少疾患/難病の診断・治療と製品開発：1063-1069．2012．
- 千田金吾：アレルギー性の副作用に対する薬剤リンパ球幼若化試験の精度と注意点．日本医事新報4591：52-53．2012．
- 千田金吾：呼吸器感染症治療におけるマクロライドの展望．Prog. Med. 別冊 32：1909-1914．2012．
- 豊嶋幹生，千田金吾：【非腫瘍性気道病変のすべて】 Ⅳ．閉塞性細気管支炎ならびに全身性疾患に伴う気道病変、その他 3．全身性疾患に伴う気道病変 2)炎症性腸疾患．日本胸部臨床71(増刊号)：S253-S257．2012．
- 豊嶋幹生, 千田金吾：3.全身性疾患に伴う気道病変 2) 炎症性腸疾患．日本胸部臨床71(増刊号)：253-257，2012
- 秋田剛史, 白井敏博, 宍戸雄一郎, 江藤尚, 須田隆文, 千田金吾：急性増悪により致死的な経過をたどった慢性夏型過敏性肺炎の一例．アレルギーの臨床32(12)：1133-1136，2012
- 小川喜子，藤井雅人，美甘真史，宍戸雄一郎，秋田剛史，森田悟，朝田和博，白井敏博，江藤 尚，原田 清：敗血症性肺塞栓症を呈したLemierre症候群の1例．日本内科学会雑誌101(6)：1663-1665，2012
- 古橋一樹，藤澤朋幸，早川啓史，横村光司，豊嶋幹生，安田和雅，菅沼秀基，白井 敏博，山田孝，増田昌文，千田金吾：外来市中肺炎治療における炎症性マーカーについて．日本呼吸器学会雑誌1(4)：294-303，2012
- 山田孝，川合智子，近藤あかり，丹羽充，宮崎洋生，松田宏幸，佐野武尚，平田 健雄，須田隆文，千田 金吾：関節リウマチ(RA)に対する抗IL-6受容体抗体(MRA)治療により非結核性抗酸菌症(NTM)が増悪した1例．日本胸部臨床71(6)：587-592，2012
2011年
英文掲載
- Fujisawa T, Chang MM, Velichko S, Thai P, Hung LY, Huang F, Phuong N, Chen Y, Wu R：NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol 45(2): 246, 2011.
- Furuhashi K, Suda T, Hasegawa H, Suzuki Y, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shibata K, Nakamura H, Chida K：Mouse Lung CD103+ and CD11bhigh dendritic cells preferentiaally induce distinct CD4+ T cell responses. Am J Respir Cell Mol Biol 46(2): 165-172, 2011.
- Hasegawa H, Inui N, Suda T,Shibata K, Nakamura Y, Watanabe H, Nakamura H, Chida K ：Expressions of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendric cells. Life Sci 89(7-8): 282-287, 2011.
- Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Karayama M,Hayakawa H, Yokomura K, Imokawa S, Yasuda K, Toyoshima M, Suganuma H, Shirai T, Inui N, Suda T, Nakamura H, Chida K：Nonspecific Interstitial Pneumonia: Prognostic Significance of High-Resolution Computed Tomography in 59 Patients . J Comput Assist Tomogr 35(5): 583-589, 2011.
- Kato M, Nakamura Y, Suda T, Ozawa Y, Inui N, Seo N, Nagata T, Koide Y, Kalinski P, Nakamura H, Chida K：Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells. Cancer Immunol Immunother 60: 1029-1038, 2011.
- Kono M, Nakamura Y, Suda T, Kato M, Kaida Y, Hashimoto D, Inui N, Hamada E, Miyazaki O, Kurashita S, Fukamachi I, Endo K, Poh-Sing Ng, Takehara K, Nakamura H, Maekawa M, Chida K：Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis. Clinica Chimica Acta 412: 2211-2215, 2011.
- Kono M, Suda T, Enomoto N, Nakamura Y, Kaida Y, Hashimoto D, Inui N, Mizuguchi T, Kato A, Shirai T, Nakamura H, Chida K：Evaluation of different perfusion durations in direct hemoperfusion with polymyxin B-immobilized fiber column therapy for acute exacerbation of interstitial pneumonias. Blood Purif 32(2): 75-81, 2011.
- Lee YC, Oslund KL, Thai P, Velichko S, Fujisawa T, Duong T, Denison MS, Wu R：2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced MUC5AC expression: aryl hydrocarbon receptor-independent/EGFR/ERK/p38-dependent SP1-based transcription. Am J Respir Cell Mol Biol 45(2): 270-276, 2011.
- Matsuura S, Inui N, Ozawa Y, Nakamura Y, Toyoshima M, Yasuda K, Yamada T, Shirai T, Suganuma H, Yokomura K, Suda T, Chida K：Phase Ⅱstudy of erlotinib as third-line monotherapy in patients with advanced non-small-cell lung cancer without epidermal growth factor receptor mutations. Jpn J Clin Oncol 41(8): 959-963, 2011.
- Miwa S, Imokawa S, Kato M, Ide K, Uchiyama H, Yokomura K, Suda T, Shirai M, Hayakawa H, Chida K：Prognosis in adult patients with idiopathic pulmonary hemosiderosis. Intern Med 50(17): 1803-1808, 2011.
- Miwa S, Shirai M, Kobayashi S, Kaida Y, Suda T, Hayakawa H, Chida K：Chronic pulmonary thromboembolism pathologically showing homogeneous cellular alveolitis. Intern Med 50(19): 2195-2200, 2011.
- Mori K, Shirai T, Mikamo M, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T, Chida K：Colored 3-Dimensional Analyses of Respiratory Resistance and Reactance in COPD and Asthma. COPD 8(6): 456-463, 2011.
- Suzuki Y, Suda T, Yokomura K, Suzuki M, Fujie M, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakano Y, Nakamura H, Chida K：Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia. J Infect 63(3): 215-222, 2011.
- Toyoshima M, Chida K, Suda T, Sato M：Bronchiolitis caused by pandemic influenza A (H1N1) 2009. Intern Med 50(2): 167-168, 2011.
- Toyoshima M, Chida K, Suda T, Sato M：Is autoimmunity really related to the pathogenesis of COPD. Am J Respir Crit Care Med 184(10): 1212-1213, 2011.
- Toyoshima M, Chida K, Suda T, Sato M：Necrotizing bronchiolitis in influenza A of swine origin (H1N1). Am J Respir Crit Care Med 184(9): 1086, 2011.
- Toyoshima M, Chida K, Suda T, Sato M：Possible relationship between asbestos exposure and bronchial asthma: a need for clarification. Am J Respir Crit Care Med 183(11): 1571-1572, 2011.
- Ugajin M, Miwa S, Shirai M, Ohba H, Eifuku T, Nakamura H, Suda T, Hayakawa H, Chida K ：Usefulness of serum procalcitonin levels in pulmonary tuberculosis. Eur Respir J 37(2): 371-375, 2011.
- Uto T, Tsujimura K, Uchijima M, Seto S, Nagata T, Suda T, Chida K, Nakamura H, Koide Y：A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70. Immunol Med Microbiol 61(2): 189-196, 2011.
和文掲載
- 千田金吾、貝田勇介、河野雅人、榎本紀之、乾直輝、中村祐太郎、須田隆文：特発性間質性肺炎例におけるMPO-ANCA陽性症例の臨床的検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 175-181, 2011.
- 千田金吾、須田隆文：特発性NSIPにおける肺病変優位型の膠原病（Lung-dominant connective tissue disease）の臨床的検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 189-194, 2011.
- 千田金吾、乾直輝、須田隆文：サルコイドーシス部門の活動報告. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 331-335, 2011.
- 千田金吾：薬剤性肺障害におけるリンパ球幼弱化試験の意義と限界. 呼吸器内科 20(2): 158-162, 2011.
- 千田金吾：呼吸器疾患と全身の関わり 2）間質性肺炎と膠原病. 日本内科学会雑誌 100(９): 2502-2508, 2011.
- 千田金吾：サルコイドーシスにおける診断・病態・治療・予後因子の解明についての研究. 日本サルコイドーシス/肉芽腫性疾患学会雑誌 31(1): 3-10, 2011.
- 千田金吾：自己免疫疾患の周辺疾患と肺病変 1）UCTD. 呼吸器内科 20(5): 416-421, 2011.
- 千田金吾：過敏性肺炎．今日の治療指針 第6版．2011、303.
- 千田金吾、橋本大：挿管・人工呼吸器．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 南江堂、2011、23-28
- 須田隆文、千田金吾：呼吸器救急での検査と処置．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、46-53
- 乾直輝：気管支鏡検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、113-118
- 中村祐太郎：スパイロメトリー．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、119-122
- 千田金吾：動脈血液ガス分析．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、123-126
- 中村祐太郎：胸腔鏡検査、胸腔鏡下肺生検．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、127-130
- 乾直輝：胸水検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、131-134
- 藤澤朋幸：気道過敏性試験．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、135-137
- 藤澤朋幸：６分間歩行試験．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、138-140
- 橋本大：ポリソムノグラフィ．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、141-143
- 榎本紀之：肺動脈造影．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、144-145
- 乾直輝：バイオマーカー．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、146-148
- 千田金吾、橋本大：呼吸器系画像検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、149-156
- 藤澤朋幸：血液培養検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、353-355
- 須田隆文：染色検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、356-360
- 藤澤朋幸：遺伝子検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、361-364
- 乾直輝：血清学的診断検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、365-368
- 榎本紀之：ウイルス抗原検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、369-372
- 須田隆文：尿中抗原検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、373-375
- 榎本紀之：クォンティフェロン、ツベルクリン反応検査．必携 内科検査・手技マニュアル この一冊ですべてがわかる！ 林秀晴,千田金吾（編）．南江堂、2011、376-378
- 芦澤洋喜、藤田総文、伊波奈穂、土屋智義、吉富淳、増田昌文、須田隆文、千田金吾：化学放射線療法が奏功した肥大性骨関節症合併肺癌の１例．日本胸部臨床 70（7）：758-763、2011
- 池田政輝、白井敏博、美甘真史、森和貴、宍戸雄一郎、秋田剛史、森田悟、朝田和博、江藤尚、石橋洋則、広瀬正秀、太田伸一郎、鈴木誠、新井一守、室博之：13年の経過で発見された良性転移性肺平滑筋腫の一例．静岡県立総合病院医学雑誌．2011
- 乾直輝：サルコイドーシス．ガイドライン外来診療2011、2011、447-450.
- 乾直輝：呼吸器で頻用される薬剤．呼吸器研修ノート．荻原弘一（編）．診断と治療社、2011、42-46.
- 妹川史朗、西本幸司、鈴木清一郎、上原正裕、池田政輝、匂坂伸也、佐藤潤、内山啓、安田和雅、中村祐太郎、須田隆文、千田金吾：グラム陰性菌や真菌の関与が示唆された加湿器肺の１例. 日本サルコイドーシス/肉芽腫性疾患学会雑誌 31(1): 41-46, 2011.
- 岩嶋大介、川口史恵、佐竹康臣、伊藤靖弘、長岡深雪、小清水直樹、菅沼秀基、小林淳：サルコイドーシスによる気管支ポリープが自然退縮した１例. 気管支学 33(6): 481-485, 2011.
- 宇賀神基、三輪清一、須田隆文、白井正浩、早川啓史、千田金吾：黄色ブドウ球菌による肺炎と鑑別を要した肺限局型Wegener肉芽腫症の1例. 日本呼吸器学会雑誌 49(4): 309-314, 2011.
- 柄山正人、千田金吾：放射線療法時の問題点. 日本胸部臨床 70(8): 823-831, 2011.
- 白井敏博．呼吸機能検査 呼吸機能検査の基準値とその使い方、今後の課題 5) ピークフローおよびその日内変動．呼吸 30(11): 967-973, 2011.
- 土屋智義、藤田総文、芦澤洋喜、伊波奈穂、吉富淳、増田昌文、須田隆文、千田金吾：日本呼吸器学会「成人市中肺炎診療ガイドライン」における A-DROPシステムとアウトカムとの整合性は十分ではない. 日本呼吸器学会雑誌 49(7): 488-495, 2011.
- 中村祐太郎、千田金吾：びまん性肺疾患の急性期の治療. 総合臨床 60(12): 2434-2440, 2011.
- 橋本大、佐藤潤、乾直輝、豊嶋幹生、須田隆文、千田金吾：低肺機能成人喘息患者におけるブデゾニド吸入用混濁液の治療効果に関する検討. アレルギー 免疫 18(6): 114-118, 2011
- 長谷川浩嗣、千田金吾：膠原病肺の性差. 日本胸部臨床 70(11): 1135-1145, 2011.
- 藤澤朋幸、榎本紀之、千田金吾：膠原病に合併する間質性肺炎. 最新医学 66(6): 1188-1195, 2011.
- 松島紗代実、横村光司、松井隆、須田隆文、千田金吾：肺尖部のわずかなすりガラス影のみを呈した肺胞蛋白症の１例. 日本呼吸器学会雑誌 49(7): 553-557, 2011
- 安井秀樹、赤松泰介、中村裕太郎、乾直輝、須田隆文、千田金吾、目黒史織、馬場聡：早期胃癌によるpulmonary tumor thrombotic microangiopathy(PTTM)の１例. 日本呼吸器学会雑誌 49(2): 122-127, 2011.
2010年
英文掲載
- Furuhashi K, Suda T, Nakamura Y, Inui N, Hashimoto D, Miwa S, Hayakawa H, Kusagaya H, Nakano Y, Nakamura H, Chida K.：Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis.. Respir Med 104 : 1204-1210,2010.
- Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H, Chida K：Antiendothelial Cell Antibodies in Patient With COPD. chest 138(6) : 1303-8,2010.
- Kato A, Suzuki Y, Suda T, Suzuki M, Fujie M, Takita T, Furuhashi M, Maruyama Y, Chida K, Hishida A：Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Hemodialysis International 14(4) : 418-424,2010.
- Matsuda H, Takeda K, Koya T, Okamoto M, Shiraishi Y, Miyahara N, Dakhama A, Matsuda JL, Gapin L, Gelfand EW.：Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gammma production.. J Immunol. 185(1) : 253-62,2010.
- Misaka S, Uchida S, Imai H, Inui N, Nishio S, Ohashi K, Watanabe H, Yamada S.：Pharmacokinetics and pharmacodynamics of midazolam administered intravenously and orally at low doses to healthy volunteers.. Clin Exp Pharmacol Physiol 37(3) : 290-295,2010.
- Suzuki Y, Suda T, Furuhashi K, Suzuki M, Hashimoto D, Nakamura Y, Inui N, Nakamura H, Chida K.：Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. . Respir Med 67(3) : 361-5,2010.
- Suda T, Kono M, Nakamura Y, Enomoto N, Kaida Y, Fujisawa T, Imokawa S, Yasuda K, Hashizume H, Yokomura K, Toyoshima M, Koshimizu N, Suganuma H, Shirai T, Hashimoto D, Inui N, Colby TV, Chida K.：Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD).. Respir Med 104(10) : 1527-34,2010.
- Shirai T, Ikeda M, Morita S, Asada K, Suda T, Chida.：Elevated alveolar nitric oxide concentration after environmental challenge in hypersensitivity pneumonitis.. Respirology 15(4) : 721-2,2010.
- Shirai T, Suda T, Inui N, Chida K.：Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD.. Allergology International 59(1) : 75-82,2010.
- Takeda K, Shiraishi Y, Matsubara S, Miyahara N, Matsuda H, Okamoto M, Joetham A, Gelfand EW.：Effect of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation.. Br J Pharmacol 160(6) : 1399-407,2010.
- Toyoshima M, Chida K, Kono M, Kaida Y, Nakamura Y, Suda T and Sugimura H：IgG4-related Lung Disease in a Worker Occupationally Exposed to Asbestos. Internal Medicine 49 : 1175-1178,2010.
- Toyoshima M, Chida K, Suda T.：Fulminant community-acquired pneumonia probably caused by Acinetobacter lwoffii.. Respirology 15(5) : 867-8,2010.
和文掲載
- 千田金吾、吾妻安良太、海老名雅仁、横山彰仁：特発性器質化肺炎、分類の意義とその後の展開. 呼吸 29(1) : 9-21,2010.
- 千田金吾：膠原病の呼吸器病変．呼吸器疾患 最新の治療2010-2012．南江堂、2010、389-393.
- 千田金吾：びまん性汎細気管支炎．今日の治療指針 第6版．2010、952.
- 千田金吾：記者クラブと免疫学的監視機構. 呼吸と循環 58(6) : 553,2010.
- 千田金吾：びまん性肺疾患とは. 成人病と生活習慣病 40(6) : 614-619,2010.
- 千田金吾、須田隆文：IIPsのうちUCTD所見に合致しない「nonUCTD-NSIP」と合致する「UCTD-NSIP」の臨床的背景の相違についての全国集計. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 45-46,2010.
- 千田金吾、須田隆文、乾直輝：サルコイドーシス部門報告. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 52-53,2010.
- 千田金吾、河野雅人、須田隆文、貝田勇介。中村祐太郎、乾直輝：特発性NSIPにおけるUCTD診断の臨床的意義に関する検討. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 157-163,2010.
- 千田金吾：肺好酸球性肉芽腫症．家庭医学大全科六訂版．法研、2010、1074.
- 千田金吾：肺リンパ脈管筋腫症．家庭医学大全科六訂版．法研、2010、1074-1075.
- 千田金吾：グッドパスチャー症候群．家庭医学大全科六訂版．法研、2010、1075-1076.
- 千田金吾：特発性肺血鉄症．家庭医学大全科六訂版．法研、2010、1076.
- 千田金吾：肺アミロイドーシス．家庭医学大全科六訂版．法研、2010、1076.
- 千田金吾：肺胞微石症．家庭医学大全科六訂版．法研、2010、1077.
- 千田金吾：無気肺．家庭医学大全科六訂版．法研、2010、1077-1078.
- 千田金吾：中葉症候群．家庭医学大全科六訂版．法研、2010、1078.
- 千田金吾：急性呼吸窮迫症候群．家庭医学大全科六訂版．法研、2010、1078-1079.
- 千田金吾：過換気症候群．家庭医学大全科六訂版．法研、2010、1079-1080.
- 千田金吾：睡眠時無呼吸症．家庭医学大全科六訂版．法研、2010、1080-1081.
- 千田金吾：２ 非特異性間質性肺炎（NSIP）．間質性肺疾患診療マニュアル．久保惠嗣 藤田次郎（編）．南江堂、2010、189-193.
- 千田金吾：肺胞蛋白症．家庭医学大全科六訂版．法研、2010、1073-1074.
- 千田金吾：肺分画症．家庭医学大全科六訂版．法研、2010、1082-1083.
- 千田金吾：気管支嚢胞．家庭医学大全科六訂版．法研、2010、1082-1083.
- 千田金吾：肺動静脈瘻．家庭医学大全科六訂版．法研、2010、1082-1083.
- 千田金吾：草野ら”気管支喘息様症状にて発症した気管内悪性リンパ腫の１例”. 気管支学 32(5) : 393,2010.
- 須田隆文：閉塞性細気管支炎の研究のあゆみと現状. 医学のあゆみ 232(4) : 247-251,2010.
- 須田隆文：間質性肺炎治療法の新展開-免疫抑制剤-. 呼吸と循環 58(4) : 375-381,2010.
- 榎本紀之 千田金吾：臨床的新展開３. 治療学 ４４(5) : 563-566,2010.
- 河野雅人、須田隆文、貝田勇介、乾直輝、中村祐太郎、千田金吾：筋炎症状を伴わなかった抗Signal recognition particle(SRP)抗体陽性間質性肺炎の1例. 日本呼吸器学会雑誌 48(1) : 92-97,2010.
- 河野雅人、千田金吾：COPとOP像を呈する膠原病肺. 日本胸部臨床 69(1) : 45-52,2010.
- 安井秀樹、松井隆、横村光司、中野豊、須田隆文、千田金吾：みかん農家に発症した職業性過敏性肺炎の3例. 日本呼吸器学会雑誌 48(2) : 172-177,2010.
- 中野豊、千田金吾：呼吸器．ナースの内科学 改訂8版．奈良信雄（編）．中外医学社、2010、169-221.
- 白井敏博、美甘真史、森和貴、池田政輝、宍戸雄一郎、秋田剛史、森田悟、朝田和博、須田隆文、千田金吾：軽・中等症持続型喘息におけるサルメテロール/フルチカゾンプロピオン酸エステル配合剤(SFC)の有用性-単一デバイスによる相乗功果(第2報)-. アレルギー・免疫 17(4) : 648-652,2010.
- 匂坂伸也，上原正裕，原田雅教，佐藤潤，内山啓，妹川史朗，安田和雅，谷岡書彦，須田隆文，千田金吾：肺多形癌5剖検例の臨床病理学的検討. 肺癌 50(6) : 803-808,2010.
- 谷口博之、長谷川好規、千田金吾、田口修：ＵＰＬＩＦＴがＣＯＰＤ診療に与えたインパクト. Ｍedical Tribute : ,2010.
- 國方佐和、横村光司、松井隆、中野豊、須田隆文、千田金吾：胸部CT上多発性のすりガラス影を示した胃癌肺転移の1例. 日本呼吸器学会雑誌 48(4) : 298-302,2010.
- 本間栄、高橋弘毅、海老名雅仁、稲瀬直彦、吾妻安良太、福田悠、萩原弘一、酒井文和、千田金吾、井上義一、谷口博之、福岡順也、長谷川好規、田口善夫、上甲剛、板東政司、杉山幸比古：「特発性間質性肺炎診断と治療の手引き」第2版. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 41-43,2010.
- 杉崎勝教、山口哲生、千田金吾：サルコイドーシスにおける代替治療について. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 平成21年研究報告書 : 295-298,2010.
- 長谷川浩嗣、中村祐太郎、河野雅人、赤松泰介、貝田勇介、乾直輝、須田隆文、千田金吾：気管支喘息を合併し、IgG4の関与が考えられた細気管支炎の1例. 日本呼吸器学会雑誌 48(4) : 317-321,2010.
- 中曽根悦子、藤澤朋幸、間藤尚子、中屋孝清、山沢英明、坂東政司、山本真一、遠藤俊輔、杉山幸比古：肺野多発陰影、縦隔リンパ節腫大および左気管支内腔に腫瘤性病変を認めたIgG4関連肺疾患の１例. 気管支学 32(6) : 498-503,2010.
- 加藤明彦，鈴木勇三，須田隆文，千田金吾，田北貴子，古橋三義，丸山行孝，菱田明：血液透析患者において，血清キヌレリン/トリプトファン比は動脈硬化性病変と関連する．腎とフリーラジカル第10集．東京医学社、2010、164-168.
- 土屋智義，藤井雅人，塚本克紀，佐藤雅樹，八木健，須田隆文，千田金吾：病理組織診断が特発性肺線維症の予後におよぼす影響. 日本呼吸器学会雑誌 48(7) : 469-474,2010.
- 藤澤朋幸，千田金吾：Ⅸ．ＩＰＦと鑑別すべき疾患 ６）膠原病肺．特発性肺線維症（IPF)．医薬ジャーナル社、2010、251-261.
- 井上裕介、小林淳、橘充弘、斎藤正男、菅沼秀基、須田隆文、千田金吾：経気管支肺生検で診断したアスペルギルスとの重複感染が疑われた肺ムーコル症の切除例. 日本呼吸器学会雑誌 48(8) : 625-631,2010.
- 大場久乃、三輪清一、白井正浩、須田隆文、早川啓史、千田金吾：自然寛解の約14年後に胸膜炎にて再燃したサルコイドーシスの１例. 日本呼吸器学会雑誌 48(8) : 632-635,2010.
- 山田孝 丹羽充 佐竹康臣 菅沼史恵 松田宏幸 佐野武尚 井田雅章 平田健雄 須田隆文 千田金吾：両側好酸球性胸水を伴って発症したRS3PE症候群の１例. 日本胸部臨床 69(8) : 764-768,2010.
- 松浦駿，黒石重城，橋本大，中村祐太郎，乾直輝，須田隆文，千田金吾：急性増悪を来したサルコイドーシスの1例. 日本サルコイドーシス/肉芽腫性疾患学会雑誌 30(1) : 43-49,2010.
- 芦澤洋喜、藤田総文、伊波奈穂、土屋智義、吉富淳、増田昌文、影山善彦、塚本浩、須田隆文、千田金吾：溶接工肺に合併した両肺尖アスペルギローマの１例. 日本呼吸器学会雑誌 48(11) : 860-865,2010.
2009年
英文掲載
- Fujisawa T, S Velichko, P Thai, LY Hung, F Huang, and R Wu：Regilation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm. the Journal of Immunology 183 : ,2009.
- Fujisawa T, Suda T, Matsuda H, Inui N, Nakamura Y, Sato J, Toyoshima M, Nakano Y, Yasuda K, Gemma H, Hayakawa H, Chida K,：Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection . Respirology 14 : 203-209,2009.
- Kuroishi S, Suda T, Fujisawa T, Ide K, Inui N, Nakamura Y, Nakamura H, Chida K.：Epithelial-mesenchymal transition induced by transforming growth factor-beta1 in mouse tracheal epithelial cells.. Respirology 14(6) : 698-703,2009.
- Ozawa Y, Inui N, Naito T, Yasuda K, Nagayama M, Shirai T, Suganuma H, Fujii M, Nakamura H, Suda T, Chida K：Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer . lung cancer 63 : 68-71,2009.
- Ozawa Y, Suda T, Nagata T, Hashimoto D, Nakamura Y, Enomoto N, Inui N, Koide Y, Nakamura H, Chida K.：Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.. Am J Respir Cell Mol Biol 41(4) : 440-448,2009.
- Ozawa Y, Suda T, Naito T, Enomoto N, Hashimoto D, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Chida K.：Cumulative incidence of and predictive factors for lung cancer in IPF.. Respirology 14(5) : 723-728,2009.
- Shirai T, Komiyama A, Hayakawa H, Hashimoto D, Suda T, Chida K.：Eosinophil-associated gastrointestinal disorders with asthma: immunohistochemical analyses.. Internal Medicine 48(15) : 1315-1321,2009.
- Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, Hashizume H, Naito T, Hashimoto D, Takehara Y, Inui N, Nakamura H, Colby TV, Chida K.：Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.. Respir Med 103 : 846-53,2009.
- Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K ：Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis. Lung 187 : 201-206,2009.
- Suzuki Y, Suda T, Furuhashi K, Suzuki M, Fujie M, Hahimoto D, Nakamura Y, Inui N, Nakamura H, Chida K.：Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.. Lung Cancer : ,2009.
- Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, Suda T, Nakamura H, Chida K.：Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification.. Radiology 252(1) : 247-254,2009.
和文掲載
- 千田金吾：肺胞蛋白症．今日の治療指針．医学書院、2009、232-233.
- 千田金吾：アレルギー性肺疾患 金属喘息 . 別冊日本臨床 : 68-71,2009.
- 千田金吾：間質性肺炎と合併症 はじめに. 医学のあゆみ 229(8) : 577,2009.
- 千田金吾：強皮症に伴う肺疾患. アレルギー・免疫 16(9) : 1368-1377,2009.
- 須田隆文：各種疾患にみられる呼吸器病変 強直性脊椎炎. 別冊日本臨床 : 598-602,2009.
- 須田隆文：呼吸器ケアのための画像診断. 呼吸器ケア 7(2) : 31-33,2009.
- 乾直輝、千田金吾：特集 特発性肺線維症 8. 鑑別すべき疾患～CHP, NSIP, CVD-IP～. 医薬ジャーナル 45(7) : 137-141,2009.
- 乾直輝：サルコイドーシスー成因とインターフェロン療法との関連を中心に. 呼吸と循環 57(5) : 519-524,2009.
- 乾直輝、榎本紀之、千田金吾：膠原病性間質性肺炎．気管支肺胞洗浄法の手引き．克誠堂出版、2009、76-78.
- 中野豊：アスピリン喘息と冠動脈れん縮性狭心症. アレルギーの臨床 385 : 56-559,2009.
- 妹川史朗、千田金吾：院内肺炎-臨床でガイドラインを実践するポイント 2）中等症例. 感染と抗菌薬 12(1) : 59-63,2009.
- 菅沼秀基、小清水直樹、長谷川浩嗣、千田金吾：アスベスト関連疾患 石綿肺. 日本胸部臨床 68(10) : S120-125,2009.
- 鈴木研一郎、白井敏博、千田金吾：アレルギー性肺疾患 薬剤性好酸球増多症. 別冊日本臨床 : 181-184,2009.
- 中村祐太郎、千田金吾：ピレスパ(ピルフェニドン). 呼吸 28(9) : 908-911,2009.
- 三輪清一、早川啓史、佐藤篤彦：肉芽腫性肺疾患：サルコイドーシス、ランゲルハンス細胞組織球症．内科学書．中山書店、改訂第7版、371-376.
- 小澤雄一、乾直輝、千田金吾：間質性肺炎と合併症 間質性肺炎合併肺癌に対する化学療法. 医学のあゆみ 229(8) : 589-593,2009.
- 鈴木勇三、三輪清一、須田隆文、千田金吾：抗結核薬による副作用に対するDLST. アレルギーの臨床 29(4) : 355-358,2009.
- 松浦駿、菅沼秀基、井上裕介、伊藤靖弘、岩嶋大介、松井潔、斉藤好久、小清水直樹、小林淳、高嶋義光、須田隆文、千田金吾：肺癌に合併した肺アスペルギルス症の臨床的検討. 日本呼吸器学会雑誌 47(6) : 455-461,2009.
2008年
英文掲載
- Kaida Y, Inui N, Suda T, Nakamura H, Watanabe H, Chida K：The CYP2A6*4 allele is determinant of S-1 pharmacokinetics in Japanese patients with non-small-cell lung cancer. Clin Pharmacol Ther 83(4) : 589-94,2008.
- Naito T, Suda T, Suzuki K, Inui N, Sato J, Chida K, Nakamura H：Lung dendritic cells have a potent capability to induce production of immunoglobulin A. Am J Respir Cell Mol Biol 38 : 161-167,2008.
- Inui N, Suda T, Chida K：Use of the QuantiFERON-TB Gold test in Japanese patients with sarcoidosis. Respir Med 102(2) : 313-315,2008.
- Matsui T, Inui N, Suda T, Chida K：Anti-endothelial cell antibodies in patients with interstitial lung diseases. Respir Med 102(1) : 128-133,2008.
- Fujisawa T, Ide K, Holzman MJ, Suda T, Suzuki K, Kuroihsi S, Chida K, Nakamura H：Involvement of the p38 MARK pathway in IL-13-induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirology 13 : 191-202,2008.
- Uchiyama H, Nakamura Y, Gemma H, Toyoshima M, Yasuda K, Inui N, Suda T, Shirai M, Shirai T, Imokawa S, Ida M, Nakano Y, Sato J, Hayakawa H, Chida K：Alterrations in Smoking Habits Are Associated With Acute Eosinophilic Pneumonia. Chest 133(5) : 1174-1180,2008.
- Aoshi T, Nagata T, Suzuki M, Uchijima M, Hashimoto D, Rafiei A, Suda T, Chida K, Koide Y：Identification of an HLA-A0201-Restricted T-Cell Epitope on the MPT51 Protein ,a Major Secreted Protein Derived from Mycobacterium tuberculosis,by MPT51 Overlapping Peptide Screening . Infect Immun 76(4) : 1565-1571,2008.
- Inui N, Matsui T, Suda T, Chida K：Anti-Endothelial Cell Antibodies in Patients With Sarcoidosis. Chest 133(4) : 955-960,2008.
- Enomoto N, Suda T, Uto T, Kato M, Kaida Y, Ozawa Y, Miyazaki H, Kuroishi S, Hashimoto D, Naito T, Fujisawa T, Matsui T, Inui N, Nakamura Y, Sato J, Mizuguchi T, Kato A, Chida K：Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology 13(3) : 452-460,2008.
- Kuroishi S, Nakamura Y, Hayakawa H, Shirai M, Nakano Y, Yasuda K, Suda T, Nakamura H, Chida K：Mycobacterium avium complex disease:prognostic implication of high-resolution computed tomography findings. Eur Respi J 32(1) : 147-152,2008.
- Suzuki Y, Miwa S, Shirai M, Ohba H, Murakami M, Fujita K, Suda T, Nakamura H, Hayakawa H, Chida K.：Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs. Chest 134(5) : 1027-32,2008.
- Ozawa Y, Inui N, Naito T, Yasuda K, fujii M, Shirai T, Nagayama M, suganuma H, Suda T, Chida K：Phase II Study of combination chemotherapy with S-1 and Weekly Cisplatin in patients with previously untreated Advanced Non-Small Cell Lung Cancer. Lung Cancer : 2008.
- Kaida Y, Inui N, Suda T, Nakamura H, Watanabe H, Chida K：Response to"The Unanswered Question:What Is the Determinant of S-1 Pharmacokinetics?". Clin Phar Ther 84(2) : 204,2008.
- Yamada M, Azuma A, Tanaka H, Takizawa H, Chida K, Taguchi Y, Mikasa K, Kadota J, Kudoh H：Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in japan:A retrospective multicenter analysis . JAGS 56(7) : 1358-1360,2008.
- Hashimoto D, Nagata T, Uchijima M, Seto S, Suda T, Chida K, Miyoshi H, Nakamura H, Koide Y：Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+T-cell responses in the lung. Vaccine 26 : 5095-5100,2008.
- Miyazaki H, Suda T, Otsuka A, Nagata M, Ozono S, Hashimoto D, Nakamura Y, Inui N, Nakamura H, Chida K：Tiotropium does not affect lower urinary tract function in COPD patients with benign prostatic hyperplasia. Pulm Pharmacol Ther 21(6) : 879-83,2008.
- Hasegawa H, Inui N, Fujisawa T, Sato J, Nakamura H, Watanabe H, Suda T, Chida K ：Once-daily inhaled glucocorticosteroid administration in controlled asthma patients. Pulm Pharmacol Ther 21(4) : 2008.
- Enomoto N, Suda T, Uto T, Kato M, Kaida Y, Ozawa Y, Miyazaki H, Kuroishi S, Hashimoto D, Naito T, Fujisawa T, Matsui T, Inui N, Nakamura Y, Sato J, Mizuguchi T, Kato A, Chida K：Possible therapeutic effect of direct haemoperfusion with apolymyxin B immobilized fibre column(PMX-DHP) on pulmonary oxygenation in acute excerbations of interstitial pneumonia. Respirology 13(3) : 452-460,2008.
- Inui N, Enomoto N, Suda T, Kageyama Y, Watanabe H, Chida K：Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem 41(13) : 1074-1077,2008.
- Nakamura Y, Shirai M, Nakano Y, Fujita K, Suda T, Chida K ：Chronic necrotizing pulmonary aspergillosis successhully diagnosed,reated, and followed by ultrathin bronchoscope. Mycoses 51 : 86-88,2008.
- Miyahara N, Ohnishi H, Matsuda H, Miyahara S, Takeda K, Koya T, Matsubara S, Okamoto M, Dakhama A, Haribabu B, Gelfand EW.：Leukotriene B4 receptor 1 expression on dendritic cells is required for the development of Th2 responses and allergen-induced airway hyperresponsiveness. J Immunol 181(2) : 1170-8,2008.
- Okamoto M, Takeda K, Joetham A, Ohnishi H, Matsuda H, Swasey CH, Swanson BJ, Yasutomo K, Dakhama A, Gelfand EW.：Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation. J Exp Med 205(5) : 1087-97,2008.
- Watchmaker PB, Urban JA, Berk E, Nakamura Y, Mailliard RB, Watkins SC, van Ham SM, Kalinski P.：Memory CD8+ T cells protect dendritic cells from CTL killing.. J Immunol 180(6) : 3857-65,2008.
- Shirai T, Furuhashi K, Suda T, Chida K：Relationship of the asthma control test with pulmonary function and exhaled nitric oxide. Ann Allergy Asthm Immunol 101(6) : 608-13,2008.
和文掲載
- 千田金吾：特発性間質性肺炎の診断と治療におけるグレーゾーン. pharma medica 26(2) : 96-97,2008.
- 千田金吾：気管支随伴リンパ組織由来のリンパ腫（ＢＡＬＴoma）について. 呼吸 27(4) : 391-400,2008.
- 千田金吾：過敏性肺炎の診断：疑うコツから原因抗原の同定まで. 呼吸器科 13(5) : 390-398,2008.
- 千田金吾：顔面と四肢の浮腫. 呼吸器疾患診療マニュアル 137(特別) : 95-,2008.
- 千田金吾，貝田勇介，柄山正人，乾直輝，中村祐太郎，宮本康敬，内藤隆文，川上純一，須田隆文：シクロスポリン吸入の薬物動態. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 研究報告書 : 118-121,2008.
- 千田金吾，加藤真人，中村祐太郎，乾直輝，貝田勇介，須田隆文：間質性肺炎患者における呼気中一酸化窒素（ＮＯ）測定の臨床的意義. 厚生労働省研究 特発性間質性肺炎の予後改善を目指したサイクロスポリン+ステロイド療法ならびにＮアセチルシステイン吸入療法に関する臨床研究 : 139-143,2008.
- 須田隆文、千田金吾：閉塞性細気管支炎. 呼吸と循環 56(7) : 711-720,2008.
- 須田隆文、貝田勇介、黒石重城、千田金吾：閉塞性細気管支炎症候群をめぐって. 呼吸 27(3) : 275-282,2008
- 柄山正人，千田金吾：類縁疾患から学ぶ鑑別診断のポイント8．気管支拡張症．COPDのすべて．2008、309-313.
- 白井敏博, 池田政輝, 穂積宏尚, 朝田和博, 鈴木研一郎, 須田隆文, 千田金吾：重症持続型喘息におけるサルメテロール/フルチカゾンプロピオン酸エステル配合剤(SFC)の有用性 単一デバイスによる相乗作用. アレルギー・免疫 15(10) : 1424-1429,2008.
- 貝田勇介、千田金吾：特発性間質性肺炎におけるANCA. 呼吸器科 14(4) : 318-323,2008.
- 乾直輝、榎本紀之、千田金吾：膠原病性間質性肺炎. 厚生労働科学研究費補助金 難治性疾患克服研究事業 びまん性肺疾患調査研究班 : 76-78,2008.